id	sid	tid	token	lemma	pos
ajlm-2286	1	1	abstract	abstract	ADJ
ajlm-2286	1	2	introduction	introduction	NOUN
ajlm-2286	1	3	methods	method	NOUN
ajlm-2286	1	4	results	result	VERB
ajlm-2286	1	5	discussion	discussion	NOUN
ajlm-2286	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2286	1	7	references	reference	NOUN
ajlm-2286	1	8	about	about	ADP
ajlm-2286	1	9	the	the	DET
ajlm-2286	1	10	author(s	author(s	NOUN
ajlm-2286	1	11	)	)	PUNCT
ajlm-2286	1	12	promise	promise	VERB
ajlm-2286	1	13	c.	c.	PROPN
ajlm-2286	1	14	nwaejigh	nwaejigh	PROPN
ajlm-2286	1	15	department	department	PROPN
ajlm-2286	1	16	of	of	ADP
ajlm-2286	1	17	chemical	chemical	PROPN
ajlm-2286	1	18	pathology	pathology	NOUN
ajlm-2286	1	19	and	and	CCONJ
ajlm-2286	1	20	immunology	immunology	NOUN
ajlm-2286	1	21	,	,	PUNCT
ajlm-2286	1	22	faculty	faculty	NOUN
ajlm-2286	1	23	of	of	ADP
ajlm-2286	1	24	basic	basic	ADJ
ajlm-2286	1	25	medical	medical	ADJ
ajlm-2286	1	26	sciences	science	NOUN
ajlm-2286	1	27	,	,	PUNCT
ajlm-2286	1	28	olabisi	olabisi	ADJ
ajlm-2286	1	29	onabanjo	onabanjo	PROPN
ajlm-2286	1	30	university	university	PROPN
ajlm-2286	1	31	,	,	PUNCT
ajlm-2286	1	32	sagamu	sagamu	PROPN
ajlm-2286	1	33	,	,	PUNCT
ajlm-2286	1	34	nigeria	nigeria	PROPN
ajlm-2286	1	35	maria	maria	PROPN
ajlm-2286	1	36	o.	o.	PROPN
ajlm-2286	2	1	ebesunun	ebesunun	PROPN
ajlm-2286	2	2	department	department	PROPN
ajlm-2286	2	3	of	of	ADP
ajlm-2286	2	4	chemical	chemical	PROPN
ajlm-2286	2	5	pathology	pathology	NOUN
ajlm-2286	2	6	and	and	CCONJ
ajlm-2286	2	7	immunology	immunology	NOUN
ajlm-2286	2	8	,	,	PUNCT
ajlm-2286	2	9	faculty	faculty	NOUN
ajlm-2286	2	10	of	of	ADP
ajlm-2286	2	11	basic	basic	ADJ
ajlm-2286	2	12	medical	medical	ADJ
ajlm-2286	2	13	sciences	science	NOUN
ajlm-2286	2	14	,	,	PUNCT
ajlm-2286	2	15	olabisi	olabisi	ADJ
ajlm-2286	2	16	onabanjo	onabanjo	PROPN
ajlm-2286	2	17	university	university	PROPN
ajlm-2286	2	18	,	,	PUNCT
ajlm-2286	2	19	sagamu	sagamu	PROPN
ajlm-2286	2	20	,	,	PUNCT
ajlm-2286	2	21	nigeria	nigeria	PROPN
ajlm-2286	2	22	oluwaseye	oluwaseye	PROPN
ajlm-2286	2	23	m.	m.	PROPN
ajlm-2286	2	24	oladimeji	oladimeji	VERB
ajlm-2286	2	25	department	department	PROPN
ajlm-2286	2	26	of	of	ADP
ajlm-2286	2	27	medicine	medicine	NOUN
ajlm-2286	2	28	,	,	PUNCT
ajlm-2286	2	29	lagos	lagos	NOUN
ajlm-2286	2	30	state	state	NOUN
ajlm-2286	2	31	university	university	PROPN
ajlm-2286	2	32	teaching	teaching	NOUN
ajlm-2286	2	33	hospital	hospital	NOUN
ajlm-2286	2	34	,	,	PUNCT
ajlm-2286	2	35	ikeja	ikeja	PROPN
ajlm-2286	2	36	,	,	PUNCT
ajlm-2286	2	37	nigeria	nigeria	PROPN
ajlm-2286	2	38	citation	citation	PROPN
ajlm-2286	2	39	nwaejigh	nwaejigh	PROPN
ajlm-2286	2	40	pc	pc	PROPN
ajlm-2286	2	41	,	,	PUNCT
ajlm-2286	2	42	ebesunun	ebesunun	PROPN
ajlm-2286	2	43	mo	mo	PROPN
ajlm-2286	2	44	,	,	PUNCT
ajlm-2286	2	45	oladimeji	oladimeji	VERB
ajlm-2286	2	46	om	om	PROPN
ajlm-2286	2	47	.	.	PUNCT
ajlm-2286	3	1	lecithin	lecithin	NOUN
ajlm-2286	3	2	-	-	PUNCT
ajlm-2286	3	3	cholesterol	cholesterol	NOUN
ajlm-2286	3	4	acyltransferase	acyltransferase	NOUN
ajlm-2286	3	5	and	and	CCONJ
ajlm-2286	3	6	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	3	7	levels	level	NOUN
ajlm-2286	3	8	in	in	ADP
ajlm-2286	3	9	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	3	10	cardiovascular	cardiovascular	ADJ
ajlm-2286	3	11	disease	disease	NOUN
ajlm-2286	3	12	patients	patient	NOUN
ajlm-2286	3	13	in	in	ADP
ajlm-2286	3	14	nigeria	nigeria	PROPN
ajlm-2286	3	15	.	.	PUNCT
ajlm-2286	4	1	afr	afr	PROPN
ajlm-2286	4	2	j	j	PROPN
ajlm-2286	4	3	lab	lab	PROPN
ajlm-2286	4	4	med	me	VERB
ajlm-2286	4	5	.	.	PUNCT
ajlm-2286	5	1	2024;13(1	2024;13(1	NUM
ajlm-2286	5	2	)	)	PUNCT
ajlm-2286	5	3	,	,	PUNCT
ajlm-2286	6	1	a2286	a2286	PROPN
ajlm-2286	6	2	.	.	PUNCT
ajlm-2286	6	3	https://doi.org/10.4102/ajlm.v13i1.2286	https://doi.org/10.4102/ajlm.v13i1.2286	PROPN
ajlm-2286	6	4	note	note	NOUN
ajlm-2286	6	5	:	:	PUNCT
ajlm-2286	6	6	additional	additional	ADJ
ajlm-2286	6	7	supporting	support	VERB
ajlm-2286	6	8	information	information	NOUN
ajlm-2286	6	9	may	may	AUX
ajlm-2286	6	10	be	be	AUX
ajlm-2286	6	11	found	find	VERB
ajlm-2286	6	12	in	in	ADP
ajlm-2286	6	13	the	the	DET
ajlm-2286	6	14	online	online	ADJ
ajlm-2286	6	15	version	version	NOUN
ajlm-2286	6	16	of	of	ADP
ajlm-2286	6	17	this	this	DET
ajlm-2286	6	18	article	article	NOUN
ajlm-2286	6	19	as	as	ADP
ajlm-2286	6	20	online	online	ADJ
ajlm-2286	6	21	supplementary	supplementary	ADJ
ajlm-2286	6	22	document	document	NOUN
ajlm-2286	6	23	1	1	NUM
ajlm-2286	6	24	.	.	PUNCT
ajlm-2286	6	25	original	original	ADJ
ajlm-2286	6	26	research	research	NOUN
ajlm-2286	6	27	lecithin	lecithin	NOUN
ajlm-2286	6	28	-	-	PUNCT
ajlm-2286	6	29	cholesterol	cholesterol	NOUN
ajlm-2286	6	30	acyltransferase	acyltransferase	NOUN
ajlm-2286	6	31	and	and	CCONJ
ajlm-2286	6	32	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	6	33	levels	level	NOUN
ajlm-2286	6	34	in	in	ADP
ajlm-2286	6	35	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	6	36	cardiovascular	cardiovascular	ADJ
ajlm-2286	6	37	disease	disease	NOUN
ajlm-2286	6	38	patients	patient	NOUN
ajlm-2286	6	39	in	in	ADP
ajlm-2286	6	40	nigeria	nigeria	PROPN
ajlm-2286	6	41	promise	promise	VERB
ajlm-2286	6	42	c.	c.	PROPN
ajlm-2286	6	43	nwaejigh	nwaejigh	PROPN
ajlm-2286	6	44	,	,	PUNCT
ajlm-2286	6	45	maria	maria	PROPN
ajlm-2286	6	46	o.	o.	PROPN
ajlm-2286	6	47	ebesunun	ebesunun	PROPN
ajlm-2286	6	48	,	,	PUNCT
ajlm-2286	6	49	oluwaseye	oluwaseye	NOUN
ajlm-2286	6	50	m.	m.	NOUN
ajlm-2286	6	51	oladimeji	oladimeji	NOUN
ajlm-2286	6	52	received	receive	VERB
ajlm-2286	6	53	:	:	PUNCT
ajlm-2286	6	54	08	08	NUM
ajlm-2286	6	55	aug	aug	PROPN
ajlm-2286	6	56	.	.	PROPN
ajlm-2286	6	57	2023	2023	NUM
ajlm-2286	6	58	;	;	PUNCT
ajlm-2286	6	59	accepted	accept	VERB
ajlm-2286	6	60	:	:	PUNCT
ajlm-2286	6	61	02	02	NUM
ajlm-2286	6	62	may	may	PROPN
ajlm-2286	6	63	2024	2024	NUM
ajlm-2286	6	64	;	;	PUNCT
ajlm-2286	6	65	published	publish	VERB
ajlm-2286	6	66	:	:	PUNCT
ajlm-2286	6	67	17	17	NUM
ajlm-2286	6	68	july	july	PROPN
ajlm-2286	6	69	2024	2024	NUM
ajlm-2286	6	70	copyright	copyright	NOUN
ajlm-2286	6	71	:	:	PUNCT
ajlm-2286	6	72	©	©	PROPN
ajlm-2286	6	73	2024	2024	NUM
ajlm-2286	6	74	.	.	PUNCT
ajlm-2286	7	1	the	the	DET
ajlm-2286	7	2	author(s	author(s	PROPN
ajlm-2286	7	3	)	)	PUNCT
ajlm-2286	7	4	.	.	PUNCT
ajlm-2286	8	1	licensee	licensee	NOUN
ajlm-2286	8	2	:	:	PUNCT
ajlm-2286	8	3	aosis	aosis	NOUN
ajlm-2286	8	4	.	.	PUNCT
ajlm-2286	9	1	this	this	PRON
ajlm-2286	9	2	is	be	AUX
ajlm-2286	9	3	an	an	DET
ajlm-2286	9	4	open	open	ADJ
ajlm-2286	9	5	access	access	NOUN
ajlm-2286	9	6	article	article	NOUN
ajlm-2286	9	7	distributed	distribute	VERB
ajlm-2286	9	8	under	under	ADP
ajlm-2286	9	9	the	the	DET
ajlm-2286	9	10	terms	term	NOUN
ajlm-2286	9	11	of	of	ADP
ajlm-2286	9	12	the	the	DET
ajlm-2286	9	13	creative	creative	ADJ
ajlm-2286	9	14	commons	common	NOUN
ajlm-2286	9	15	attribution	attribution	NOUN
ajlm-2286	9	16	license	license	NOUN
ajlm-2286	9	17	,	,	PUNCT
ajlm-2286	9	18	which	which	PRON
ajlm-2286	9	19	permits	permit	VERB
ajlm-2286	9	20	unrestricted	unrestricted	ADJ
ajlm-2286	9	21	use	use	NOUN
ajlm-2286	9	22	,	,	PUNCT
ajlm-2286	9	23	distribution	distribution	NOUN
ajlm-2286	9	24	,	,	PUNCT
ajlm-2286	9	25	and	and	CCONJ
ajlm-2286	9	26	reproduction	reproduction	NOUN
ajlm-2286	9	27	in	in	ADP
ajlm-2286	9	28	any	any	DET
ajlm-2286	9	29	medium	medium	NOUN
ajlm-2286	9	30	,	,	PUNCT
ajlm-2286	9	31	provided	provide	VERB
ajlm-2286	9	32	the	the	DET
ajlm-2286	9	33	original	original	ADJ
ajlm-2286	9	34	work	work	NOUN
ajlm-2286	9	35	is	be	AUX
ajlm-2286	9	36	properly	properly	ADV
ajlm-2286	9	37	cited	cite	VERB
ajlm-2286	9	38	.	.	PUNCT
ajlm-2286	10	1	abstract	abstract	ADJ
ajlm-2286	10	2	background	background	NOUN
ajlm-2286	10	3	:	:	PUNCT
ajlm-2286	10	4	recent	recent	ADJ
ajlm-2286	10	5	evidence	evidence	NOUN
ajlm-2286	10	6	has	have	AUX
ajlm-2286	10	7	linked	link	VERB
ajlm-2286	10	8	changes	change	NOUN
ajlm-2286	10	9	in	in	ADP
ajlm-2286	10	10	plasma	plasma	NOUN
ajlm-2286	10	11	lecithin	lecithin	NOUN
ajlm-2286	10	12	-	-	PUNCT
ajlm-2286	10	13	cholesterol	cholesterol	NOUN
ajlm-2286	10	14	acyltransferase	acyltransferase	NOUN
ajlm-2286	10	15	(	(	PUNCT
ajlm-2286	10	16	lcat	lcat	ADJ
ajlm-2286	10	17	)	)	PUNCT
ajlm-2286	10	18	and	and	CCONJ
ajlm-2286	10	19	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	10	20	(	(	PUNCT
ajlm-2286	10	21	pon-1	pon-1	NOUN
ajlm-2286	10	22	)	)	PUNCT
ajlm-2286	10	23	levels	level	NOUN
ajlm-2286	10	24	with	with	ADP
ajlm-2286	10	25	increased	increase	VERB
ajlm-2286	10	26	risk	risk	NOUN
ajlm-2286	10	27	for	for	ADP
ajlm-2286	10	28	development	development	NOUN
ajlm-2286	10	29	of	of	ADP
ajlm-2286	10	30	premature	premature	ADJ
ajlm-2286	10	31	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	10	32	cardiovascular	cardiovascular	ADJ
ajlm-2286	10	33	disease	disease	NOUN
ajlm-2286	10	34	(	(	PUNCT
ajlm-2286	10	35	ascvd	ascvd	NOUN
ajlm-2286	10	36	)	)	PUNCT
ajlm-2286	10	37	in	in	ADP
ajlm-2286	10	38	different	different	ADJ
ajlm-2286	10	39	populations	population	NOUN
ajlm-2286	10	40	.	.	PUNCT
ajlm-2286	11	1	however	however	ADV
ajlm-2286	11	2	,	,	PUNCT
ajlm-2286	11	3	studies	study	NOUN
ajlm-2286	11	4	on	on	ADP
ajlm-2286	11	5	this	this	PRON
ajlm-2286	11	6	in	in	ADP
ajlm-2286	11	7	nigeria	nigeria	PROPN
ajlm-2286	11	8	and	and	CCONJ
ajlm-2286	11	9	sub	sub	ADJ
ajlm-2286	11	10	-	-	ADJ
ajlm-2286	11	11	saharan	saharan	ADJ
ajlm-2286	11	12	africa	africa	PROPN
ajlm-2286	11	13	are	be	AUX
ajlm-2286	11	14	scarce	scarce	ADJ
ajlm-2286	11	15	.	.	PUNCT
ajlm-2286	12	1	objective	objective	NOUN
ajlm-2286	12	2	:	:	PUNCT
ajlm-2286	12	3	this	this	DET
ajlm-2286	12	4	study	study	NOUN
ajlm-2286	12	5	assessed	assess	VERB
ajlm-2286	12	6	the	the	DET
ajlm-2286	12	7	association	association	NOUN
ajlm-2286	12	8	between	between	ADP
ajlm-2286	12	9	reduced	reduce	VERB
ajlm-2286	12	10	plasma	plasma	NOUN
ajlm-2286	12	11	lcat	lcat	NOUN
ajlm-2286	12	12	and	and	CCONJ
ajlm-2286	12	13	pon-1	pon-1	PUNCT
ajlm-2286	12	14	levels	level	NOUN
ajlm-2286	12	15	and	and	CCONJ
ajlm-2286	12	16	an	an	DET
ajlm-2286	12	17	increased	increase	VERB
ajlm-2286	12	18	risk	risk	NOUN
ajlm-2286	12	19	of	of	ADP
ajlm-2286	12	20	ascvd	ascvd	NOUN
ajlm-2286	12	21	,	,	PUNCT
ajlm-2286	12	22	and	and	CCONJ
ajlm-2286	12	23	their	their	PRON
ajlm-2286	12	24	potential	potential	NOUN
ajlm-2286	12	25	as	as	ADP
ajlm-2286	12	26	biomarkers	biomarker	NOUN
ajlm-2286	12	27	for	for	ADP
ajlm-2286	12	28	ascvd	ascvd	NOUN
ajlm-2286	12	29	.	.	PUNCT
ajlm-2286	13	1	methods	method	NOUN
ajlm-2286	13	2	:	:	PUNCT
ajlm-2286	13	3	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	13	4	cardiovascular	cardiovascular	ADJ
ajlm-2286	13	5	disease	disease	NOUN
ajlm-2286	13	6	patients	patient	NOUN
ajlm-2286	13	7	and	and	CCONJ
ajlm-2286	13	8	healthy	healthy	ADJ
ajlm-2286	13	9	controls	control	NOUN
ajlm-2286	13	10	were	be	AUX
ajlm-2286	13	11	randomly	randomly	ADV
ajlm-2286	13	12	selected	select	VERB
ajlm-2286	13	13	for	for	ADP
ajlm-2286	13	14	this	this	DET
ajlm-2286	13	15	cross	cross	ADJ
ajlm-2286	13	16	-	-	ADJ
ajlm-2286	13	17	sectional	sectional	ADJ
ajlm-2286	13	18	case	case	NOUN
ajlm-2286	13	19	-	-	PUNCT
ajlm-2286	13	20	control	control	NOUN
ajlm-2286	13	21	study	study	NOUN
ajlm-2286	13	22	from	from	ADP
ajlm-2286	13	23	the	the	DET
ajlm-2286	13	24	lagos	lagos	PROPN
ajlm-2286	13	25	state	state	PROPN
ajlm-2286	13	26	university	university	PROPN
ajlm-2286	13	27	teaching	teaching	NOUN
ajlm-2286	13	28	hospital	hospital	NOUN
ajlm-2286	13	29	,	,	PUNCT
ajlm-2286	13	30	ikeja	ikeja	NOUN
ajlm-2286	13	31	,	,	PUNCT
ajlm-2286	13	32	lagos	lago	NOUN
ajlm-2286	13	33	,	,	PUNCT
ajlm-2286	13	34	nigeria	nigeria	PROPN
ajlm-2286	13	35	,	,	PUNCT
ajlm-2286	13	36	between	between	ADP
ajlm-2286	13	37	march	march	PROPN
ajlm-2286	13	38	2022	2022	NUM
ajlm-2286	13	39	and	and	CCONJ
ajlm-2286	13	40	march	march	PROPN
ajlm-2286	13	41	2023	2023	NUM
ajlm-2286	13	42	.	.	PUNCT
ajlm-2286	14	1	plasma	plasma	NOUN
ajlm-2286	14	2	lcat	lcat	NOUN
ajlm-2286	14	3	and	and	CCONJ
ajlm-2286	14	4	pon-1	pon-1	PRON
ajlm-2286	14	5	were	be	AUX
ajlm-2286	14	6	determined	determine	VERB
ajlm-2286	14	7	by	by	ADP
ajlm-2286	14	8	sandwich	sandwich	NOUN
ajlm-2286	14	9	enzyme	enzyme	NOUN
ajlm-2286	14	10	-	-	PUNCT
ajlm-2286	14	11	linked	link	VERB
ajlm-2286	14	12	immunosorbent	immunosorbent	NOUN
ajlm-2286	14	13	assay	assay	ADV
ajlm-2286	14	14	,	,	PUNCT
ajlm-2286	14	15	while	while	SCONJ
ajlm-2286	14	16	the	the	DET
ajlm-2286	14	17	lipid	lipid	NOUN
ajlm-2286	14	18	profile	profile	NOUN
ajlm-2286	14	19	was	be	AUX
ajlm-2286	14	20	measured	measure	VERB
ajlm-2286	14	21	by	by	ADP
ajlm-2286	14	22	spectrophotometry	spectrophotometry	NOUN
ajlm-2286	14	23	.	.	PUNCT
ajlm-2286	15	1	results	result	NOUN
ajlm-2286	15	2	:	:	PUNCT
ajlm-2286	15	3	a	a	DET
ajlm-2286	15	4	total	total	NOUN
ajlm-2286	15	5	of	of	ADP
ajlm-2286	15	6	153	153	NUM
ajlm-2286	15	7	ascvd	ascvd	NOUN
ajlm-2286	15	8	patients	patient	NOUN
ajlm-2286	15	9	(	(	PUNCT
ajlm-2286	15	10	mean	mean	INTJ
ajlm-2286	15	11	age	age	NOUN
ajlm-2286	15	12	:	:	PUNCT
ajlm-2286	15	13	52.92	52.92	NUM
ajlm-2286	15	14	±	±	NUM
ajlm-2286	15	15	10.24	10.24	NUM
ajlm-2286	15	16	years	year	NOUN
ajlm-2286	15	17	)	)	PUNCT
ajlm-2286	15	18	and	and	CCONJ
ajlm-2286	15	19	50	50	NUM
ajlm-2286	15	20	healthy	healthy	ADJ
ajlm-2286	15	21	controls	control	NOUN
ajlm-2286	15	22	(	(	PUNCT
ajlm-2286	15	23	mean	mean	INTJ
ajlm-2286	15	24	age	age	NOUN
ajlm-2286	15	25	:	:	PUNCT
ajlm-2286	15	26	46.96	46.96	NUM
ajlm-2286	15	27	±	±	NUM
ajlm-2286	15	28	11.05	11.05	NUM
ajlm-2286	15	29	years	year	NOUN
ajlm-2286	15	30	)	)	PUNCT
ajlm-2286	15	31	were	be	AUX
ajlm-2286	15	32	included	include	VERB
ajlm-2286	15	33	in	in	ADP
ajlm-2286	15	34	the	the	DET
ajlm-2286	15	35	analyses	analysis	NOUN
ajlm-2286	15	36	.	.	PUNCT
ajlm-2286	16	1	stastistically	stastistically	ADV
ajlm-2286	16	2	significant	significant	ADJ
ajlm-2286	16	3	increases	increase	NOUN
ajlm-2286	16	4	were	be	AUX
ajlm-2286	16	5	observed	observe	VERB
ajlm-2286	16	6	in	in	ADP
ajlm-2286	16	7	the	the	DET
ajlm-2286	16	8	mean	mean	ADJ
ajlm-2286	16	9	body	body	NOUN
ajlm-2286	16	10	weight	weight	NOUN
ajlm-2286	16	11	,	,	PUNCT
ajlm-2286	16	12	hip	hip	NOUN
ajlm-2286	16	13	circumference	circumference	NOUN
ajlm-2286	16	14	,	,	PUNCT
ajlm-2286	16	15	waist	waist	NOUN
ajlm-2286	16	16	circumference	circumference	NOUN
ajlm-2286	16	17	,	,	PUNCT
ajlm-2286	16	18	waist	waist	NOUN
ajlm-2286	16	19	-	-	PUNCT
ajlm-2286	16	20	to	to	ADP
ajlm-2286	16	21	-	-	PUNCT
ajlm-2286	16	22	hip	hip	NOUN
ajlm-2286	16	23	ratio	ratio	NOUN
ajlm-2286	16	24	,	,	PUNCT
ajlm-2286	16	25	body	body	NOUN
ajlm-2286	16	26	mass	mass	PROPN
ajlm-2286	16	27	index	index	NOUN
ajlm-2286	16	28	,	,	PUNCT
ajlm-2286	16	29	diastolic	diastolic	NOUN
ajlm-2286	16	30	and	and	CCONJ
ajlm-2286	16	31	systolic	systolic	ADJ
ajlm-2286	16	32	blood	blood	NOUN
ajlm-2286	16	33	pressure	pressure	NOUN
ajlm-2286	16	34	(	(	PUNCT
ajlm-2286	16	35	all	all	PRON
ajlm-2286	16	36	p	p	NOUN
ajlm-2286	16	37	≤	≤	NUM
ajlm-2286	16	38	0.001	0.001	NUM
ajlm-2286	16	39	)	)	PUNCT
ajlm-2286	16	40	,	,	PUNCT
ajlm-2286	16	41	and	and	CCONJ
ajlm-2286	16	42	pulse	pulse	NOUN
ajlm-2286	16	43	rate	rate	NOUN
ajlm-2286	16	44	(	(	PUNCT
ajlm-2286	16	45	p	p	X
ajlm-2286	16	46	=	=	NOUN
ajlm-2286	16	47	0.003	0.003	NUM
ajlm-2286	16	48	)	)	PUNCT
ajlm-2286	16	49	compared	compare	VERB
ajlm-2286	16	50	to	to	ADP
ajlm-2286	16	51	the	the	DET
ajlm-2286	16	52	control	control	NOUN
ajlm-2286	16	53	values	value	NOUN
ajlm-2286	16	54	.	.	PUNCT
ajlm-2286	17	1	statistically	statistically	ADV
ajlm-2286	17	2	significant	significant	ADJ
ajlm-2286	17	3	increases	increase	NOUN
ajlm-2286	17	4	were	be	AUX
ajlm-2286	17	5	also	also	ADV
ajlm-2286	17	6	observed	observe	VERB
ajlm-2286	17	7	in	in	ADP
ajlm-2286	17	8	the	the	DET
ajlm-2286	17	9	mean	mean	ADJ
ajlm-2286	17	10	plasma	plasma	NOUN
ajlm-2286	17	11	total	total	NOUN
ajlm-2286	17	12	cholesterol	cholesterol	NOUN
ajlm-2286	17	13	,	,	PUNCT
ajlm-2286	17	14	triglycerides	triglyceride	NOUN
ajlm-2286	17	15	,	,	PUNCT
ajlm-2286	17	16	low	low	ADJ
ajlm-2286	17	17	-	-	PUNCT
ajlm-2286	17	18	density	density	NOUN
ajlm-2286	17	19	lipoprotein	lipoprotein	ADJ
ajlm-2286	17	20	cholesterol	cholesterol	NOUN
ajlm-2286	17	21	,	,	PUNCT
ajlm-2286	17	22	and	and	CCONJ
ajlm-2286	17	23	non	non	ADJ
ajlm-2286	17	24	-	-	ADJ
ajlm-2286	17	25	high	high	ADJ
ajlm-2286	17	26	-	-	PUNCT
ajlm-2286	17	27	density	density	NOUN
ajlm-2286	17	28	lipoprotein	lipoprotein	ADJ
ajlm-2286	17	29	cholesterol	cholesterol	NOUN
ajlm-2286	17	30	(	(	PUNCT
ajlm-2286	17	31	all	all	PRON
ajlm-2286	18	1	p	p	NOUN
ajlm-2286	18	2	≤	≤	NUM
ajlm-2286	18	3	0.001	0.001	NUM
ajlm-2286	18	4	)	)	PUNCT
ajlm-2286	18	5	.	.	PUNCT
ajlm-2286	19	1	in	in	ADP
ajlm-2286	19	2	contrast	contrast	NOUN
ajlm-2286	19	3	,	,	PUNCT
ajlm-2286	19	4	the	the	DET
ajlm-2286	19	5	mean	mean	ADJ
ajlm-2286	19	6	plasma	plasma	NOUN
ajlm-2286	19	7	high	high	ADJ
ajlm-2286	19	8	-	-	PUNCT
ajlm-2286	19	9	density	density	NOUN
ajlm-2286	19	10	lipoprotein	lipoprotein	ADJ
ajlm-2286	19	11	cholesterol	cholesterol	NOUN
ajlm-2286	19	12	,	,	PUNCT
ajlm-2286	19	13	lcat	lcat	ADJ
ajlm-2286	19	14	,	,	PUNCT
ajlm-2286	19	15	and	and	CCONJ
ajlm-2286	19	16	pon-1	pon-1	X
ajlm-2286	19	17	(	(	PUNCT
ajlm-2286	19	18	p	p	NOUN
ajlm-2286	19	19	≤	≤	NUM
ajlm-2286	19	20	0.001	0.001	NUM
ajlm-2286	19	21	)	)	PUNCT
ajlm-2286	19	22	were	be	AUX
ajlm-2286	19	23	notably	notably	ADV
ajlm-2286	19	24	reduced	reduce	VERB
ajlm-2286	19	25	compared	compare	VERB
ajlm-2286	19	26	to	to	ADP
ajlm-2286	19	27	the	the	DET
ajlm-2286	19	28	control	control	NOUN
ajlm-2286	19	29	values	value	NOUN
ajlm-2286	19	30	.	.	PUNCT
ajlm-2286	20	1	conclusion	conclusion	NOUN
ajlm-2286	20	2	:	:	PUNCT
ajlm-2286	20	3	the	the	DET
ajlm-2286	20	4	present	present	ADJ
ajlm-2286	20	5	study	study	NOUN
ajlm-2286	20	6	provides	provide	VERB
ajlm-2286	20	7	supportive	supportive	ADJ
ajlm-2286	20	8	evidence	evidence	NOUN
ajlm-2286	20	9	that	that	PRON
ajlm-2286	20	10	changes	change	VERB
ajlm-2286	20	11	in	in	ADP
ajlm-2286	20	12	plasma	plasma	NOUN
ajlm-2286	20	13	lcat	lcat	NOUN
ajlm-2286	20	14	and	and	CCONJ
ajlm-2286	20	15	pon-1	pon-1	PUNCT
ajlm-2286	20	16	could	could	AUX
ajlm-2286	20	17	predispose	predispose	VERB
ajlm-2286	20	18	individuals	individual	NOUN
ajlm-2286	20	19	to	to	PART
ajlm-2286	20	20	risk	risk	VERB
ajlm-2286	20	21	of	of	ADP
ajlm-2286	20	22	premature	premature	ADJ
ajlm-2286	20	23	ascvd	ascvd	NOUN
ajlm-2286	20	24	.	.	PUNCT
ajlm-2286	21	1	what	what	PRON
ajlm-2286	21	2	this	this	DET
ajlm-2286	21	3	study	study	NOUN
ajlm-2286	21	4	adds	add	VERB
ajlm-2286	21	5	:	:	PUNCT
ajlm-2286	21	6	plasma	plasma	NOUN
ajlm-2286	21	7	lcat	lcat	NOUN
ajlm-2286	21	8	and	and	CCONJ
ajlm-2286	21	9	pon-1	pon-1	PUNCT
ajlm-2286	21	10	may	may	AUX
ajlm-2286	21	11	serve	serve	VERB
ajlm-2286	21	12	as	as	ADP
ajlm-2286	21	13	independent	independent	ADJ
ajlm-2286	21	14	markers	marker	NOUN
ajlm-2286	21	15	or	or	CCONJ
ajlm-2286	21	16	complement	complement	VERB
ajlm-2286	21	17	other	other	ADJ
ajlm-2286	21	18	established	establish	VERB
ajlm-2286	21	19	cardiovascular	cardiovascular	ADJ
ajlm-2286	21	20	disease	disease	NOUN
ajlm-2286	21	21	markers	marker	NOUN
ajlm-2286	21	22	to	to	PART
ajlm-2286	21	23	discriminate	discriminate	VERB
ajlm-2286	21	24	the	the	DET
ajlm-2286	21	25	risk	risk	NOUN
ajlm-2286	21	26	of	of	ADP
ajlm-2286	21	27	ascvd	ascvd	NOUN
ajlm-2286	21	28	when	when	SCONJ
ajlm-2286	21	29	it	it	PRON
ajlm-2286	21	30	is	be	AUX
ajlm-2286	21	31	unclear	unclear	ADJ
ajlm-2286	21	32	.	.	PUNCT
ajlm-2286	22	1	keywords	keyword	NOUN
ajlm-2286	22	2	:	:	PUNCT
ajlm-2286	22	3	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	22	4	cardiovascular	cardiovascular	ADJ
ajlm-2286	22	5	disease	disease	NOUN
ajlm-2286	22	6	;	;	PUNCT
ajlm-2286	22	7	lecithin	lecithin	NOUN
ajlm-2286	22	8	-	-	PUNCT
ajlm-2286	22	9	cholesterol	cholesterol	NOUN
ajlm-2286	22	10	acyltransferase	acyltransferase	NOUN
ajlm-2286	22	11	;	;	PUNCT
ajlm-2286	22	12	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	22	13	;	;	PUNCT
ajlm-2286	22	14	lipid	lipid	NOUN
ajlm-2286	22	15	profile	profile	NOUN
ajlm-2286	22	16	;	;	PUNCT
ajlm-2286	22	17	anthropometric	anthropometric	ADJ
ajlm-2286	22	18	variables	variable	NOUN
ajlm-2286	22	19	.	.	PUNCT
ajlm-2286	23	1	introduction	introduction	NOUN
ajlm-2286	23	2	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	23	3	cardiovascular	cardiovascular	ADJ
ajlm-2286	23	4	disease	disease	NOUN
ajlm-2286	23	5	(	(	PUNCT
ajlm-2286	23	6	ascvd	ascvd	NOUN
ajlm-2286	23	7	)	)	PUNCT
ajlm-2286	23	8	is	be	AUX
ajlm-2286	23	9	characterised	characterise	VERB
ajlm-2286	23	10	by	by	ADP
ajlm-2286	23	11	plaque	plaque	NOUN
ajlm-2286	23	12	buildup	buildup	NOUN
ajlm-2286	23	13	in	in	ADP
ajlm-2286	23	14	the	the	DET
ajlm-2286	23	15	arteries	artery	NOUN
ajlm-2286	23	16	,	,	PUNCT
ajlm-2286	23	17	leading	lead	VERB
ajlm-2286	23	18	to	to	ADP
ajlm-2286	23	19	reduced	reduce	VERB
ajlm-2286	23	20	blood	blood	NOUN
ajlm-2286	23	21	flow	flow	NOUN
ajlm-2286	23	22	and	and	CCONJ
ajlm-2286	23	23	an	an	DET
ajlm-2286	23	24	increased	increase	VERB
ajlm-2286	23	25	risk	risk	NOUN
ajlm-2286	23	26	of	of	ADP
ajlm-2286	23	27	heart	heart	NOUN
ajlm-2286	23	28	attacks	attack	NOUN
ajlm-2286	23	29	and	and	CCONJ
ajlm-2286	23	30	strokes.1	strokes.1	NOUN
ajlm-2286	23	31	it	it	PRON
ajlm-2286	23	32	poses	pose	VERB
ajlm-2286	23	33	a	a	DET
ajlm-2286	23	34	major	major	ADJ
ajlm-2286	23	35	health	health	NOUN
ajlm-2286	23	36	concern	concern	NOUN
ajlm-2286	23	37	worldwide	worldwide	ADV
ajlm-2286	23	38	due	due	ADP
ajlm-2286	23	39	to	to	ADP
ajlm-2286	23	40	its	its	PRON
ajlm-2286	23	41	high	high	ADJ
ajlm-2286	23	42	morbidity	morbidity	NOUN
ajlm-2286	23	43	and	and	CCONJ
ajlm-2286	23	44	mortality	mortality	NOUN
ajlm-2286	23	45	rates.2	rates.2	NOUN
ajlm-2286	23	46	despite	despite	SCONJ
ajlm-2286	23	47	advances	advance	NOUN
ajlm-2286	23	48	in	in	ADP
ajlm-2286	23	49	treating	treat	VERB
ajlm-2286	23	50	ascvd	ascvd	NOUN
ajlm-2286	23	51	,	,	PUNCT
ajlm-2286	23	52	identifying	identify	VERB
ajlm-2286	23	53	novel	novel	ADJ
ajlm-2286	23	54	risk	risk	NOUN
ajlm-2286	23	55	factors	factor	NOUN
ajlm-2286	23	56	for	for	ADP
ajlm-2286	23	57	ascvd	ascvd	NOUN
ajlm-2286	23	58	remains	remain	VERB
ajlm-2286	23	59	crucial	crucial	ADJ
ajlm-2286	23	60	for	for	ADP
ajlm-2286	23	61	improving	improve	VERB
ajlm-2286	23	62	patient	patient	ADJ
ajlm-2286	23	63	outcomes	outcome	NOUN
ajlm-2286	23	64	.	.	PUNCT
ajlm-2286	24	1	in	in	ADP
ajlm-2286	24	2	recent	recent	ADJ
ajlm-2286	24	3	years	year	NOUN
ajlm-2286	24	4	,	,	PUNCT
ajlm-2286	24	5	studies	study	NOUN
ajlm-2286	24	6	in	in	ADP
ajlm-2286	24	7	europe3,4	europe3,4	PROPN
ajlm-2286	24	8	and	and	CCONJ
ajlm-2286	24	9	asia5,6	asia5,6	PROPN
ajlm-2286	24	10	have	have	AUX
ajlm-2286	24	11	focused	focus	VERB
ajlm-2286	24	12	on	on	ADP
ajlm-2286	24	13	the	the	DET
ajlm-2286	24	14	role	role	NOUN
ajlm-2286	24	15	of	of	ADP
ajlm-2286	24	16	plasma	plasma	NOUN
ajlm-2286	24	17	lecithin	lecithin	NOUN
ajlm-2286	24	18	-	-	PUNCT
ajlm-2286	24	19	cholesterol	cholesterol	NOUN
ajlm-2286	24	20	acyltransferase	acyltransferase	NOUN
ajlm-2286	24	21	(	(	PUNCT
ajlm-2286	24	22	lcat	lcat	ADJ
ajlm-2286	24	23	)	)	PUNCT
ajlm-2286	24	24	and	and	CCONJ
ajlm-2286	24	25	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	24	26	(	(	PUNCT
ajlm-2286	24	27	pon-1	pon-1	NOUN
ajlm-2286	24	28	)	)	PUNCT
ajlm-2286	24	29	levels	level	NOUN
ajlm-2286	24	30	as	as	ADP
ajlm-2286	24	31	potential	potential	ADJ
ajlm-2286	24	32	biomarkers	biomarker	NOUN
ajlm-2286	24	33	for	for	ADP
ajlm-2286	24	34	predicting	predict	VERB
ajlm-2286	24	35	cardiovascular	cardiovascular	ADJ
ajlm-2286	24	36	risk	risk	NOUN
ajlm-2286	24	37	.	.	PUNCT
ajlm-2286	25	1	however	however	ADV
ajlm-2286	25	2	,	,	PUNCT
ajlm-2286	25	3	there	there	PRON
ajlm-2286	25	4	is	be	VERB
ajlm-2286	25	5	a	a	DET
ajlm-2286	25	6	paucity	paucity	NOUN
ajlm-2286	25	7	of	of	ADP
ajlm-2286	25	8	information	information	NOUN
ajlm-2286	25	9	on	on	ADP
ajlm-2286	25	10	the	the	DET
ajlm-2286	25	11	relationship	relationship	NOUN
ajlm-2286	25	12	between	between	ADP
ajlm-2286	25	13	these	these	DET
ajlm-2286	25	14	biomarkers	biomarker	NOUN
ajlm-2286	25	15	(	(	PUNCT
ajlm-2286	25	16	lcat	lcat	ADJ
ajlm-2286	25	17	and	and	CCONJ
ajlm-2286	25	18	pon-1	pon-1	NOUN
ajlm-2286	25	19	)	)	PUNCT
ajlm-2286	25	20	and	and	CCONJ
ajlm-2286	25	21	ascvd	ascvd	NOUN
ajlm-2286	25	22	in	in	ADP
ajlm-2286	25	23	africa	africa	PROPN
ajlm-2286	25	24	,	,	PUNCT
ajlm-2286	25	25	especially	especially	ADV
ajlm-2286	25	26	in	in	ADP
ajlm-2286	25	27	sub	sub	ADJ
ajlm-2286	25	28	-	-	ADJ
ajlm-2286	25	29	saharan	saharan	ADJ
ajlm-2286	25	30	africa	africa	PROPN
ajlm-2286	25	31	.	.	PUNCT
ajlm-2286	26	1	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	26	2	is	be	AUX
ajlm-2286	26	3	an	an	DET
ajlm-2286	26	4	enzyme	enzyme	NOUN
ajlm-2286	26	5	primarily	primarily	ADV
ajlm-2286	26	6	synthesised	synthesise	VERB
ajlm-2286	26	7	in	in	ADP
ajlm-2286	26	8	the	the	DET
ajlm-2286	26	9	liver	liver	NOUN
ajlm-2286	26	10	and	and	CCONJ
ajlm-2286	26	11	has	have	AUX
ajlm-2286	26	12	been	be	AUX
ajlm-2286	26	13	shown	show	VERB
ajlm-2286	26	14	to	to	PART
ajlm-2286	26	15	have	have	VERB
ajlm-2286	26	16	a	a	DET
ajlm-2286	26	17	protective	protective	ADJ
ajlm-2286	26	18	effect	effect	NOUN
ajlm-2286	26	19	against	against	ADP
ajlm-2286	26	20	atherosclerosis,7	atherosclerosis,7	NOUN
ajlm-2286	26	21	which	which	PRON
ajlm-2286	26	22	is	be	AUX
ajlm-2286	26	23	the	the	DET
ajlm-2286	26	24	underlying	underlying	ADJ
ajlm-2286	26	25	cause	cause	NOUN
ajlm-2286	26	26	of	of	ADP
ajlm-2286	26	27	several	several	ADJ
ajlm-2286	26	28	cardiovascular	cardiovascular	ADJ
ajlm-2286	26	29	diseases	disease	NOUN
ajlm-2286	26	30	,	,	PUNCT
ajlm-2286	26	31	including	include	VERB
ajlm-2286	26	32	ascvd	ascvd	NOUN
ajlm-2286	26	33	.	.	PUNCT
ajlm-2286	27	1	some	some	DET
ajlm-2286	27	2	studies	study	NOUN
ajlm-2286	27	3	have	have	AUX
ajlm-2286	27	4	shown	show	VERB
ajlm-2286	27	5	that	that	SCONJ
ajlm-2286	27	6	individuals	individual	NOUN
ajlm-2286	27	7	with	with	ADP
ajlm-2286	27	8	low	low	ADJ
ajlm-2286	27	9	levels	level	NOUN
ajlm-2286	27	10	of	of	ADP
ajlm-2286	27	11	pon-1	pon-1	PUNCT
ajlm-2286	27	12	activity	activity	NOUN
ajlm-2286	27	13	and	and	CCONJ
ajlm-2286	27	14	concentrations	concentration	NOUN
ajlm-2286	27	15	have	have	VERB
ajlm-2286	27	16	an	an	DET
ajlm-2286	27	17	increased	increase	VERB
ajlm-2286	27	18	risk	risk	NOUN
ajlm-2286	27	19	of	of	ADP
ajlm-2286	27	20	developing	develop	VERB
ajlm-2286	27	21	ascvd	ascvd	NOUN
ajlm-2286	27	22	,	,	PUNCT
ajlm-2286	27	23	while	while	SCONJ
ajlm-2286	27	24	others	other	NOUN
ajlm-2286	27	25	have	have	AUX
ajlm-2286	27	26	found	find	VERB
ajlm-2286	27	27	no	no	DET
ajlm-2286	27	28	association	association	NOUN
ajlm-2286	27	29	between	between	ADP
ajlm-2286	27	30	decreased	decrease	VERB
ajlm-2286	27	31	pon-1	pon-1	PRON
ajlm-2286	27	32	activity	activity	NOUN
ajlm-2286	27	33	and	and	CCONJ
ajlm-2286	27	34	ascvd.6,8	ascvd.6,8	NUM
ajlm-2286	27	35	reduced	reduce	VERB
ajlm-2286	27	36	pon-1	pon-1	PUNCT
ajlm-2286	27	37	concentrations	concentration	NOUN
ajlm-2286	27	38	in	in	ADP
ajlm-2286	27	39	ascvd	ascvd	NOUN
ajlm-2286	27	40	patients	patient	NOUN
ajlm-2286	27	41	suggest	suggest	VERB
ajlm-2286	27	42	that	that	SCONJ
ajlm-2286	27	43	pon-1	pon-1	PUNCT
ajlm-2286	27	44	may	may	AUX
ajlm-2286	27	45	play	play	VERB
ajlm-2286	27	46	a	a	DET
ajlm-2286	27	47	protective	protective	ADJ
ajlm-2286	27	48	role	role	NOUN
ajlm-2286	27	49	against	against	ADP
ajlm-2286	27	50	the	the	DET
ajlm-2286	27	51	development	development	NOUN
ajlm-2286	27	52	of	of	ADP
ajlm-2286	27	53	ascvd	ascvd	PROPN
ajlm-2286	27	54	.	.	PUNCT
ajlm-2286	28	1	low	low	ADJ
ajlm-2286	28	2	pon-1	pon-1	PUNCT
ajlm-2286	28	3	concentrations	concentration	NOUN
ajlm-2286	28	4	have	have	AUX
ajlm-2286	28	5	also	also	ADV
ajlm-2286	28	6	been	be	AUX
ajlm-2286	28	7	shown	show	VERB
ajlm-2286	28	8	to	to	PART
ajlm-2286	28	9	be	be	AUX
ajlm-2286	28	10	a	a	DET
ajlm-2286	28	11	predictor	predictor	NOUN
ajlm-2286	28	12	of	of	ADP
ajlm-2286	28	13	ascvd	ascvd	NOUN
ajlm-2286	28	14	risk.7	risk.7	PROPN
ajlm-2286	28	15	in	in	ADP
ajlm-2286	28	16	one	one	NUM
ajlm-2286	28	17	study	study	NOUN
ajlm-2286	28	18	,	,	PUNCT
ajlm-2286	28	19	individuals	individual	NOUN
ajlm-2286	28	20	with	with	ADP
ajlm-2286	28	21	low	low	ADJ
ajlm-2286	28	22	pon-1	pon-1	PRON
ajlm-2286	28	23	activity	activity	NOUN
ajlm-2286	28	24	were	be	AUX
ajlm-2286	28	25	found	find	VERB
ajlm-2286	28	26	to	to	PART
ajlm-2286	28	27	have	have	VERB
ajlm-2286	28	28	a	a	DET
ajlm-2286	28	29	2.4	2.4	NUM
ajlm-2286	28	30	-	-	ADJ
ajlm-2286	28	31	fold	fold	ADJ
ajlm-2286	28	32	increased	increase	VERB
ajlm-2286	28	33	risk	risk	NOUN
ajlm-2286	28	34	of	of	ADP
ajlm-2286	28	35	developing	develop	VERB
ajlm-2286	28	36	ascvd.9	ascvd.9	PROPN
ajlm-2286	28	37	it	it	PRON
ajlm-2286	28	38	is	be	AUX
ajlm-2286	28	39	also	also	ADV
ajlm-2286	28	40	important	important	ADJ
ajlm-2286	28	41	to	to	PART
ajlm-2286	28	42	note	note	VERB
ajlm-2286	28	43	that	that	SCONJ
ajlm-2286	28	44	the	the	DET
ajlm-2286	28	45	relationship	relationship	NOUN
ajlm-2286	28	46	between	between	ADP
ajlm-2286	28	47	pon-1	pon-1	PUNCT
ajlm-2286	28	48	activity	activity	NOUN
ajlm-2286	28	49	and	and	CCONJ
ajlm-2286	28	50	ascvd	ascvd	NOUN
ajlm-2286	28	51	is	be	AUX
ajlm-2286	28	52	complex	complex	ADJ
ajlm-2286	28	53	and	and	CCONJ
ajlm-2286	28	54	multifactorial	multifactorial	ADJ
ajlm-2286	28	55	.	.	PUNCT
ajlm-2286	29	1	genetic	genetic	ADJ
ajlm-2286	29	2	variation	variation	NOUN
ajlm-2286	29	3	,	,	PUNCT
ajlm-2286	29	4	environmental	environmental	ADJ
ajlm-2286	29	5	factors	factor	NOUN
ajlm-2286	29	6	,	,	PUNCT
ajlm-2286	29	7	and	and	CCONJ
ajlm-2286	29	8	lifestyle	lifestyle	NOUN
ajlm-2286	29	9	habits	habit	NOUN
ajlm-2286	29	10	can	can	AUX
ajlm-2286	29	11	also	also	ADV
ajlm-2286	29	12	influence	influence	VERB
ajlm-2286	29	13	the	the	DET
ajlm-2286	29	14	regulation	regulation	NOUN
ajlm-2286	29	15	of	of	ADP
ajlm-2286	29	16	pon-1	pon-1	PUNCT
ajlm-2286	29	17	concentrations	concentration	NOUN
ajlm-2286	29	18	and	and	CCONJ
ajlm-2286	29	19	,	,	PUNCT
ajlm-2286	29	20	subsequently	subsequently	ADV
ajlm-2286	29	21	,	,	PUNCT
ajlm-2286	29	22	ascvd	ascvd	PROPN
ajlm-2286	29	23	risks.10,11	risks.10,11	NOUN
ajlm-2286	29	24	for	for	ADP
ajlm-2286	29	25	example	example	NOUN
ajlm-2286	29	26	,	,	PUNCT
ajlm-2286	29	27	smoking	smoking	NOUN
ajlm-2286	29	28	has	have	AUX
ajlm-2286	29	29	been	be	AUX
ajlm-2286	29	30	shown	show	VERB
ajlm-2286	29	31	to	to	PART
ajlm-2286	29	32	reduce	reduce	VERB
ajlm-2286	29	33	pon-1	pon-1	PUNCT
ajlm-2286	29	34	activity,12	activity,12	NOUN
ajlm-2286	29	35	while	while	SCONJ
ajlm-2286	29	36	diets	diet	NOUN
ajlm-2286	29	37	high	high	ADJ
ajlm-2286	29	38	in	in	ADP
ajlm-2286	29	39	antioxidants	antioxidant	NOUN
ajlm-2286	29	40	can	can	AUX
ajlm-2286	29	41	increase	increase	VERB
ajlm-2286	29	42	pon-1	pon-1	PUNCT
ajlm-2286	29	43	activity.11	activity.11	NOUN
ajlm-2286	29	44	on	on	ADP
ajlm-2286	29	45	the	the	DET
ajlm-2286	29	46	other	other	ADJ
ajlm-2286	29	47	hand	hand	NOUN
ajlm-2286	29	48	,	,	PUNCT
ajlm-2286	29	49	lcat	lcat	PROPN
ajlm-2286	29	50	has	have	AUX
ajlm-2286	29	51	long	long	ADV
ajlm-2286	29	52	been	be	AUX
ajlm-2286	29	53	recognised	recognise	VERB
ajlm-2286	29	54	as	as	ADP
ajlm-2286	29	55	a	a	DET
ajlm-2286	29	56	key	key	ADJ
ajlm-2286	29	57	regulator	regulator	NOUN
ajlm-2286	29	58	of	of	ADP
ajlm-2286	29	59	high	high	ADJ
ajlm-2286	29	60	-	-	PUNCT
ajlm-2286	29	61	density	density	NOUN
ajlm-2286	29	62	lipoprotein	lipoprotein	ADJ
ajlm-2286	29	63	metabolism	metabolism	NOUN
ajlm-2286	29	64	;	;	PUNCT
ajlm-2286	29	65	however	however	ADV
ajlm-2286	29	66	,	,	PUNCT
ajlm-2286	29	67	the	the	DET
ajlm-2286	29	68	role	role	NOUN
ajlm-2286	29	69	of	of	ADP
ajlm-2286	29	70	this	this	DET
ajlm-2286	29	71	enzyme	enzyme	NOUN
ajlm-2286	29	72	in	in	ADP
ajlm-2286	29	73	human	human	ADJ
ajlm-2286	29	74	atherogenesis	atherogenesis	NOUN
ajlm-2286	29	75	and	and	CCONJ
ajlm-2286	29	76	ascvd	ascvd	NOUN
ajlm-2286	29	77	has	have	AUX
ajlm-2286	29	78	remained	remain	VERB
ajlm-2286	29	79	controversial.13	controversial.13	NOUN
ajlm-2286	29	80	earlier	early	ADJ
ajlm-2286	29	81	studies	study	NOUN
ajlm-2286	29	82	reported	report	VERB
ajlm-2286	29	83	increases14,15	increases14,15	PROPN
ajlm-2286	29	84	and	and	CCONJ
ajlm-2286	29	85	decreases3,5	decreases3,5	PROPN
ajlm-2286	29	86	in	in	ADP
ajlm-2286	29	87	plasma	plasma	NOUN
ajlm-2286	29	88	lcat	lcat	ADJ
ajlm-2286	29	89	activity	activity	NOUN
ajlm-2286	29	90	and	and	CCONJ
ajlm-2286	29	91	concentrations	concentration	NOUN
ajlm-2286	29	92	in	in	ADP
ajlm-2286	29	93	patients	patient	NOUN
ajlm-2286	29	94	with	with	ADP
ajlm-2286	29	95	ascvd	ascvd	NOUN
ajlm-2286	29	96	.	.	PUNCT
ajlm-2286	30	1	studies	study	NOUN
ajlm-2286	30	2	have	have	AUX
ajlm-2286	30	3	also	also	ADV
ajlm-2286	30	4	reported	report	VERB
ajlm-2286	30	5	that	that	SCONJ
ajlm-2286	30	6	plasma	plasma	NOUN
ajlm-2286	30	7	lcat	lcat	ADJ
ajlm-2286	30	8	concentrations	concentration	NOUN
ajlm-2286	30	9	can	can	AUX
ajlm-2286	30	10	be	be	AUX
ajlm-2286	30	11	regulated	regulate	VERB
ajlm-2286	30	12	by	by	ADP
ajlm-2286	30	13	a	a	DET
ajlm-2286	30	14	complex	complex	ADJ
ajlm-2286	30	15	interplay	interplay	NOUN
ajlm-2286	30	16	of	of	ADP
ajlm-2286	30	17	several	several	ADJ
ajlm-2286	30	18	factors	factor	NOUN
ajlm-2286	30	19	,	,	PUNCT
ajlm-2286	30	20	such	such	ADJ
ajlm-2286	30	21	as	as	ADP
ajlm-2286	30	22	genetics	genetic	NOUN
ajlm-2286	30	23	,	,	PUNCT
ajlm-2286	30	24	hormonal	hormonal	ADJ
ajlm-2286	30	25	,	,	PUNCT
ajlm-2286	30	26	dietary	dietary	ADJ
ajlm-2286	30	27	,	,	PUNCT
ajlm-2286	30	28	inflammatory	inflammatory	ADJ
ajlm-2286	30	29	,	,	PUNCT
ajlm-2286	30	30	medication	medication	NOUN
ajlm-2286	30	31	,	,	PUNCT
ajlm-2286	30	32	and	and	CCONJ
ajlm-2286	30	33	lifestyle	lifestyle	PROPN
ajlm-2286	30	34	factors.15,16	factors.15,16	NOUN
ajlm-2286	30	35	furthermore	furthermore	ADV
ajlm-2286	30	36	,	,	PUNCT
ajlm-2286	30	37	research	research	NOUN
ajlm-2286	30	38	has	have	AUX
ajlm-2286	30	39	suggested	suggest	VERB
ajlm-2286	30	40	that	that	SCONJ
ajlm-2286	30	41	there	there	PRON
ajlm-2286	30	42	may	may	AUX
ajlm-2286	30	43	be	be	AUX
ajlm-2286	30	44	a	a	DET
ajlm-2286	30	45	correlation	correlation	NOUN
ajlm-2286	30	46	between	between	ADP
ajlm-2286	30	47	pon-1	pon-1	PUNCT
ajlm-2286	30	48	and	and	CCONJ
ajlm-2286	30	49	lcat	lcat	ADJ
ajlm-2286	30	50	concentrations	concentration	NOUN
ajlm-2286	30	51	,	,	PUNCT
ajlm-2286	30	52	as	as	SCONJ
ajlm-2286	30	53	both	both	DET
ajlm-2286	30	54	enzymes	enzyme	NOUN
ajlm-2286	30	55	are	be	AUX
ajlm-2286	30	56	involved	involve	VERB
ajlm-2286	30	57	in	in	ADP
ajlm-2286	30	58	lipid	lipid	ADJ
ajlm-2286	30	59	metabolism	metabolism	NOUN
ajlm-2286	30	60	and	and	CCONJ
ajlm-2286	30	61	may	may	AUX
ajlm-2286	30	62	be	be	AUX
ajlm-2286	30	63	regulated	regulate	VERB
ajlm-2286	30	64	by	by	ADP
ajlm-2286	30	65	similar	similar	ADJ
ajlm-2286	30	66	factors	factor	NOUN
ajlm-2286	30	67	.	.	PUNCT
ajlm-2286	31	1	earlier	early	ADJ
ajlm-2286	31	2	studies	study	NOUN
ajlm-2286	31	3	have	have	AUX
ajlm-2286	31	4	also	also	ADV
ajlm-2286	31	5	linked	link	VERB
ajlm-2286	31	6	lcat	lcat	ADJ
ajlm-2286	31	7	and	and	CCONJ
ajlm-2286	31	8	pon-1	pon-1	X
ajlm-2286	31	9	to	to	ADP
ajlm-2286	31	10	several	several	ADJ
ajlm-2286	31	11	chronic	chronic	ADJ
ajlm-2286	31	12	diseases	disease	NOUN
ajlm-2286	31	13	beyond	beyond	ADP
ajlm-2286	31	14	ascvd	ascvd	NOUN
ajlm-2286	31	15	,	,	PUNCT
ajlm-2286	31	16	including	include	VERB
ajlm-2286	31	17	diabetes	diabetes	NOUN
ajlm-2286	31	18	,	,	PUNCT
ajlm-2286	31	19	chronic	chronic	ADJ
ajlm-2286	31	20	kidney	kidney	NOUN
ajlm-2286	31	21	disease	disease	NOUN
ajlm-2286	31	22	,	,	PUNCT
ajlm-2286	31	23	and	and	CCONJ
ajlm-2286	31	24	alzheimer	alzheimer	PROPN
ajlm-2286	31	25	’s	’s	PART
ajlm-2286	31	26	disease.17,18,19	disease.17,18,19	PUNCT
ajlm-2286	31	27	this	this	DET
ajlm-2286	31	28	study	study	NOUN
ajlm-2286	31	29	assessed	assess	VERB
ajlm-2286	31	30	the	the	DET
ajlm-2286	31	31	association	association	NOUN
ajlm-2286	31	32	between	between	ADP
ajlm-2286	31	33	reduced	reduce	VERB
ajlm-2286	31	34	plasma	plasma	NOUN
ajlm-2286	31	35	lcat	lcat	NOUN
ajlm-2286	31	36	and	and	CCONJ
ajlm-2286	31	37	pon-1	pon-1	PUNCT
ajlm-2286	31	38	levels	level	NOUN
ajlm-2286	31	39	and	and	CCONJ
ajlm-2286	31	40	an	an	DET
ajlm-2286	31	41	increased	increase	VERB
ajlm-2286	31	42	risk	risk	NOUN
ajlm-2286	31	43	of	of	ADP
ajlm-2286	31	44	ascvd	ascvd	NOUN
ajlm-2286	31	45	,	,	PUNCT
ajlm-2286	31	46	and	and	CCONJ
ajlm-2286	31	47	their	their	PRON
ajlm-2286	31	48	significance	significance	NOUN
ajlm-2286	31	49	as	as	ADP
ajlm-2286	31	50	potential	potential	ADJ
ajlm-2286	31	51	biomarkers	biomarker	NOUN
ajlm-2286	31	52	for	for	ADP
ajlm-2286	31	53	ascvd	ascvd	NOUN
ajlm-2286	31	54	in	in	ADP
ajlm-2286	31	55	nigeria	nigeria	PROPN
ajlm-2286	31	56	and	and	CCONJ
ajlm-2286	31	57	beyond	beyond	ADP
ajlm-2286	31	58	.	.	PUNCT
ajlm-2286	32	1	this	this	DET
ajlm-2286	32	2	study	study	NOUN
ajlm-2286	32	3	examined	examine	VERB
ajlm-2286	32	4	plasma	plasma	NOUN
ajlm-2286	32	5	lcat	lcat	NOUN
ajlm-2286	32	6	,	,	PUNCT
ajlm-2286	32	7	pon-1	pon-1	NOUN
ajlm-2286	32	8	,	,	PUNCT
ajlm-2286	32	9	lipid	lipid	NOUN
ajlm-2286	32	10	profile	profile	NOUN
ajlm-2286	32	11	,	,	PUNCT
ajlm-2286	32	12	and	and	CCONJ
ajlm-2286	32	13	anthropometric	anthropometric	ADJ
ajlm-2286	32	14	indices	index	NOUN
ajlm-2286	32	15	in	in	ADP
ajlm-2286	32	16	ascvd	ascvd	NOUN
ajlm-2286	32	17	patients	patient	NOUN
ajlm-2286	32	18	.	.	PUNCT
ajlm-2286	33	1	methods	method	NOUN
ajlm-2286	33	2	ethical	ethical	ADJ
ajlm-2286	33	3	considerations	consideration	NOUN
ajlm-2286	33	4	ethical	ethical	ADJ
ajlm-2286	33	5	approval	approval	NOUN
ajlm-2286	33	6	for	for	ADP
ajlm-2286	33	7	this	this	DET
ajlm-2286	33	8	study	study	NOUN
ajlm-2286	33	9	was	be	AUX
ajlm-2286	33	10	obtained	obtain	VERB
ajlm-2286	33	11	from	from	ADP
ajlm-2286	33	12	the	the	DET
ajlm-2286	33	13	university	university	NOUN
ajlm-2286	33	14	’s	’s	PART
ajlm-2286	33	15	health	health	NOUN
ajlm-2286	33	16	research	research	NOUN
ajlm-2286	33	17	and	and	CCONJ
ajlm-2286	33	18	ethics	ethic	NOUN
ajlm-2286	33	19	committee	committee	NOUN
ajlm-2286	33	20	of	of	ADP
ajlm-2286	33	21	the	the	DET
ajlm-2286	33	22	lagos	lagos	PROPN
ajlm-2286	33	23	state	state	PROPN
ajlm-2286	33	24	university	university	PROPN
ajlm-2286	33	25	teaching	teaching	NOUN
ajlm-2286	33	26	hospital	hospital	NOUN
ajlm-2286	33	27	,	,	PUNCT
ajlm-2286	33	28	ikeja	ikeja	NOUN
ajlm-2286	33	29	,	,	PUNCT
ajlm-2286	33	30	lagos	lago	NOUN
ajlm-2286	33	31	,	,	PUNCT
ajlm-2286	33	32	nigeria	nigeria	PROPN
ajlm-2286	33	33	(	(	PUNCT
ajlm-2286	33	34	reference	reference	NOUN
ajlm-2286	33	35	number	number	NOUN
ajlm-2286	33	36	:	:	PUNCT
ajlm-2286	33	37	lrec/06/10/1706	lrec/06/10/1706	PROPN
ajlm-2286	33	38	)	)	PUNCT
ajlm-2286	33	39	.	.	PUNCT
ajlm-2286	34	1	written	write	VERB
ajlm-2286	34	2	informed	informed	ADJ
ajlm-2286	34	3	consent	consent	NOUN
ajlm-2286	34	4	was	be	AUX
ajlm-2286	34	5	obtained	obtain	VERB
ajlm-2286	34	6	from	from	ADP
ajlm-2286	34	7	each	each	DET
ajlm-2286	34	8	enrollee	enrollee	NOUN
ajlm-2286	34	9	to	to	PART
ajlm-2286	34	10	participate	participate	VERB
ajlm-2286	34	11	in	in	ADP
ajlm-2286	34	12	the	the	DET
ajlm-2286	34	13	study	study	NOUN
ajlm-2286	34	14	;	;	PUNCT
ajlm-2286	34	15	all	all	DET
ajlm-2286	34	16	participants	participant	NOUN
ajlm-2286	34	17	were	be	AUX
ajlm-2286	34	18	residents	resident	NOUN
ajlm-2286	34	19	of	of	ADP
ajlm-2286	34	20	lagos	lagos	PROPN
ajlm-2286	34	21	state	state	NOUN
ajlm-2286	34	22	,	,	PUNCT
ajlm-2286	34	23	nigeria	nigeria	PROPN
ajlm-2286	34	24	.	.	PUNCT
ajlm-2286	35	1	participants	participant	NOUN
ajlm-2286	35	2	’	'	PUNCT
ajlm-2286	35	3	anonymity	anonymity	NOUN
ajlm-2286	35	4	was	be	AUX
ajlm-2286	35	5	maintained	maintain	VERB
ajlm-2286	35	6	using	use	VERB
ajlm-2286	35	7	a	a	DET
ajlm-2286	35	8	barcode	barcode	NOUN
ajlm-2286	35	9	system	system	NOUN
ajlm-2286	35	10	,	,	PUNCT
ajlm-2286	35	11	and	and	CCONJ
ajlm-2286	35	12	the	the	DET
ajlm-2286	35	13	generated	generate	VERB
ajlm-2286	35	14	data	datum	NOUN
ajlm-2286	35	15	were	be	AUX
ajlm-2286	35	16	treated	treat	VERB
ajlm-2286	35	17	with	with	ADP
ajlm-2286	35	18	the	the	DET
ajlm-2286	35	19	utmost	utmost	ADJ
ajlm-2286	35	20	confidentiality	confidentiality	NOUN
ajlm-2286	35	21	.	.	PUNCT
ajlm-2286	36	1	the	the	DET
ajlm-2286	36	2	generated	generate	VERB
ajlm-2286	36	3	data	datum	NOUN
ajlm-2286	36	4	were	be	AUX
ajlm-2286	36	5	used	use	VERB
ajlm-2286	36	6	only	only	ADV
ajlm-2286	36	7	for	for	ADP
ajlm-2286	36	8	this	this	DET
ajlm-2286	36	9	research	research	NOUN
ajlm-2286	36	10	.	.	PUNCT
ajlm-2286	37	1	study	study	NOUN
ajlm-2286	37	2	design	design	VERB
ajlm-2286	37	3	the	the	DET
ajlm-2286	37	4	study	study	NOUN
ajlm-2286	37	5	was	be	AUX
ajlm-2286	37	6	a	a	DET
ajlm-2286	37	7	cross	cross	ADJ
ajlm-2286	37	8	-	-	ADJ
ajlm-2286	37	9	sectional	sectional	ADJ
ajlm-2286	37	10	case	case	NOUN
ajlm-2286	37	11	-	-	PUNCT
ajlm-2286	37	12	control	control	NOUN
ajlm-2286	37	13	study	study	NOUN
ajlm-2286	37	14	.	.	PUNCT
ajlm-2286	38	1	the	the	DET
ajlm-2286	38	2	sample	sample	NOUN
ajlm-2286	38	3	size	size	NOUN
ajlm-2286	38	4	of	of	ADP
ajlm-2286	38	5	138	138	NUM
ajlm-2286	38	6	was	be	AUX
ajlm-2286	38	7	determined	determine	VERB
ajlm-2286	38	8	using	use	VERB
ajlm-2286	38	9	the	the	DET
ajlm-2286	38	10	prevalence	prevalence	NOUN
ajlm-2286	38	11	of	of	ADP
ajlm-2286	38	12	a	a	DET
ajlm-2286	38	13	previous	previous	ADJ
ajlm-2286	38	14	study	study	NOUN
ajlm-2286	38	15	in	in	ADP
ajlm-2286	38	16	the	the	DET
ajlm-2286	38	17	region,20	region,20	NOUN
ajlm-2286	38	18	based	base	VERB
ajlm-2286	38	19	on	on	ADP
ajlm-2286	38	20	a	a	DET
ajlm-2286	38	21	10	10	NUM
ajlm-2286	38	22	%	%	NOUN
ajlm-2286	38	23	prevalence	prevalence	NOUN
ajlm-2286	38	24	rate	rate	NOUN
ajlm-2286	38	25	of	of	ADP
ajlm-2286	38	26	cardiovascular	cardiovascular	ADJ
ajlm-2286	38	27	disease	disease	NOUN
ajlm-2286	38	28	in	in	ADP
ajlm-2286	38	29	nigeria.21	nigeria.21	PROPN
ajlm-2286	38	30	the	the	DET
ajlm-2286	38	31	study	study	NOUN
ajlm-2286	38	32	enrolled	enrol	VERB
ajlm-2286	38	33	confirmed	confirm	VERB
ajlm-2286	38	34	ascvd	ascvd	NOUN
ajlm-2286	38	35	patients	patient	NOUN
ajlm-2286	38	36	attending	attend	VERB
ajlm-2286	38	37	the	the	DET
ajlm-2286	38	38	cardio	cardio	NOUN
ajlm-2286	38	39	clinic	clinic	NOUN
ajlm-2286	38	40	and	and	CCONJ
ajlm-2286	38	41	those	those	PRON
ajlm-2286	38	42	admitted	admit	VERB
ajlm-2286	38	43	into	into	ADP
ajlm-2286	38	44	the	the	DET
ajlm-2286	38	45	state	state	NOUN
ajlm-2286	38	46	university	university	PROPN
ajlm-2286	38	47	teaching	teaching	NOUN
ajlm-2286	38	48	hospital	hospital	NOUN
ajlm-2286	38	49	emergency	emergency	NOUN
ajlm-2286	38	50	medical	medical	ADJ
ajlm-2286	38	51	wards	ward	NOUN
ajlm-2286	38	52	(	(	PUNCT
ajlm-2286	38	53	both	both	PRON
ajlm-2286	38	54	located	locate	VERB
ajlm-2286	38	55	at	at	ADP
ajlm-2286	38	56	lagos	lagos	PROPN
ajlm-2286	38	57	state	state	NOUN
ajlm-2286	38	58	university	university	PROPN
ajlm-2286	38	59	teaching	teaching	NOUN
ajlm-2286	38	60	hospital	hospital	NOUN
ajlm-2286	38	61	,	,	PUNCT
ajlm-2286	38	62	ikeja	ikeja	NOUN
ajlm-2286	38	63	,	,	PUNCT
ajlm-2286	38	64	lagos	lago	NOUN
ajlm-2286	38	65	,	,	PUNCT
ajlm-2286	38	66	nigeria	nigeria	PROPN
ajlm-2286	38	67	)	)	PUNCT
ajlm-2286	38	68	between	between	ADP
ajlm-2286	38	69	march	march	PROPN
ajlm-2286	38	70	2022	2022	NUM
ajlm-2286	38	71	and	and	CCONJ
ajlm-2286	38	72	march	march	PROPN
ajlm-2286	38	73	2023	2023	NUM
ajlm-2286	38	74	.	.	PUNCT
ajlm-2286	39	1	a	a	DET
ajlm-2286	39	2	simple	simple	ADJ
ajlm-2286	39	3	random	random	ADJ
ajlm-2286	39	4	sampling	sampling	NOUN
ajlm-2286	39	5	technique	technique	NOUN
ajlm-2286	39	6	was	be	AUX
ajlm-2286	39	7	used	use	VERB
ajlm-2286	39	8	to	to	PART
ajlm-2286	39	9	select	select	VERB
ajlm-2286	39	10	patients	patient	NOUN
ajlm-2286	39	11	diagnosed	diagnose	VERB
ajlm-2286	39	12	with	with	ADP
ajlm-2286	39	13	ischaemic	ischaemic	ADJ
ajlm-2286	39	14	heart	heart	NOUN
ajlm-2286	39	15	disease	disease	NOUN
ajlm-2286	39	16	(	(	PUNCT
ajlm-2286	39	17	ihd	ihd	ADJ
ajlm-2286	39	18	)	)	PUNCT
ajlm-2286	39	19	,	,	PUNCT
ajlm-2286	39	20	stroke	stroke	NOUN
ajlm-2286	39	21	,	,	PUNCT
ajlm-2286	39	22	hypertensive	hypertensive	ADJ
ajlm-2286	39	23	heart	heart	NOUN
ajlm-2286	39	24	disease	disease	NOUN
ajlm-2286	39	25	,	,	PUNCT
ajlm-2286	39	26	myocardial	myocardial	ADJ
ajlm-2286	39	27	infarction	infarction	NOUN
ajlm-2286	39	28	and	and	CCONJ
ajlm-2286	39	29	congestive	congestive	ADJ
ajlm-2286	39	30	heart	heart	NOUN
ajlm-2286	39	31	failure	failure	NOUN
ajlm-2286	39	32	as	as	SCONJ
ajlm-2286	39	33	diagnosed	diagnose	VERB
ajlm-2286	39	34	by	by	ADP
ajlm-2286	39	35	the	the	DET
ajlm-2286	39	36	attending	attend	VERB
ajlm-2286	39	37	consultant	consultant	NOUN
ajlm-2286	39	38	cardiologist	cardiologist	NOUN
ajlm-2286	39	39	based	base	VERB
ajlm-2286	39	40	on	on	ADP
ajlm-2286	39	41	the	the	DET
ajlm-2286	39	42	patient	patient	NOUN
ajlm-2286	39	43	’s	’s	PART
ajlm-2286	39	44	medical	medical	ADJ
ajlm-2286	39	45	history	history	NOUN
ajlm-2286	39	46	,	,	PUNCT
ajlm-2286	39	47	clinical	clinical	ADJ
ajlm-2286	39	48	presentation	presentation	NOUN
ajlm-2286	39	49	,	,	PUNCT
ajlm-2286	39	50	electrocardiographic	electrocardiographic	ADJ
ajlm-2286	39	51	changes	change	NOUN
ajlm-2286	39	52	,	,	PUNCT
ajlm-2286	39	53	echocardiographic	echocardiographic	ADJ
ajlm-2286	39	54	changes	change	NOUN
ajlm-2286	39	55	,	,	PUNCT
ajlm-2286	39	56	and	and	CCONJ
ajlm-2286	39	57	biochemical	biochemical	ADJ
ajlm-2286	39	58	characteristics	characteristic	NOUN
ajlm-2286	39	59	.	.	PUNCT
ajlm-2286	40	1	for	for	ADP
ajlm-2286	40	2	the	the	DET
ajlm-2286	40	3	control	control	NOUN
ajlm-2286	40	4	group	group	NOUN
ajlm-2286	40	5	,	,	PUNCT
ajlm-2286	40	6	50	50	NUM
ajlm-2286	40	7	healthy	healthy	ADJ
ajlm-2286	40	8	volunteers	volunteer	NOUN
ajlm-2286	40	9	with	with	ADP
ajlm-2286	40	10	no	no	DET
ajlm-2286	40	11	history	history	NOUN
ajlm-2286	40	12	of	of	ADP
ajlm-2286	40	13	chronic	chronic	ADJ
ajlm-2286	40	14	or	or	CCONJ
ajlm-2286	40	15	degenerative	degenerative	ADJ
ajlm-2286	40	16	diseases	disease	NOUN
ajlm-2286	40	17	were	be	AUX
ajlm-2286	40	18	selected	select	VERB
ajlm-2286	40	19	from	from	ADP
ajlm-2286	40	20	among	among	ADP
ajlm-2286	40	21	patients	patient	NOUN
ajlm-2286	40	22	’	’	PART
ajlm-2286	40	23	relatives	relative	NOUN
ajlm-2286	40	24	and	and	CCONJ
ajlm-2286	40	25	staff	staff	NOUN
ajlm-2286	40	26	at	at	ADP
ajlm-2286	40	27	the	the	DET
ajlm-2286	40	28	state	state	NOUN
ajlm-2286	40	29	university	university	PROPN
ajlm-2286	40	30	teaching	teaching	NOUN
ajlm-2286	40	31	hospital	hospital	NOUN
ajlm-2286	40	32	.	.	PUNCT
ajlm-2286	41	1	a	a	DET
ajlm-2286	41	2	sample	sample	NOUN
ajlm-2286	41	3	frame	frame	NOUN
ajlm-2286	41	4	was	be	AUX
ajlm-2286	41	5	drawn	draw	VERB
ajlm-2286	41	6	from	from	ADP
ajlm-2286	41	7	the	the	DET
ajlm-2286	41	8	controls	control	NOUN
ajlm-2286	41	9	recruited	recruit	VERB
ajlm-2286	41	10	.	.	PUNCT
ajlm-2286	42	1	a	a	DET
ajlm-2286	42	2	table	table	NOUN
ajlm-2286	42	3	of	of	ADP
ajlm-2286	42	4	random	random	ADJ
ajlm-2286	42	5	numbers	number	NOUN
ajlm-2286	42	6	was	be	AUX
ajlm-2286	42	7	then	then	ADV
ajlm-2286	42	8	used	use	VERB
ajlm-2286	42	9	to	to	PART
ajlm-2286	42	10	select	select	VERB
ajlm-2286	42	11	the	the	DET
ajlm-2286	42	12	controls	control	NOUN
ajlm-2286	42	13	that	that	PRON
ajlm-2286	42	14	participated	participate	VERB
ajlm-2286	42	15	in	in	ADP
ajlm-2286	42	16	the	the	DET
ajlm-2286	42	17	study	study	NOUN
ajlm-2286	42	18	.	.	PUNCT
ajlm-2286	43	1	a	a	DET
ajlm-2286	43	2	standard	standard	ADJ
ajlm-2286	43	3	,	,	PUNCT
ajlm-2286	43	4	structured	structured	ADJ
ajlm-2286	43	5	questionnaire	questionnaire	NOUN
ajlm-2286	43	6	was	be	AUX
ajlm-2286	43	7	administered	administer	VERB
ajlm-2286	43	8	via	via	ADP
ajlm-2286	43	9	paper	paper	NOUN
ajlm-2286	43	10	to	to	ADP
ajlm-2286	43	11	all	all	DET
ajlm-2286	43	12	participants	participant	NOUN
ajlm-2286	43	13	by	by	ADP
ajlm-2286	43	14	the	the	DET
ajlm-2286	43	15	researchers	researcher	NOUN
ajlm-2286	43	16	(	(	PUNCT
ajlm-2286	43	17	online	online	PROPN
ajlm-2286	43	18	supplementary	supplementary	ADJ
ajlm-2286	43	19	figure	figure	NOUN
ajlm-2286	43	20	1	1	NUM
ajlm-2286	43	21	)	)	PUNCT
ajlm-2286	43	22	.	.	PUNCT
ajlm-2286	44	1	the	the	DET
ajlm-2286	44	2	questionnaire	questionnaire	NOUN
ajlm-2286	44	3	was	be	AUX
ajlm-2286	44	4	used	use	VERB
ajlm-2286	44	5	alongside	alongside	ADP
ajlm-2286	44	6	patients	patient	NOUN
ajlm-2286	44	7	’	'	PUNCT
ajlm-2286	44	8	medical	medical	ADJ
ajlm-2286	44	9	records	record	NOUN
ajlm-2286	44	10	to	to	PART
ajlm-2286	44	11	address	address	VERB
ajlm-2286	44	12	the	the	DET
ajlm-2286	44	13	general	general	ADJ
ajlm-2286	44	14	characteristics	characteristic	NOUN
ajlm-2286	44	15	of	of	ADP
ajlm-2286	44	16	all	all	DET
ajlm-2286	44	17	participants	participant	NOUN
ajlm-2286	44	18	and	and	CCONJ
ajlm-2286	44	19	to	to	PART
ajlm-2286	44	20	exclude	exclude	VERB
ajlm-2286	44	21	participants	participant	NOUN
ajlm-2286	44	22	on	on	ADP
ajlm-2286	44	23	hormonal	hormonal	ADJ
ajlm-2286	44	24	therapy	therapy	NOUN
ajlm-2286	44	25	,	,	PUNCT
ajlm-2286	44	26	lipid	lipid	NOUN
ajlm-2286	44	27	-	-	PUNCT
ajlm-2286	44	28	lowering	lower	VERB
ajlm-2286	44	29	medications	medication	NOUN
ajlm-2286	44	30	,	,	PUNCT
ajlm-2286	44	31	and	and	CCONJ
ajlm-2286	44	32	those	those	PRON
ajlm-2286	44	33	with	with	ADP
ajlm-2286	44	34	chronic	chronic	ADJ
ajlm-2286	44	35	and	and	CCONJ
ajlm-2286	44	36	degenerative	degenerative	ADJ
ajlm-2286	44	37	diseases	disease	NOUN
ajlm-2286	44	38	,	,	PUNCT
ajlm-2286	44	39	such	such	ADJ
ajlm-2286	44	40	as	as	ADP
ajlm-2286	44	41	diabetes	diabetes	NOUN
ajlm-2286	44	42	,	,	PUNCT
ajlm-2286	44	43	cancer	cancer	NOUN
ajlm-2286	44	44	,	,	PUNCT
ajlm-2286	44	45	and	and	CCONJ
ajlm-2286	44	46	chronic	chronic	ADJ
ajlm-2286	44	47	kidney	kidney	NOUN
ajlm-2286	44	48	and	and	CCONJ
ajlm-2286	44	49	liver	liver	NOUN
ajlm-2286	44	50	diseases	disease	NOUN
ajlm-2286	44	51	,	,	PUNCT
ajlm-2286	44	52	as	as	SCONJ
ajlm-2286	44	53	these	these	DET
ajlm-2286	44	54	diseases	disease	NOUN
ajlm-2286	44	55	and	and	CCONJ
ajlm-2286	44	56	medications	medication	NOUN
ajlm-2286	44	57	may	may	AUX
ajlm-2286	44	58	alter	alter	VERB
ajlm-2286	44	59	the	the	DET
ajlm-2286	44	60	outcome	outcome	NOUN
ajlm-2286	44	61	of	of	ADP
ajlm-2286	44	62	the	the	DET
ajlm-2286	44	63	results	result	NOUN
ajlm-2286	44	64	in	in	ADP
ajlm-2286	44	65	the	the	DET
ajlm-2286	44	66	participants	participant	NOUN
ajlm-2286	44	67	.	.	PUNCT
ajlm-2286	45	1	figure	figure	VERB
ajlm-2286	45	2	1	1	NUM
ajlm-2286	45	3	:	:	PUNCT
ajlm-2286	45	4	graded	grade	VERB
ajlm-2286	45	5	variations	variation	NOUN
ajlm-2286	45	6	in	in	ADP
ajlm-2286	45	7	the	the	DET
ajlm-2286	45	8	mean	mean	ADJ
ajlm-2286	45	9	plasma	plasma	NOUN
ajlm-2286	45	10	lecithin	lecithin	NOUN
ajlm-2286	45	11	-	-	PUNCT
ajlm-2286	45	12	cholesterol	cholesterol	NOUN
ajlm-2286	45	13	acyltransferase	acyltransferase	NOUN
ajlm-2286	45	14	concentrations	concentration	NOUN
ajlm-2286	45	15	in	in	ADP
ajlm-2286	45	16	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	45	17	cardiovascular	cardiovascular	ADJ
ajlm-2286	45	18	disease	disease	NOUN
ajlm-2286	45	19	subclasses	subclass	NOUN
ajlm-2286	45	20	and	and	CCONJ
ajlm-2286	45	21	controls	control	NOUN
ajlm-2286	45	22	at	at	ADP
ajlm-2286	45	23	lagos	lagos	PROPN
ajlm-2286	45	24	state	state	NOUN
ajlm-2286	45	25	university	university	PROPN
ajlm-2286	45	26	teaching	teaching	NOUN
ajlm-2286	45	27	hospital	hospital	NOUN
ajlm-2286	45	28	,	,	PUNCT
ajlm-2286	45	29	lagos	lago	NOUN
ajlm-2286	45	30	,	,	PUNCT
ajlm-2286	45	31	nigeria	nigeria	PROPN
ajlm-2286	45	32	,	,	PUNCT
ajlm-2286	45	33	between	between	ADP
ajlm-2286	45	34	march	march	PROPN
ajlm-2286	45	35	2022	2022	NUM
ajlm-2286	45	36	and	and	CCONJ
ajlm-2286	45	37	march	march	PROPN
ajlm-2286	45	38	2023	2023	NUM
ajlm-2286	45	39	.	.	PUNCT
ajlm-2286	46	1	anthropometry	anthropometry	NOUN
ajlm-2286	46	2	anthropometric	anthropometric	ADJ
ajlm-2286	46	3	measurements	measurement	NOUN
ajlm-2286	46	4	(	(	PUNCT
ajlm-2286	46	5	weight	weight	NOUN
ajlm-2286	46	6	,	,	PUNCT
ajlm-2286	46	7	height	height	NOUN
ajlm-2286	46	8	,	,	PUNCT
ajlm-2286	46	9	waist	waist	NOUN
ajlm-2286	46	10	,	,	PUNCT
ajlm-2286	46	11	and	and	CCONJ
ajlm-2286	46	12	hip	hip	NOUN
ajlm-2286	46	13	circumference	circumference	NOUN
ajlm-2286	46	14	)	)	PUNCT
ajlm-2286	46	15	were	be	AUX
ajlm-2286	46	16	measured	measure	VERB
ajlm-2286	46	17	using	use	VERB
ajlm-2286	46	18	standard	standard	ADJ
ajlm-2286	46	19	procedures	procedure	NOUN
ajlm-2286	46	20	.	.	PUNCT
ajlm-2286	47	1	heights	height	NOUN
ajlm-2286	47	2	were	be	AUX
ajlm-2286	47	3	measured	measure	VERB
ajlm-2286	47	4	to	to	ADP
ajlm-2286	47	5	the	the	DET
ajlm-2286	47	6	nearest	near	ADJ
ajlm-2286	47	7	centimetre	centimetre	NOUN
ajlm-2286	47	8	with	with	ADP
ajlm-2286	47	9	participants	participant	NOUN
ajlm-2286	47	10	in	in	ADP
ajlm-2286	47	11	standing	standing	NOUN
ajlm-2286	47	12	positions	position	NOUN
ajlm-2286	47	13	,	,	PUNCT
ajlm-2286	47	14	without	without	ADP
ajlm-2286	47	15	footwear	footwear	NOUN
ajlm-2286	47	16	,	,	PUNCT
ajlm-2286	47	17	using	use	VERB
ajlm-2286	47	18	a	a	DET
ajlm-2286	47	19	non	non	ADJ
ajlm-2286	47	20	-	-	ADJ
ajlm-2286	47	21	stretchable	stretchable	ADJ
ajlm-2286	47	22	measuring	measuring	NOUN
ajlm-2286	47	23	tape	tape	NOUN
ajlm-2286	47	24	.	.	PUNCT
ajlm-2286	48	1	each	each	DET
ajlm-2286	48	2	participant	participant	NOUN
ajlm-2286	48	3	’s	’s	PART
ajlm-2286	48	4	body	body	NOUN
ajlm-2286	48	5	weight	weight	NOUN
ajlm-2286	48	6	was	be	AUX
ajlm-2286	48	7	measured	measure	VERB
ajlm-2286	48	8	with	with	ADP
ajlm-2286	48	9	light	light	ADJ
ajlm-2286	48	10	clothing	clothing	NOUN
ajlm-2286	48	11	and	and	CCONJ
ajlm-2286	48	12	without	without	ADP
ajlm-2286	48	13	shoes	shoe	NOUN
ajlm-2286	48	14	on	on	ADP
ajlm-2286	48	15	a	a	DET
ajlm-2286	48	16	digital	digital	ADJ
ajlm-2286	48	17	scale	scale	NOUN
ajlm-2286	48	18	(	(	PUNCT
ajlm-2286	48	19	omron	omron	PROPN
ajlm-2286	48	20	h	h	PROPN
ajlm-2286	48	21	bf-514c	bf-514c	PROPN
ajlm-2286	48	22	,	,	PUNCT
ajlm-2286	48	23	kyoto	kyoto	PROPN
ajlm-2286	48	24	,	,	PUNCT
ajlm-2286	48	25	japan	japan	PROPN
ajlm-2286	48	26	)	)	PUNCT
ajlm-2286	48	27	.	.	PUNCT
ajlm-2286	49	1	body	body	NOUN
ajlm-2286	49	2	mass	mass	PROPN
ajlm-2286	49	3	index	index	NOUN
ajlm-2286	49	4	(	(	PUNCT
ajlm-2286	49	5	bmi	bmi	PROPN
ajlm-2286	49	6	)	)	PUNCT
ajlm-2286	49	7	was	be	AUX
ajlm-2286	49	8	then	then	ADV
ajlm-2286	49	9	deduced	deduce	VERB
ajlm-2286	49	10	from	from	ADP
ajlm-2286	49	11	the	the	DET
ajlm-2286	49	12	participants	participant	NOUN
ajlm-2286	49	13	’	'	PUNCT
ajlm-2286	49	14	weight	weight	NOUN
ajlm-2286	49	15	(	(	PUNCT
ajlm-2286	49	16	kg	kg	NOUN
ajlm-2286	49	17	)	)	PUNCT
ajlm-2286	49	18	and	and	CCONJ
ajlm-2286	49	19	their	their	PRON
ajlm-2286	49	20	height	height	NOUN
ajlm-2286	49	21	(	(	PUNCT
ajlm-2286	49	22	m	m	NOUN
ajlm-2286	49	23	)	)	PUNCT
ajlm-2286	49	24	;	;	PUNCT
ajlm-2286	49	25	bmi	bmi	PROPN
ajlm-2286	49	26	=	=	SYM
ajlm-2286	49	27	kg	kg	PROPN
ajlm-2286	49	28	/	/	SYM
ajlm-2286	49	29	m2	m2	PROPN
ajlm-2286	49	30	.	.	PROPN
ajlm-2286	49	31	waist	waist	NOUN
ajlm-2286	49	32	circumference	circumference	NOUN
ajlm-2286	49	33	(	(	PUNCT
ajlm-2286	49	34	cm	cm	NOUN
ajlm-2286	49	35	)	)	PUNCT
ajlm-2286	49	36	was	be	AUX
ajlm-2286	49	37	measured	measure	VERB
ajlm-2286	49	38	at	at	ADP
ajlm-2286	49	39	the	the	DET
ajlm-2286	49	40	midpoint	midpoint	NOUN
ajlm-2286	49	41	between	between	ADP
ajlm-2286	49	42	the	the	DET
ajlm-2286	49	43	rib	rib	NOUN
ajlm-2286	49	44	cage	cage	NOUN
ajlm-2286	49	45	’s	’s	PART
ajlm-2286	49	46	lower	low	ADJ
ajlm-2286	49	47	border	border	NOUN
ajlm-2286	49	48	and	and	CCONJ
ajlm-2286	49	49	the	the	DET
ajlm-2286	49	50	hip	hip	NOUN
ajlm-2286	49	51	bones	bone	NOUN
ajlm-2286	49	52	’	'	PUNCT
ajlm-2286	49	53	iliac	iliac	NOUN
ajlm-2286	49	54	crest	crest	NOUN
ajlm-2286	49	55	,	,	PUNCT
ajlm-2286	49	56	measured	measure	VERB
ajlm-2286	49	57	in	in	ADP
ajlm-2286	49	58	the	the	DET
ajlm-2286	49	59	horizontal	horizontal	ADJ
ajlm-2286	49	60	plane	plane	NOUN
ajlm-2286	49	61	with	with	ADP
ajlm-2286	49	62	the	the	DET
ajlm-2286	49	63	participant	participant	NOUN
ajlm-2286	49	64	standing	stand	VERB
ajlm-2286	49	65	during	during	ADP
ajlm-2286	49	66	inspired	inspire	VERB
ajlm-2286	49	67	expiration	expiration	NOUN
ajlm-2286	49	68	using	use	VERB
ajlm-2286	49	69	a	a	DET
ajlm-2286	49	70	non	non	ADJ
ajlm-2286	49	71	-	-	ADJ
ajlm-2286	49	72	stretchable	stretchable	ADJ
ajlm-2286	49	73	tape	tape	NOUN
ajlm-2286	49	74	.	.	PUNCT
ajlm-2286	50	1	the	the	DET
ajlm-2286	50	2	hip	hip	NOUN
ajlm-2286	50	3	circumference	circumference	NOUN
ajlm-2286	50	4	(	(	PUNCT
ajlm-2286	50	5	cm	cm	NOUN
ajlm-2286	50	6	)	)	PUNCT
ajlm-2286	50	7	was	be	AUX
ajlm-2286	50	8	taken	take	VERB
ajlm-2286	50	9	at	at	ADP
ajlm-2286	50	10	the	the	DET
ajlm-2286	50	11	level	level	NOUN
ajlm-2286	50	12	of	of	ADP
ajlm-2286	50	13	the	the	DET
ajlm-2286	50	14	greater	great	ADJ
ajlm-2286	50	15	trochanter	trochanter	NOUN
ajlm-2286	50	16	,	,	PUNCT
ajlm-2286	50	17	that	that	ADV
ajlm-2286	50	18	is	is	ADV
ajlm-2286	50	19	,	,	PUNCT
ajlm-2286	50	20	around	around	ADP
ajlm-2286	50	21	the	the	DET
ajlm-2286	50	22	point	point	NOUN
ajlm-2286	50	23	with	with	ADP
ajlm-2286	50	24	the	the	DET
ajlm-2286	50	25	maximum	maximum	ADJ
ajlm-2286	50	26	circumference	circumference	NOUN
ajlm-2286	50	27	over	over	ADP
ajlm-2286	50	28	the	the	DET
ajlm-2286	50	29	buttocks	buttock	NOUN
ajlm-2286	50	30	.	.	PUNCT
ajlm-2286	51	1	both	both	PRON
ajlm-2286	51	2	waist	waist	NOUN
ajlm-2286	51	3	and	and	CCONJ
ajlm-2286	51	4	hip	hip	NOUN
ajlm-2286	51	5	circumferences	circumference	NOUN
ajlm-2286	51	6	were	be	AUX
ajlm-2286	51	7	then	then	ADV
ajlm-2286	51	8	used	use	VERB
ajlm-2286	51	9	to	to	PART
ajlm-2286	51	10	determine	determine	VERB
ajlm-2286	51	11	the	the	DET
ajlm-2286	51	12	waist	waist	NOUN
ajlm-2286	51	13	-	-	PUNCT
ajlm-2286	51	14	hip	hip	NOUN
ajlm-2286	51	15	ratio	ratio	NOUN
ajlm-2286	51	16	of	of	ADP
ajlm-2286	51	17	participants	participant	NOUN
ajlm-2286	51	18	.	.	PUNCT
ajlm-2286	52	1	all	all	DET
ajlm-2286	52	2	participants	participant	NOUN
ajlm-2286	52	3	’	'	PUNCT
ajlm-2286	52	4	systolic	systolic	ADJ
ajlm-2286	52	5	and	and	CCONJ
ajlm-2286	52	6	diastolic	diastolic	ADJ
ajlm-2286	52	7	blood	blood	NOUN
ajlm-2286	52	8	pressures	pressure	NOUN
ajlm-2286	52	9	in	in	ADP
ajlm-2286	52	10	millimetres	millimetre	NOUN
ajlm-2286	52	11	of	of	ADP
ajlm-2286	52	12	mercury	mercury	NOUN
ajlm-2286	52	13	were	be	AUX
ajlm-2286	52	14	measured	measure	VERB
ajlm-2286	52	15	twice	twice	ADV
ajlm-2286	52	16	using	use	VERB
ajlm-2286	52	17	an	an	DET
ajlm-2286	52	18	omron	omron	ADJ
ajlm-2286	52	19	electronic	electronic	ADJ
ajlm-2286	52	20	blood	blood	NOUN
ajlm-2286	52	21	pressure	pressure	NOUN
ajlm-2286	52	22	monitor	monitor	NOUN
ajlm-2286	52	23	(	(	PUNCT
ajlm-2286	52	24	omron	omron	PROPN
ajlm-2286	52	25	bp	bp	PROPN
ajlm-2286	52	26	7250	7250	NUM
ajlm-2286	52	27	,	,	PUNCT
ajlm-2286	52	28	kyoto	kyoto	PROPN
ajlm-2286	52	29	,	,	PUNCT
ajlm-2286	52	30	japan	japan	PROPN
ajlm-2286	52	31	)	)	PUNCT
ajlm-2286	52	32	and	and	CCONJ
ajlm-2286	52	33	the	the	DET
ajlm-2286	52	34	average	average	NOUN
ajlm-2286	52	35	was	be	AUX
ajlm-2286	52	36	recorded	record	VERB
ajlm-2286	52	37	and	and	CCONJ
ajlm-2286	52	38	used	use	VERB
ajlm-2286	52	39	in	in	ADP
ajlm-2286	52	40	the	the	DET
ajlm-2286	52	41	analyses	analysis	NOUN
ajlm-2286	52	42	.	.	PUNCT
ajlm-2286	53	1	blood	blood	NOUN
ajlm-2286	53	2	sample	sample	NOUN
ajlm-2286	53	3	collection	collection	NOUN
ajlm-2286	53	4	about	about	ADV
ajlm-2286	53	5	7	7	NUM
ajlm-2286	53	6	ml	ml	NOUN
ajlm-2286	53	7	of	of	ADP
ajlm-2286	53	8	venous	venous	ADJ
ajlm-2286	53	9	blood	blood	NOUN
ajlm-2286	53	10	were	be	AUX
ajlm-2286	53	11	collected	collect	VERB
ajlm-2286	53	12	by	by	ADP
ajlm-2286	53	13	the	the	DET
ajlm-2286	53	14	researchers	researcher	NOUN
ajlm-2286	53	15	from	from	ADP
ajlm-2286	53	16	patients	patient	NOUN
ajlm-2286	53	17	and	and	CCONJ
ajlm-2286	53	18	controls	control	NOUN
ajlm-2286	53	19	after	after	ADP
ajlm-2286	53	20	an	an	DET
ajlm-2286	53	21	overnight	overnight	ADJ
ajlm-2286	53	22	fast	fast	NOUN
ajlm-2286	53	23	of	of	ADP
ajlm-2286	53	24	8	8	NUM
ajlm-2286	53	25	h	h	NOUN
ajlm-2286	53	26	–	–	PUNCT
ajlm-2286	53	27	12	12	NUM
ajlm-2286	53	28	h	h	NOUN
ajlm-2286	53	29	and	and	CCONJ
ajlm-2286	53	30	dispensed	dispense	VERB
ajlm-2286	53	31	into	into	ADP
ajlm-2286	53	32	a	a	DET
ajlm-2286	53	33	potassium	potassium	NOUN
ajlm-2286	53	34	-	-	PUNCT
ajlm-2286	53	35	ethylene	ethylene	NOUN
ajlm-2286	53	36	-	-	PUNCT
ajlm-2286	53	37	diamine	diamine	NOUN
ajlm-2286	53	38	tetra	tetra	NOUN
ajlm-2286	53	39	-	-	PUNCT
ajlm-2286	53	40	acetic	acetic	ADJ
ajlm-2286	53	41	acid	acid	NOUN
ajlm-2286	53	42	sample	sample	NOUN
ajlm-2286	53	43	container	container	NOUN
ajlm-2286	53	44	(	(	PUNCT
ajlm-2286	53	45	1	1	NUM
ajlm-2286	53	46	mg	mg	NUM
ajlm-2286	53	47	/	/	SYM
ajlm-2286	53	48	ml	ml	NOUN
ajlm-2286	53	49	of	of	ADP
ajlm-2286	53	50	blood	blood	NOUN
ajlm-2286	53	51	)	)	PUNCT
ajlm-2286	53	52	.	.	PUNCT
ajlm-2286	54	1	each	each	DET
ajlm-2286	54	2	sample	sample	NOUN
ajlm-2286	54	3	was	be	AUX
ajlm-2286	54	4	immediately	immediately	ADV
ajlm-2286	54	5	placed	place	VERB
ajlm-2286	54	6	in	in	ADP
ajlm-2286	54	7	a	a	DET
ajlm-2286	54	8	cold	cold	ADJ
ajlm-2286	54	9	chain	chain	NOUN
ajlm-2286	54	10	until	until	SCONJ
ajlm-2286	54	11	centrifuged	centrifuge	VERB
ajlm-2286	54	12	at	at	ADP
ajlm-2286	54	13	3000	3000	NUM
ajlm-2286	54	14	rpm	rpm	NOUN
ajlm-2286	54	15	for	for	ADP
ajlm-2286	54	16	5	5	NUM
ajlm-2286	54	17	min	min	NOUN
ajlm-2286	54	18	.	.	PUNCT
ajlm-2286	55	1	the	the	DET
ajlm-2286	55	2	plasma	plasma	NOUN
ajlm-2286	55	3	was	be	AUX
ajlm-2286	55	4	carefully	carefully	ADV
ajlm-2286	55	5	separated	separate	VERB
ajlm-2286	55	6	from	from	ADP
ajlm-2286	55	7	the	the	DET
ajlm-2286	55	8	cells	cell	NOUN
ajlm-2286	55	9	into	into	ADP
ajlm-2286	55	10	labelled	label	VERB
ajlm-2286	55	11	screw	screw	NOUN
ajlm-2286	55	12	-	-	PUNCT
ajlm-2286	55	13	capped	cap	VERB
ajlm-2286	55	14	bottles	bottle	NOUN
ajlm-2286	55	15	and	and	CCONJ
ajlm-2286	55	16	stored	store	VERB
ajlm-2286	55	17	at	at	ADP
ajlm-2286	55	18	–	–	PUNCT
ajlm-2286	55	19	20	20	NUM
ajlm-2286	56	1	°	°	NUM
ajlm-2286	56	2	c	c	NOUN
ajlm-2286	56	3	until	until	ADP
ajlm-2286	56	4	assayed	assayed	ADJ
ajlm-2286	56	5	.	.	PUNCT
ajlm-2286	57	1	biochemical	biochemical	ADJ
ajlm-2286	57	2	analysis	analysis	NOUN
ajlm-2286	57	3	lipid	lipid	NOUN
ajlm-2286	57	4	profile	profile	NOUN
ajlm-2286	57	5	parameters	parameter	NOUN
ajlm-2286	57	6	were	be	AUX
ajlm-2286	57	7	assayed	assayed	ADJ
ajlm-2286	57	8	using	use	VERB
ajlm-2286	57	9	commercially	commercially	ADV
ajlm-2286	57	10	available	available	ADJ
ajlm-2286	57	11	kits	kit	NOUN
ajlm-2286	57	12	(	(	PUNCT
ajlm-2286	57	13	randox	randox	NOUN
ajlm-2286	57	14	cholesterol	cholesterol	NOUN
ajlm-2286	57	15	,	,	PUNCT
ajlm-2286	57	16	high	high	ADJ
ajlm-2286	57	17	-	-	PUNCT
ajlm-2286	57	18	density	density	NOUN
ajlm-2286	57	19	lipoprotein	lipoprotein	ADJ
ajlm-2286	57	20	cholesterol	cholesterol	NOUN
ajlm-2286	57	21	[	[	X
ajlm-2286	57	22	hdlc	hdlc	NOUN
ajlm-2286	57	23	]	]	PUNCT
ajlm-2286	57	24	,	,	PUNCT
ajlm-2286	57	25	and	and	CCONJ
ajlm-2286	57	26	triglycerides	triglyceride	NOUN
ajlm-2286	58	1	[	[	X
ajlm-2286	58	2	tg	tg	X
ajlm-2286	58	3	]	]	PUNCT
ajlm-2286	58	4	)	)	PUNCT
ajlm-2286	58	5	from	from	ADP
ajlm-2286	58	6	randox	randox	PROPN
ajlm-2286	58	7	laboratories	laboratories	PROPN
ajlm-2286	58	8	ltd	ltd	PROPN
ajlm-2286	58	9	.	.	PROPN
ajlm-2286	58	10	,	,	PUNCT
ajlm-2286	58	11	crumlin	crumlin	PROPN
ajlm-2286	58	12	,	,	PUNCT
ajlm-2286	58	13	united	united	ADJ
ajlm-2286	58	14	kingdom	kingdom	PROPN
ajlm-2286	58	15	.	.	PUNCT
ajlm-2286	59	1	the	the	DET
ajlm-2286	59	2	method	method	NOUN
ajlm-2286	59	3	of	of	ADP
ajlm-2286	59	4	allain	allain	PROPN
ajlm-2286	59	5	et	et	PROPN
ajlm-2286	59	6	al.22	al.22	PROPN
ajlm-2286	59	7	was	be	AUX
ajlm-2286	59	8	used	use	VERB
ajlm-2286	59	9	for	for	ADP
ajlm-2286	59	10	the	the	DET
ajlm-2286	59	11	estimation	estimation	NOUN
ajlm-2286	59	12	of	of	ADP
ajlm-2286	59	13	total	total	ADJ
ajlm-2286	59	14	cholesterol	cholesterol	NOUN
ajlm-2286	59	15	(	(	PUNCT
ajlm-2286	59	16	tc	tc	NOUN
ajlm-2286	59	17	)	)	PUNCT
ajlm-2286	59	18	and	and	CCONJ
ajlm-2286	59	19	hdlc	hdlc	PROPN
ajlm-2286	59	20	,	,	PUNCT
ajlm-2286	59	21	while	while	SCONJ
ajlm-2286	59	22	bucolo	bucolo	PROPN
ajlm-2286	59	23	and	and	CCONJ
ajlm-2286	59	24	david’s23	david’s23	NOUN
ajlm-2286	59	25	method	method	NOUN
ajlm-2286	59	26	was	be	AUX
ajlm-2286	59	27	employed	employ	VERB
ajlm-2286	59	28	for	for	ADP
ajlm-2286	59	29	the	the	DET
ajlm-2286	59	30	estimation	estimation	NOUN
ajlm-2286	59	31	of	of	ADP
ajlm-2286	59	32	triglycerides	triglyceride	NOUN
ajlm-2286	59	33	.	.	PUNCT
ajlm-2286	60	1	low	low	ADJ
ajlm-2286	60	2	-	-	PUNCT
ajlm-2286	60	3	density	density	NOUN
ajlm-2286	60	4	lipoprotein	lipoprotein	ADJ
ajlm-2286	60	5	cholesterol	cholesterol	NOUN
ajlm-2286	60	6	(	(	PUNCT
ajlm-2286	60	7	ldlc	ldlc	NOUN
ajlm-2286	60	8	)	)	PUNCT
ajlm-2286	60	9	was	be	AUX
ajlm-2286	60	10	calculated	calculate	VERB
ajlm-2286	60	11	using	use	VERB
ajlm-2286	60	12	friedewald	friedewald	PROPN
ajlm-2286	60	13	et	et	PROPN
ajlm-2286	60	14	al	al	PROPN
ajlm-2286	60	15	.	.	PROPN
ajlm-2286	60	16	’s24	’s24	PROPN
ajlm-2286	60	17	formulae	formulae	PROPN
ajlm-2286	60	18	.	.	PUNCT
ajlm-2286	61	1	non	non	ADJ
ajlm-2286	61	2	-	-	ADJ
ajlm-2286	61	3	hdlc	hdlc	ADJ
ajlm-2286	61	4	(	(	PUNCT
ajlm-2286	61	5	nhdlc	nhdlc	NOUN
ajlm-2286	61	6	)	)	PUNCT
ajlm-2286	61	7	is	be	AUX
ajlm-2286	61	8	the	the	DET
ajlm-2286	61	9	sum	sum	NOUN
ajlm-2286	61	10	of	of	ADP
ajlm-2286	61	11	all	all	DET
ajlm-2286	61	12	the	the	DET
ajlm-2286	61	13	cholesterol	cholesterol	NOUN
ajlm-2286	61	14	present	present	ADJ
ajlm-2286	61	15	in	in	ADP
ajlm-2286	61	16	each	each	DET
ajlm-2286	61	17	lipoprotein	lipoprotein	NOUN
ajlm-2286	61	18	except	except	SCONJ
ajlm-2286	61	19	hdlc	hdlc	NOUN
ajlm-2286	61	20	,	,	PUNCT
ajlm-2286	61	21	and	and	CCONJ
ajlm-2286	61	22	it	it	PRON
ajlm-2286	61	23	is	be	AUX
ajlm-2286	61	24	derived	derive	VERB
ajlm-2286	61	25	by	by	ADP
ajlm-2286	61	26	deducting	deduct	VERB
ajlm-2286	61	27	hdlc	hdlc	NOUN
ajlm-2286	61	28	from	from	ADP
ajlm-2286	61	29	the	the	DET
ajlm-2286	61	30	tc	tc	NOUN
ajlm-2286	61	31	of	of	ADP
ajlm-2286	61	32	the	the	DET
ajlm-2286	61	33	conventional	conventional	ADJ
ajlm-2286	61	34	lipid	lipid	NOUN
ajlm-2286	61	35	panel.25	panel.25	PROPN
ajlm-2286	61	36	plasma	plasma	NOUN
ajlm-2286	61	37	human	human	PROPN
ajlm-2286	61	38	pon-1	pon-1	PUNCT
ajlm-2286	61	39	and	and	CCONJ
ajlm-2286	61	40	lcat	lcat	ADJ
ajlm-2286	61	41	concentrations	concentration	NOUN
ajlm-2286	61	42	were	be	AUX
ajlm-2286	61	43	determined	determine	VERB
ajlm-2286	61	44	using	use	VERB
ajlm-2286	61	45	the	the	DET
ajlm-2286	61	46	sandwich	sandwich	NOUN
ajlm-2286	61	47	enzyme	enzyme	NOUN
ajlm-2286	61	48	-	-	PUNCT
ajlm-2286	61	49	linked	link	VERB
ajlm-2286	61	50	immunosorbent	immunosorbent	NOUN
ajlm-2286	61	51	assay	assay	NOUN
ajlm-2286	61	52	method26	method26	NOUN
ajlm-2286	61	53	kit	kit	NOUN
ajlm-2286	61	54	supplied	supply	VERB
ajlm-2286	61	55	by	by	ADP
ajlm-2286	61	56	elabscience	elabscience	NOUN
ajlm-2286	61	57	biotechnology	biotechnology	NOUN
ajlm-2286	61	58	limited	limit	VERB
ajlm-2286	61	59	company	company	NOUN
ajlm-2286	61	60	,	,	PUNCT
ajlm-2286	61	61	wuhan	wuhan	PROPN
ajlm-2286	61	62	,	,	PUNCT
ajlm-2286	61	63	china	china	PROPN
ajlm-2286	61	64	.	.	PUNCT
ajlm-2286	62	1	quality	quality	PROPN
ajlm-2286	62	2	control	control	PROPN
ajlm-2286	62	3	sera	sera	NOUN
ajlm-2286	62	4	were	be	AUX
ajlm-2286	62	5	assayed	assayed	ADJ
ajlm-2286	62	6	along	along	ADP
ajlm-2286	62	7	with	with	ADP
ajlm-2286	62	8	the	the	DET
ajlm-2286	62	9	research	research	NOUN
ajlm-2286	62	10	samples	sample	NOUN
ajlm-2286	62	11	during	during	ADP
ajlm-2286	62	12	each	each	DET
ajlm-2286	62	13	batch	batch	NOUN
ajlm-2286	62	14	of	of	ADP
ajlm-2286	62	15	tests	test	NOUN
ajlm-2286	62	16	.	.	PUNCT
ajlm-2286	63	1	data	datum	NOUN
ajlm-2286	63	2	analysis	analysis	NOUN
ajlm-2286	63	3	all	all	DET
ajlm-2286	63	4	results	result	NOUN
ajlm-2286	63	5	were	be	AUX
ajlm-2286	63	6	analysed	analyse	VERB
ajlm-2286	63	7	using	use	VERB
ajlm-2286	63	8	statistical	statistical	ADJ
ajlm-2286	63	9	package	package	NOUN
ajlm-2286	63	10	for	for	ADP
ajlm-2286	63	11	social	social	ADJ
ajlm-2286	63	12	science	science	NOUN
ajlm-2286	63	13	software	software	NOUN
ajlm-2286	63	14	version	version	NOUN
ajlm-2286	63	15	21	21	NUM
ajlm-2286	63	16	for	for	ADP
ajlm-2286	63	17	windows	window	NOUN
ajlm-2286	63	18	10	10	NUM
ajlm-2286	63	19	by	by	ADP
ajlm-2286	63	20	ibm	ibm	PROPN
ajlm-2286	63	21	corporation	corporation	NOUN
ajlm-2286	63	22	(	(	PUNCT
ajlm-2286	63	23	chicago	chicago	PROPN
ajlm-2286	63	24	,	,	PUNCT
ajlm-2286	63	25	illinois	illinois	PROPN
ajlm-2286	63	26	,	,	PUNCT
ajlm-2286	63	27	united	united	PROPN
ajlm-2286	63	28	states	states	PROPN
ajlm-2286	63	29	)	)	PUNCT
ajlm-2286	63	30	.	.	PUNCT
ajlm-2286	64	1	the	the	DET
ajlm-2286	64	2	results	result	NOUN
ajlm-2286	64	3	were	be	AUX
ajlm-2286	64	4	expressed	express	VERB
ajlm-2286	64	5	as	as	ADP
ajlm-2286	64	6	the	the	DET
ajlm-2286	64	7	mean	mean	ADJ
ajlm-2286	64	8	and	and	CCONJ
ajlm-2286	64	9	standard	standard	ADJ
ajlm-2286	64	10	deviation	deviation	NOUN
ajlm-2286	64	11	(	(	PUNCT
ajlm-2286	64	12	mean	mean	PROPN
ajlm-2286	64	13	±	±	NUM
ajlm-2286	64	14	s.d	s.d	PROPN
ajlm-2286	64	15	.	.	PUNCT
ajlm-2286	64	16	)	)	PUNCT
ajlm-2286	64	17	.	.	PUNCT
ajlm-2286	65	1	a	a	DET
ajlm-2286	65	2	student	student	NOUN
ajlm-2286	65	3	’s	’s	PART
ajlm-2286	65	4	t	t	PROPN
ajlm-2286	65	5	-	-	PUNCT
ajlm-2286	65	6	test	test	NOUN
ajlm-2286	65	7	was	be	AUX
ajlm-2286	65	8	used	use	VERB
ajlm-2286	65	9	to	to	PART
ajlm-2286	65	10	compare	compare	VERB
ajlm-2286	65	11	the	the	DET
ajlm-2286	65	12	statistical	statistical	ADJ
ajlm-2286	65	13	difference	difference	NOUN
ajlm-2286	65	14	between	between	ADP
ajlm-2286	65	15	the	the	DET
ajlm-2286	65	16	two	two	NUM
ajlm-2286	65	17	means	mean	NOUN
ajlm-2286	65	18	,	,	PUNCT
ajlm-2286	65	19	and	and	CCONJ
ajlm-2286	65	20	the	the	DET
ajlm-2286	65	21	differences	difference	NOUN
ajlm-2286	65	22	were	be	AUX
ajlm-2286	65	23	regarded	regard	VERB
ajlm-2286	65	24	as	as	ADV
ajlm-2286	65	25	significant	significant	ADJ
ajlm-2286	65	26	at	at	ADP
ajlm-2286	65	27	p	p	X
ajlm-2286	65	28	<	<	X
ajlm-2286	65	29	0.05	0.05	NUM
ajlm-2286	65	30	.	.	PUNCT
ajlm-2286	66	1	an	an	DET
ajlm-2286	66	2	analysis	analysis	NOUN
ajlm-2286	66	3	of	of	ADP
ajlm-2286	66	4	variance	variance	NOUN
ajlm-2286	66	5	was	be	AUX
ajlm-2286	66	6	used	use	VERB
ajlm-2286	66	7	to	to	PART
ajlm-2286	66	8	determine	determine	VERB
ajlm-2286	66	9	differences	difference	NOUN
ajlm-2286	66	10	within	within	ADP
ajlm-2286	66	11	groups	group	NOUN
ajlm-2286	66	12	,	,	PUNCT
ajlm-2286	66	13	and	and	CCONJ
ajlm-2286	66	14	the	the	DET
ajlm-2286	66	15	differences	difference	NOUN
ajlm-2286	66	16	were	be	AUX
ajlm-2286	66	17	regarded	regard	VERB
ajlm-2286	66	18	as	as	ADV
ajlm-2286	66	19	significant	significant	ADJ
ajlm-2286	66	20	at	at	ADP
ajlm-2286	66	21	p	p	X
ajlm-2286	66	22	<	<	X
ajlm-2286	66	23	0.01	0.01	NUM
ajlm-2286	66	24	.	.	PUNCT
ajlm-2286	67	1	the	the	DET
ajlm-2286	67	2	relationships	relationship	NOUN
ajlm-2286	67	3	between	between	ADP
ajlm-2286	67	4	lcat	lcat	NOUN
ajlm-2286	67	5	,	,	PUNCT
ajlm-2286	67	6	pon-1	pon-1	NOUN
ajlm-2286	67	7	,	,	PUNCT
ajlm-2286	67	8	and	and	CCONJ
ajlm-2286	67	9	conventional	conventional	ADJ
ajlm-2286	67	10	lipid	lipid	NOUN
ajlm-2286	67	11	parameters	parameter	NOUN
ajlm-2286	67	12	were	be	AUX
ajlm-2286	67	13	assessed	assess	VERB
ajlm-2286	67	14	using	use	VERB
ajlm-2286	67	15	pearson	pearson	PROPN
ajlm-2286	67	16	’s	’s	PART
ajlm-2286	67	17	bivariate	bivariate	ADJ
ajlm-2286	67	18	correlation	correlation	NOUN
ajlm-2286	67	19	and	and	CCONJ
ajlm-2286	67	20	were	be	AUX
ajlm-2286	67	21	regarded	regard	VERB
ajlm-2286	67	22	as	as	ADV
ajlm-2286	67	23	significant	significant	ADJ
ajlm-2286	67	24	at	at	ADP
ajlm-2286	67	25	p	p	NOUN
ajlm-2286	67	26	<	<	X
ajlm-2286	67	27	0.01	0.01	NUM
ajlm-2286	67	28	and	and	CCONJ
ajlm-2286	67	29	p	p	X
ajlm-2286	67	30	<	<	X
ajlm-2286	67	31	0.05	0.05	NUM
ajlm-2286	67	32	(	(	PUNCT
ajlm-2286	67	33	two	two	NUM
ajlm-2286	67	34	-	-	PUNCT
ajlm-2286	67	35	tailed	tail	VERB
ajlm-2286	67	36	)	)	PUNCT
ajlm-2286	67	37	.	.	PUNCT
ajlm-2286	68	1	results	result	VERB
ajlm-2286	68	2	general	general	ADJ
ajlm-2286	68	3	characteristics	characteristic	NOUN
ajlm-2286	68	4	of	of	ADP
ajlm-2286	68	5	study	study	NOUN
ajlm-2286	68	6	population	population	NOUN
ajlm-2286	68	7	a	a	DET
ajlm-2286	68	8	total	total	NOUN
ajlm-2286	68	9	of	of	ADP
ajlm-2286	68	10	153	153	NUM
ajlm-2286	68	11	confirmed	confirm	VERB
ajlm-2286	68	12	ascvd	ascvd	NOUN
ajlm-2286	68	13	patients	patient	NOUN
ajlm-2286	68	14	(	(	PUNCT
ajlm-2286	68	15	65	65	NUM
ajlm-2286	68	16	men	man	NOUN
ajlm-2286	68	17	and	and	CCONJ
ajlm-2286	68	18	88	88	NUM
ajlm-2286	68	19	women	woman	NOUN
ajlm-2286	68	20	)	)	PUNCT
ajlm-2286	68	21	aged	age	VERB
ajlm-2286	68	22	between	between	ADP
ajlm-2286	68	23	22	22	NUM
ajlm-2286	68	24	years	year	NOUN
ajlm-2286	68	25	and	and	CCONJ
ajlm-2286	68	26	64	64	NUM
ajlm-2286	68	27	years	year	NOUN
ajlm-2286	68	28	were	be	AUX
ajlm-2286	68	29	enrolled	enrol	VERB
ajlm-2286	68	30	in	in	ADP
ajlm-2286	68	31	the	the	DET
ajlm-2286	68	32	study	study	NOUN
ajlm-2286	68	33	.	.	PUNCT
ajlm-2286	69	1	this	this	DET
ajlm-2286	69	2	comprised	comprise	VERB
ajlm-2286	69	3	patients	patient	NOUN
ajlm-2286	69	4	suffering	suffer	VERB
ajlm-2286	69	5	from	from	ADP
ajlm-2286	69	6	ihd	ihd	ADJ
ajlm-2286	69	7	(	(	PUNCT
ajlm-2286	69	8	n	n	NOUN
ajlm-2286	69	9	=	=	NUM
ajlm-2286	69	10	35	35	NUM
ajlm-2286	69	11	)	)	PUNCT
ajlm-2286	69	12	,	,	PUNCT
ajlm-2286	69	13	stroke	stroke	NOUN
ajlm-2286	69	14	(	(	PUNCT
ajlm-2286	69	15	n	n	NOUN
ajlm-2286	69	16	=	=	NUM
ajlm-2286	69	17	20	20	NUM
ajlm-2286	69	18	)	)	PUNCT
ajlm-2286	69	19	,	,	PUNCT
ajlm-2286	69	20	hypertensive	hypertensive	ADJ
ajlm-2286	69	21	heart	heart	NOUN
ajlm-2286	69	22	disease	disease	NOUN
ajlm-2286	69	23	(	(	PUNCT
ajlm-2286	69	24	n	n	NOUN
ajlm-2286	69	25	=	=	SYM
ajlm-2286	69	26	43	43	NUM
ajlm-2286	69	27	)	)	PUNCT
ajlm-2286	69	28	,	,	PUNCT
ajlm-2286	69	29	myocardial	myocardial	ADJ
ajlm-2286	69	30	infarction	infarction	NOUN
ajlm-2286	69	31	(	(	PUNCT
ajlm-2286	69	32	n	n	NOUN
ajlm-2286	69	33	=	=	NUM
ajlm-2286	69	34	15	15	NUM
ajlm-2286	69	35	)	)	PUNCT
ajlm-2286	69	36	,	,	PUNCT
ajlm-2286	69	37	and	and	CCONJ
ajlm-2286	69	38	congestive	congestive	ADJ
ajlm-2286	69	39	heart	heart	NOUN
ajlm-2286	69	40	failure	failure	NOUN
ajlm-2286	69	41	(	(	PUNCT
ajlm-2286	69	42	n	n	NOUN
ajlm-2286	69	43	=	=	NUM
ajlm-2286	69	44	40	40	NUM
ajlm-2286	69	45	)	)	PUNCT
ajlm-2286	69	46	.	.	PUNCT
ajlm-2286	70	1	a	a	DET
ajlm-2286	70	2	total	total	NOUN
ajlm-2286	70	3	of	of	ADP
ajlm-2286	70	4	112	112	NUM
ajlm-2286	70	5	patients	patient	NOUN
ajlm-2286	70	6	attended	attend	VERB
ajlm-2286	70	7	the	the	DET
ajlm-2286	70	8	cardio	cardio	NOUN
ajlm-2286	70	9	clinic	clinic	NOUN
ajlm-2286	70	10	and	and	CCONJ
ajlm-2286	70	11	41	41	NUM
ajlm-2286	70	12	were	be	AUX
ajlm-2286	70	13	patients	patient	NOUN
ajlm-2286	70	14	admitted	admit	VERB
ajlm-2286	70	15	into	into	ADP
ajlm-2286	70	16	the	the	DET
ajlm-2286	70	17	state	state	NOUN
ajlm-2286	70	18	university	university	PROPN
ajlm-2286	70	19	teaching	teaching	NOUN
ajlm-2286	70	20	hospital	hospital	NOUN
ajlm-2286	70	21	emergency	emergency	NOUN
ajlm-2286	70	22	medical	medical	ADJ
ajlm-2286	70	23	wards	ward	NOUN
ajlm-2286	70	24	.	.	PUNCT
ajlm-2286	71	1	controls	control	NOUN
ajlm-2286	71	2	comprised	comprise	VERB
ajlm-2286	71	3	50	50	NUM
ajlm-2286	71	4	healthy	healthy	ADJ
ajlm-2286	71	5	volunteers	volunteer	NOUN
ajlm-2286	71	6	(	(	PUNCT
ajlm-2286	71	7	22	22	NUM
ajlm-2286	71	8	men	man	NOUN
ajlm-2286	71	9	and	and	CCONJ
ajlm-2286	71	10	28	28	NUM
ajlm-2286	71	11	women	woman	NOUN
ajlm-2286	71	12	)	)	PUNCT
ajlm-2286	71	13	aged	age	VERB
ajlm-2286	71	14	between	between	ADP
ajlm-2286	71	15	22	22	NUM
ajlm-2286	71	16	years	year	NOUN
ajlm-2286	71	17	and	and	CCONJ
ajlm-2286	71	18	64	64	NUM
ajlm-2286	71	19	years	year	NOUN
ajlm-2286	71	20	.	.	PUNCT
ajlm-2286	72	1	there	there	PRON
ajlm-2286	72	2	were	be	VERB
ajlm-2286	72	3	statistically	statistically	ADV
ajlm-2286	72	4	significant	significant	ADJ
ajlm-2286	72	5	differences	difference	NOUN
ajlm-2286	72	6	between	between	ADP
ajlm-2286	72	7	ascvd	ascvd	NOUN
ajlm-2286	72	8	patients	patient	NOUN
ajlm-2286	72	9	compared	compare	VERB
ajlm-2286	72	10	to	to	ADP
ajlm-2286	72	11	controls	control	NOUN
ajlm-2286	72	12	,	,	PUNCT
ajlm-2286	72	13	with	with	ADP
ajlm-2286	72	14	ascvd	ascvd	NOUN
ajlm-2286	72	15	patients	patient	NOUN
ajlm-2286	72	16	generally	generally	ADV
ajlm-2286	72	17	having	have	VERB
ajlm-2286	72	18	higher	high	ADJ
ajlm-2286	72	19	values	value	NOUN
ajlm-2286	72	20	for	for	ADP
ajlm-2286	72	21	mean	mean	NOUN
ajlm-2286	72	22	age	age	NOUN
ajlm-2286	72	23	,	,	PUNCT
ajlm-2286	72	24	weight	weight	NOUN
ajlm-2286	72	25	,	,	PUNCT
ajlm-2286	72	26	waist	waist	NOUN
ajlm-2286	72	27	circumference	circumference	NOUN
ajlm-2286	72	28	,	,	PUNCT
ajlm-2286	72	29	waist	waist	NOUN
ajlm-2286	72	30	-	-	PUNCT
ajlm-2286	72	31	hip	hip	NOUN
ajlm-2286	72	32	ratio	ratio	NOUN
ajlm-2286	72	33	,	,	PUNCT
ajlm-2286	72	34	bmi	bmi	PROPN
ajlm-2286	72	35	,	,	PUNCT
ajlm-2286	72	36	systolic	systolic	ADJ
ajlm-2286	72	37	blood	blood	NOUN
ajlm-2286	72	38	pressure	pressure	NOUN
ajlm-2286	72	39	,	,	PUNCT
ajlm-2286	72	40	diastolic	diastolic	ADJ
ajlm-2286	72	41	blood	blood	NOUN
ajlm-2286	72	42	pressure	pressure	NOUN
ajlm-2286	72	43	(	(	PUNCT
ajlm-2286	72	44	all	all	DET
ajlm-2286	72	45	p	p	X
ajlm-2286	72	46	<	<	X
ajlm-2286	72	47	0.001	0.001	NUM
ajlm-2286	72	48	)	)	PUNCT
ajlm-2286	72	49	,	,	PUNCT
ajlm-2286	72	50	as	as	ADV
ajlm-2286	72	51	well	well	ADV
ajlm-2286	72	52	as	as	ADP
ajlm-2286	72	53	hip	hip	NOUN
ajlm-2286	72	54	circumference	circumference	NOUN
ajlm-2286	72	55	(	(	PUNCT
ajlm-2286	72	56	p	p	NOUN
ajlm-2286	72	57	=	=	NOUN
ajlm-2286	72	58	0.030	0.030	NUM
ajlm-2286	72	59	)	)	PUNCT
ajlm-2286	72	60	and	and	CCONJ
ajlm-2286	72	61	pulse	pulse	NOUN
ajlm-2286	72	62	(	(	PUNCT
ajlm-2286	72	63	p	p	X
ajlm-2286	72	64	=	=	NOUN
ajlm-2286	72	65	0.003	0.003	NUM
ajlm-2286	72	66	)	)	PUNCT
ajlm-2286	72	67	(	(	PUNCT
ajlm-2286	72	68	table	table	NOUN
ajlm-2286	72	69	1	1	NUM
ajlm-2286	72	70	)	)	PUNCT
ajlm-2286	72	71	.	.	PUNCT
ajlm-2286	73	1	when	when	SCONJ
ajlm-2286	73	2	ascvd	ascvd	NOUN
ajlm-2286	73	3	male	male	ADJ
ajlm-2286	73	4	patients	patient	NOUN
ajlm-2286	73	5	were	be	AUX
ajlm-2286	73	6	compared	compare	VERB
ajlm-2286	73	7	to	to	ADP
ajlm-2286	73	8	female	female	ADJ
ajlm-2286	73	9	patients	patient	NOUN
ajlm-2286	73	10	,	,	PUNCT
ajlm-2286	73	11	statistically	statistically	ADV
ajlm-2286	73	12	significant	significant	ADJ
ajlm-2286	73	13	variations	variation	NOUN
ajlm-2286	73	14	were	be	AUX
ajlm-2286	73	15	only	only	ADV
ajlm-2286	73	16	observed	observe	VERB
ajlm-2286	73	17	for	for	ADP
ajlm-2286	73	18	mean	mean	ADJ
ajlm-2286	73	19	height	height	NOUN
ajlm-2286	73	20	,	,	PUNCT
ajlm-2286	73	21	waist	waist	NOUN
ajlm-2286	73	22	circumference	circumference	NOUN
ajlm-2286	73	23	,	,	PUNCT
ajlm-2286	73	24	waist	waist	NOUN
ajlm-2286	73	25	-	-	PUNCT
ajlm-2286	73	26	hip	hip	NOUN
ajlm-2286	73	27	ratio	ratio	NOUN
ajlm-2286	73	28	(	(	PUNCT
ajlm-2286	73	29	all	all	DET
ajlm-2286	73	30	p	p	X
ajlm-2286	73	31	<	<	X
ajlm-2286	73	32	0.001	0.001	NUM
ajlm-2286	73	33	)	)	PUNCT
ajlm-2286	73	34	,	,	PUNCT
ajlm-2286	73	35	as	as	ADV
ajlm-2286	73	36	well	well	ADV
ajlm-2286	73	37	as	as	ADP
ajlm-2286	73	38	weight	weight	NOUN
ajlm-2286	73	39	(	(	PUNCT
ajlm-2286	73	40	p	p	NOUN
ajlm-2286	73	41	=	=	NOUN
ajlm-2286	73	42	0.006	0.006	NUM
ajlm-2286	73	43	)	)	PUNCT
ajlm-2286	73	44	and	and	CCONJ
ajlm-2286	73	45	hip	hip	NOUN
ajlm-2286	73	46	circumference	circumference	NOUN
ajlm-2286	73	47	(	(	PUNCT
ajlm-2286	73	48	p	p	NOUN
ajlm-2286	73	49	=	=	NOUN
ajlm-2286	73	50	0.013	0.013	NUM
ajlm-2286	73	51	)	)	PUNCT
ajlm-2286	73	52	.	.	PUNCT
ajlm-2286	74	1	no	no	DET
ajlm-2286	74	2	significant	significant	ADJ
ajlm-2286	74	3	difference	difference	NOUN
ajlm-2286	74	4	was	be	AUX
ajlm-2286	74	5	observed	observe	VERB
ajlm-2286	74	6	in	in	ADP
ajlm-2286	74	7	the	the	DET
ajlm-2286	74	8	mean	mean	ADJ
ajlm-2286	74	9	height	height	NOUN
ajlm-2286	74	10	of	of	ADP
ajlm-2286	74	11	ascvd	ascvd	NOUN
ajlm-2286	74	12	patients	patient	NOUN
ajlm-2286	74	13	compared	compare	VERB
ajlm-2286	74	14	to	to	ADP
ajlm-2286	74	15	the	the	DET
ajlm-2286	74	16	controls	control	NOUN
ajlm-2286	74	17	.	.	PUNCT
ajlm-2286	75	1	table	table	NOUN
ajlm-2286	75	2	1	1	NUM
ajlm-2286	75	3	:	:	PUNCT
ajlm-2286	75	4	 	 	SPACE
ajlm-2286	75	5	general	general	ADJ
ajlm-2286	75	6	characteristics	characteristic	NOUN
ajlm-2286	75	7	,	,	PUNCT
ajlm-2286	75	8	anthropometry	anthropometry	NOUN
ajlm-2286	75	9	,	,	PUNCT
ajlm-2286	75	10	blood	blood	NOUN
ajlm-2286	75	11	pressure	pressure	NOUN
ajlm-2286	75	12	,	,	PUNCT
ajlm-2286	75	13	and	and	CCONJ
ajlm-2286	75	14	pulse	pulse	NOUN
ajlm-2286	75	15	readings	reading	NOUN
ajlm-2286	75	16	of	of	ADP
ajlm-2286	75	17	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	75	18	cardiovascular	cardiovascular	ADJ
ajlm-2286	75	19	disease	disease	NOUN
ajlm-2286	75	20	patients	patient	NOUN
ajlm-2286	75	21	and	and	CCONJ
ajlm-2286	75	22	controls	control	NOUN
ajlm-2286	75	23	at	at	ADP
ajlm-2286	75	24	lagos	lagos	PROPN
ajlm-2286	75	25	state	state	NOUN
ajlm-2286	75	26	university	university	PROPN
ajlm-2286	75	27	teaching	teaching	NOUN
ajlm-2286	75	28	hospital	hospital	NOUN
ajlm-2286	75	29	,	,	PUNCT
ajlm-2286	75	30	lagos	lago	NOUN
ajlm-2286	75	31	,	,	PUNCT
ajlm-2286	75	32	nigeria	nigeria	PROPN
ajlm-2286	75	33	,	,	PUNCT
ajlm-2286	75	34	between	between	ADP
ajlm-2286	75	35	march	march	PROPN
ajlm-2286	75	36	2022	2022	NUM
ajlm-2286	75	37	and	and	CCONJ
ajlm-2286	75	38	march	march	PROPN
ajlm-2286	75	39	2023	2023	NUM
ajlm-2286	75	40	.	.	PUNCT
ajlm-2286	76	1	lipid	lipid	NOUN
ajlm-2286	76	2	profile	profile	NOUN
ajlm-2286	76	3	,	,	PUNCT
ajlm-2286	76	4	lecithin	lecithin	NOUN
ajlm-2286	76	5	-	-	PUNCT
ajlm-2286	76	6	cholesterol	cholesterol	NOUN
ajlm-2286	76	7	acyltransferase	acyltransferase	NOUN
ajlm-2286	76	8	,	,	PUNCT
ajlm-2286	76	9	and	and	CCONJ
ajlm-2286	76	10	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	76	11	in	in	ADP
ajlm-2286	76	12	all	all	DET
ajlm-2286	76	13	participants	participant	NOUN
ajlm-2286	76	14	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	76	15	cardiovascular	cardiovascular	ADJ
ajlm-2286	76	16	disease	disease	NOUN
ajlm-2286	76	17	patients	patient	NOUN
ajlm-2286	76	18	had	have	VERB
ajlm-2286	76	19	statistically	statistically	ADV
ajlm-2286	76	20	significant	significant	ADJ
ajlm-2286	76	21	differences	difference	NOUN
ajlm-2286	76	22	compared	compare	VERB
ajlm-2286	76	23	to	to	ADP
ajlm-2286	76	24	controls	control	NOUN
ajlm-2286	76	25	with	with	ADP
ajlm-2286	76	26	higher	high	ADJ
ajlm-2286	76	27	values	value	NOUN
ajlm-2286	76	28	for	for	ADP
ajlm-2286	76	29	mean	mean	ADJ
ajlm-2286	76	30	plasma	plasma	NOUN
ajlm-2286	76	31	tc	tc	NOUN
ajlm-2286	76	32	,	,	PUNCT
ajlm-2286	76	33	triglycerides	triglyceride	NOUN
ajlm-2286	76	34	,	,	PUNCT
ajlm-2286	76	35	ldlc	ldlc	NOUN
ajlm-2286	76	36	,	,	PUNCT
ajlm-2286	76	37	and	and	CCONJ
ajlm-2286	76	38	nhdlc	nhdlc	NOUN
ajlm-2286	76	39	(	(	PUNCT
ajlm-2286	76	40	all	all	DET
ajlm-2286	76	41	p	p	X
ajlm-2286	76	42	<	<	X
ajlm-2286	76	43	0.001	0.001	NUM
ajlm-2286	76	44	)	)	PUNCT
ajlm-2286	76	45	(	(	PUNCT
ajlm-2286	76	46	table	table	NOUN
ajlm-2286	76	47	2	2	NUM
ajlm-2286	76	48	)	)	PUNCT
ajlm-2286	76	49	.	.	PUNCT
ajlm-2286	77	1	conversely	conversely	ADV
ajlm-2286	77	2	,	,	PUNCT
ajlm-2286	77	3	statistically	statistically	ADV
ajlm-2286	77	4	significant	significant	ADJ
ajlm-2286	77	5	differences	difference	NOUN
ajlm-2286	77	6	were	be	AUX
ajlm-2286	77	7	observed	observe	VERB
ajlm-2286	77	8	for	for	ADP
ajlm-2286	77	9	mean	mean	ADJ
ajlm-2286	77	10	plasma	plasma	NOUN
ajlm-2286	77	11	hdlc	hdlc	NOUN
ajlm-2286	77	12	,	,	PUNCT
ajlm-2286	77	13	pon-1	pon-1	NOUN
ajlm-2286	77	14	,	,	PUNCT
ajlm-2286	77	15	and	and	CCONJ
ajlm-2286	77	16	lcat	lcat	ADJ
ajlm-2286	77	17	(	(	PUNCT
ajlm-2286	77	18	all	all	PRON
ajlm-2286	77	19	p	p	X
ajlm-2286	77	20	<	<	X
ajlm-2286	77	21	0.001	0.001	NUM
ajlm-2286	77	22	)	)	PUNCT
ajlm-2286	77	23	with	with	ADP
ajlm-2286	77	24	lower	low	ADJ
ajlm-2286	77	25	values	value	NOUN
ajlm-2286	77	26	for	for	ADP
ajlm-2286	77	27	ascvd	ascvd	NOUN
ajlm-2286	77	28	patients	patient	NOUN
ajlm-2286	77	29	compared	compare	VERB
ajlm-2286	77	30	to	to	PART
ajlm-2286	77	31	control	control	VERB
ajlm-2286	77	32	values	value	NOUN
ajlm-2286	77	33	.	.	PUNCT
ajlm-2286	78	1	table	table	NOUN
ajlm-2286	78	2	2	2	NUM
ajlm-2286	78	3	:	:	PUNCT
ajlm-2286	78	4	 	 	SPACE
ajlm-2286	78	5	lipid	lipid	NOUN
ajlm-2286	78	6	profile	profile	NOUN
ajlm-2286	78	7	,	,	PUNCT
ajlm-2286	78	8	lecithin	lecithin	NOUN
ajlm-2286	78	9	-	-	PUNCT
ajlm-2286	78	10	cholesterol	cholesterol	NOUN
ajlm-2286	78	11	acyltransferase	acyltransferase	NOUN
ajlm-2286	78	12	,	,	PUNCT
ajlm-2286	78	13	and	and	CCONJ
ajlm-2286	78	14	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	78	15	of	of	ADP
ajlm-2286	78	16	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	78	17	cardiovascular	cardiovascular	ADJ
ajlm-2286	78	18	disease	disease	NOUN
ajlm-2286	78	19	patients	patient	NOUN
ajlm-2286	78	20	and	and	CCONJ
ajlm-2286	78	21	controls	control	NOUN
ajlm-2286	78	22	at	at	ADP
ajlm-2286	78	23	lagos	lagos	PROPN
ajlm-2286	78	24	state	state	NOUN
ajlm-2286	78	25	university	university	PROPN
ajlm-2286	78	26	teaching	teaching	NOUN
ajlm-2286	78	27	hospital	hospital	NOUN
ajlm-2286	78	28	,	,	PUNCT
ajlm-2286	78	29	lagos	lago	NOUN
ajlm-2286	78	30	,	,	PUNCT
ajlm-2286	78	31	nigeria	nigeria	PROPN
ajlm-2286	78	32	,	,	PUNCT
ajlm-2286	78	33	between	between	ADP
ajlm-2286	78	34	march	march	PROPN
ajlm-2286	78	35	2022	2022	NUM
ajlm-2286	78	36	and	and	CCONJ
ajlm-2286	78	37	march	march	PROPN
ajlm-2286	78	38	2023	2023	NUM
ajlm-2286	78	39	.	.	PUNCT
ajlm-2286	79	1	lipid	lipid	NOUN
ajlm-2286	79	2	profile	profile	NOUN
ajlm-2286	79	3	,	,	PUNCT
ajlm-2286	79	4	lecithin	lecithin	NOUN
ajlm-2286	79	5	-	-	PUNCT
ajlm-2286	79	6	cholesterol	cholesterol	NOUN
ajlm-2286	79	7	acyltransferase	acyltransferase	NOUN
ajlm-2286	79	8	,	,	PUNCT
ajlm-2286	79	9	and	and	CCONJ
ajlm-2286	79	10	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	79	11	in	in	ADP
ajlm-2286	79	12	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	79	13	cardiovascular	cardiovascular	ADJ
ajlm-2286	79	14	disease	disease	NOUN
ajlm-2286	79	15	subclasses	subclass	NOUN
ajlm-2286	79	16	statistically	statistically	ADV
ajlm-2286	79	17	significant	significant	ADJ
ajlm-2286	79	18	differences	difference	NOUN
ajlm-2286	79	19	were	be	AUX
ajlm-2286	79	20	observed	observe	VERB
ajlm-2286	79	21	in	in	ADP
ajlm-2286	79	22	mean	mean	ADJ
ajlm-2286	79	23	values	value	NOUN
ajlm-2286	79	24	of	of	ADP
ajlm-2286	79	25	plasma	plasma	NOUN
ajlm-2286	79	26	tc	tc	NOUN
ajlm-2286	79	27	,	,	PUNCT
ajlm-2286	79	28	triglycerides	triglyceride	NOUN
ajlm-2286	79	29	,	,	PUNCT
ajlm-2286	79	30	ldlc	ldlc	NOUN
ajlm-2286	79	31	,	,	PUNCT
ajlm-2286	79	32	and	and	CCONJ
ajlm-2286	79	33	nhdlc	nhdlc	NOUN
ajlm-2286	79	34	(	(	PUNCT
ajlm-2286	79	35	all	all	DET
ajlm-2286	79	36	p	p	NOUN
ajlm-2286	79	37	≤	≤	NUM
ajlm-2286	79	38	0.001	0.001	NUM
ajlm-2286	79	39	)	)	PUNCT
ajlm-2286	79	40	with	with	ADP
ajlm-2286	79	41	higher	high	ADJ
ajlm-2286	79	42	values	value	NOUN
ajlm-2286	79	43	for	for	ADP
ajlm-2286	79	44	subclasses	subclass	NOUN
ajlm-2286	79	45	of	of	ADP
ajlm-2286	79	46	ascvd	ascvd	NOUN
ajlm-2286	79	47	compared	compare	VERB
ajlm-2286	79	48	with	with	ADP
ajlm-2286	79	49	controls	control	NOUN
ajlm-2286	79	50	(	(	PUNCT
ajlm-2286	79	51	table	table	NOUN
ajlm-2286	79	52	3	3	NUM
ajlm-2286	79	53	)	)	PUNCT
ajlm-2286	79	54	.	.	PUNCT
ajlm-2286	80	1	on	on	ADP
ajlm-2286	80	2	the	the	DET
ajlm-2286	80	3	other	other	ADJ
ajlm-2286	80	4	hand	hand	NOUN
ajlm-2286	80	5	,	,	PUNCT
ajlm-2286	80	6	statistically	statistically	ADV
ajlm-2286	80	7	significant	significant	ADJ
ajlm-2286	80	8	differences	difference	NOUN
ajlm-2286	80	9	were	be	AUX
ajlm-2286	80	10	noted	note	VERB
ajlm-2286	80	11	in	in	ADP
ajlm-2286	80	12	mean	mean	ADJ
ajlm-2286	80	13	values	value	NOUN
ajlm-2286	80	14	for	for	ADP
ajlm-2286	80	15	plasma	plasma	NOUN
ajlm-2286	80	16	hdlc	hdlc	NOUN
ajlm-2286	80	17	,	,	PUNCT
ajlm-2286	80	18	pon-1	pon-1	NOUN
ajlm-2286	80	19	,	,	PUNCT
ajlm-2286	80	20	and	and	CCONJ
ajlm-2286	80	21	lcat	lcat	ADJ
ajlm-2286	80	22	(	(	PUNCT
ajlm-2286	80	23	all	all	PRON
ajlm-2286	80	24	p	p	NOUN
ajlm-2286	80	25	≤	≤	NUM
ajlm-2286	80	26	0.001	0.001	NUM
ajlm-2286	80	27	)	)	PUNCT
ajlm-2286	80	28	with	with	ADP
ajlm-2286	80	29	lower	low	ADJ
ajlm-2286	80	30	values	value	NOUN
ajlm-2286	80	31	for	for	ADP
ajlm-2286	80	32	subclasses	subclass	NOUN
ajlm-2286	80	33	of	of	ADP
ajlm-2286	80	34	ascvd	ascvd	NOUN
ajlm-2286	80	35	compared	compare	VERB
ajlm-2286	80	36	with	with	ADP
ajlm-2286	80	37	controls	control	NOUN
ajlm-2286	80	38	.	.	PUNCT
ajlm-2286	81	1	the	the	DET
ajlm-2286	81	2	largest	large	ADJ
ajlm-2286	81	3	differences	difference	NOUN
ajlm-2286	81	4	in	in	ADP
ajlm-2286	81	5	atherogenic	atherogenic	ADJ
ajlm-2286	81	6	lipids	lipid	NOUN
ajlm-2286	81	7	(	(	PUNCT
ajlm-2286	81	8	tc	tc	NOUN
ajlm-2286	81	9	and	and	CCONJ
ajlm-2286	81	10	triglycerides	triglyceride	NOUN
ajlm-2286	81	11	)	)	PUNCT
ajlm-2286	81	12	and	and	CCONJ
ajlm-2286	81	13	lipoproteins	lipoprotein	NOUN
ajlm-2286	81	14	(	(	PUNCT
ajlm-2286	81	15	ldlc	ldlc	NOUN
ajlm-2286	81	16	and	and	CCONJ
ajlm-2286	81	17	nhdlc	nhdlc	NOUN
ajlm-2286	81	18	)	)	PUNCT
ajlm-2286	81	19	were	be	AUX
ajlm-2286	81	20	observed	observe	VERB
ajlm-2286	81	21	among	among	ADP
ajlm-2286	81	22	patients	patient	NOUN
ajlm-2286	81	23	with	with	ADP
ajlm-2286	81	24	myocardial	myocardial	ADJ
ajlm-2286	81	25	infarction	infarction	NOUN
ajlm-2286	81	26	and	and	CCONJ
ajlm-2286	81	27	ihd	ihd	ADJ
ajlm-2286	81	28	.	.	PUNCT
ajlm-2286	82	1	conversely	conversely	ADV
ajlm-2286	82	2	,	,	PUNCT
ajlm-2286	82	3	these	these	DET
ajlm-2286	82	4	same	same	ADJ
ajlm-2286	82	5	two	two	NUM
ajlm-2286	82	6	ascvd	ascvd	NOUN
ajlm-2286	82	7	subclasses	subclass	NOUN
ajlm-2286	82	8	also	also	ADV
ajlm-2286	82	9	recorded	record	VERB
ajlm-2286	82	10	the	the	DET
ajlm-2286	82	11	lowest	low	ADJ
ajlm-2286	82	12	concentrations	concentration	NOUN
ajlm-2286	82	13	of	of	ADP
ajlm-2286	82	14	plasma	plasma	NOUN
ajlm-2286	82	15	hdlc	hdlc	NOUN
ajlm-2286	82	16	(	(	PUNCT
ajlm-2286	82	17	anti	anti	ADJ
ajlm-2286	82	18	-	-	ADJ
ajlm-2286	82	19	atherogenic	atherogenic	ADJ
ajlm-2286	82	20	lipoprotein	lipoprotein	NOUN
ajlm-2286	82	21	)	)	PUNCT
ajlm-2286	82	22	.	.	PUNCT
ajlm-2286	83	1	a	a	DET
ajlm-2286	83	2	similar	similar	ADJ
ajlm-2286	83	3	trend	trend	NOUN
ajlm-2286	83	4	was	be	AUX
ajlm-2286	83	5	observed	observe	VERB
ajlm-2286	83	6	in	in	ADP
ajlm-2286	83	7	the	the	DET
ajlm-2286	83	8	non	non	ADJ
ajlm-2286	83	9	-	-	ADJ
ajlm-2286	83	10	conventional	conventional	ADJ
ajlm-2286	83	11	lipid	lipid	NOUN
ajlm-2286	83	12	-	-	PUNCT
ajlm-2286	83	13	related	relate	VERB
ajlm-2286	83	14	ascvd	ascvd	NOUN
ajlm-2286	83	15	biomarkers	biomarker	NOUN
ajlm-2286	83	16	(	(	PUNCT
ajlm-2286	83	17	pon-1	pon-1	X
ajlm-2286	83	18	and	and	CCONJ
ajlm-2286	83	19	lcat	lcat	ADJ
ajlm-2286	83	20	)	)	PUNCT
ajlm-2286	83	21	,	,	PUNCT
ajlm-2286	83	22	where	where	SCONJ
ajlm-2286	83	23	myocardial	myocardial	ADJ
ajlm-2286	83	24	infarction	infarction	NOUN
ajlm-2286	83	25	and	and	CCONJ
ajlm-2286	83	26	ihd	ihd	ADJ
ajlm-2286	83	27	patients	patient	NOUN
ajlm-2286	83	28	were	be	AUX
ajlm-2286	83	29	noted	note	VERB
ajlm-2286	83	30	to	to	PART
ajlm-2286	83	31	have	have	VERB
ajlm-2286	83	32	the	the	DET
ajlm-2286	83	33	lowest	low	ADJ
ajlm-2286	83	34	concentrations	concentration	NOUN
ajlm-2286	83	35	of	of	ADP
ajlm-2286	83	36	plasma	plasma	NOUN
ajlm-2286	83	37	pon-1	pon-1	PUNCT
ajlm-2286	83	38	and	and	CCONJ
ajlm-2286	83	39	lcat	lcat	ADJ
ajlm-2286	83	40	.	.	PUNCT
ajlm-2286	84	1	table	table	NOUN
ajlm-2286	84	2	3	3	NUM
ajlm-2286	84	3	:	:	PUNCT
ajlm-2286	84	4	 	 	SPACE
ajlm-2286	84	5	lipid	lipid	NOUN
ajlm-2286	84	6	profile	profile	NOUN
ajlm-2286	84	7	,	,	PUNCT
ajlm-2286	84	8	lecithin	lecithin	NOUN
ajlm-2286	84	9	-	-	PUNCT
ajlm-2286	84	10	cholesterol	cholesterol	NOUN
ajlm-2286	84	11	acyltransferase	acyltransferase	NOUN
ajlm-2286	84	12	,	,	PUNCT
ajlm-2286	84	13	and	and	CCONJ
ajlm-2286	84	14	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	84	15	of	of	ADP
ajlm-2286	84	16	different	different	ADJ
ajlm-2286	84	17	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	84	18	cardiovascular	cardiovascular	ADJ
ajlm-2286	84	19	disease	disease	NOUN
ajlm-2286	84	20	subclasses	subclass	NOUN
ajlm-2286	84	21	and	and	CCONJ
ajlm-2286	84	22	controls	control	NOUN
ajlm-2286	84	23	at	at	ADP
ajlm-2286	84	24	lagos	lagos	PROPN
ajlm-2286	84	25	state	state	NOUN
ajlm-2286	84	26	university	university	PROPN
ajlm-2286	84	27	teaching	teaching	NOUN
ajlm-2286	84	28	hospital	hospital	NOUN
ajlm-2286	84	29	,	,	PUNCT
ajlm-2286	84	30	lagos	lago	NOUN
ajlm-2286	84	31	,	,	PUNCT
ajlm-2286	84	32	nigeria	nigeria	PROPN
ajlm-2286	84	33	,	,	PUNCT
ajlm-2286	84	34	between	between	ADP
ajlm-2286	84	35	march	march	PROPN
ajlm-2286	84	36	2022	2022	NUM
ajlm-2286	84	37	and	and	CCONJ
ajlm-2286	84	38	march	march	PROPN
ajlm-2286	84	39	2023	2023	NUM
ajlm-2286	84	40	.	.	PUNCT
ajlm-2286	85	1	association	association	NOUN
ajlm-2286	85	2	between	between	ADP
ajlm-2286	85	3	lecithin	lecithin	NOUN
ajlm-2286	85	4	-	-	PUNCT
ajlm-2286	85	5	cholesterol	cholesterol	NOUN
ajlm-2286	85	6	acyltransferase	acyltransferase	NOUN
ajlm-2286	85	7	,	,	PUNCT
ajlm-2286	85	8	paraoxonase-1	paraoxonase-1	PROPN
ajlm-2286	85	9	,	,	PUNCT
ajlm-2286	85	10	and	and	CCONJ
ajlm-2286	85	11	conventional	conventional	ADJ
ajlm-2286	85	12	lipid	lipid	NOUN
ajlm-2286	85	13	profiles	profile	NOUN
ajlm-2286	85	14	a	a	DET
ajlm-2286	85	15	statistically	statistically	ADV
ajlm-2286	85	16	significant	significant	ADJ
ajlm-2286	85	17	,	,	PUNCT
ajlm-2286	85	18	negative	negative	ADJ
ajlm-2286	85	19	correlation	correlation	NOUN
ajlm-2286	85	20	was	be	AUX
ajlm-2286	85	21	observed	observe	VERB
ajlm-2286	85	22	between	between	ADP
ajlm-2286	85	23	mean	mean	ADJ
ajlm-2286	85	24	body	body	NOUN
ajlm-2286	85	25	weight	weight	NOUN
ajlm-2286	85	26	and	and	CCONJ
ajlm-2286	85	27	both	both	DET
ajlm-2286	85	28	pon-1	pon-1	NUM
ajlm-2286	85	29	(	(	PUNCT
ajlm-2286	85	30	r	r	NOUN
ajlm-2286	85	31	=	=	SYM
ajlm-2286	85	32	-0.246	-0.246	NOUN
ajlm-2286	85	33	,	,	PUNCT
ajlm-2286	85	34	p	p	X
ajlm-2286	85	35	=	=	NOUN
ajlm-2286	85	36	0.002	0.002	NUM
ajlm-2286	85	37	)	)	PUNCT
ajlm-2286	85	38	and	and	CCONJ
ajlm-2286	85	39	lcat	lcat	ADJ
ajlm-2286	85	40	(	(	PUNCT
ajlm-2286	85	41	r	r	NOUN
ajlm-2286	85	42	=	=	SYM
ajlm-2286	85	43	-0.236	-0.236	PROPN
ajlm-2286	85	44	,	,	PUNCT
ajlm-2286	85	45	p	p	NOUN
ajlm-2286	85	46	=	=	NOUN
ajlm-2286	85	47	0.001	0.001	NUM
ajlm-2286	85	48	)	)	PUNCT
ajlm-2286	85	49	(	(	PUNCT
ajlm-2286	85	50	table	table	NOUN
ajlm-2286	85	51	4	4	NUM
ajlm-2286	85	52	)	)	PUNCT
ajlm-2286	85	53	.	.	PUNCT
ajlm-2286	86	1	a	a	DET
ajlm-2286	86	2	strong	strong	ADJ
ajlm-2286	86	3	negative	negative	ADJ
ajlm-2286	86	4	correlation	correlation	NOUN
ajlm-2286	86	5	was	be	AUX
ajlm-2286	86	6	noted	note	VERB
ajlm-2286	86	7	between	between	ADP
ajlm-2286	86	8	lcat	lcat	ADJ
ajlm-2286	86	9	and	and	CCONJ
ajlm-2286	86	10	atherogenic	atherogenic	ADJ
ajlm-2286	86	11	ldlc	ldlc	NOUN
ajlm-2286	86	12	(	(	PUNCT
ajlm-2286	86	13	r	r	NOUN
ajlm-2286	86	14	=	=	SYM
ajlm-2286	86	15	-0.213	-0.213	NOUN
ajlm-2286	86	16	,	,	PUNCT
ajlm-2286	86	17	p	p	NOUN
ajlm-2286	86	18	=	=	NOUN
ajlm-2286	86	19	0.004	0.004	NUM
ajlm-2286	86	20	)	)	PUNCT
ajlm-2286	86	21	,	,	PUNCT
ajlm-2286	86	22	tc	tc	PRON
ajlm-2286	86	23	(	(	PUNCT
ajlm-2286	86	24	r	r	NOUN
ajlm-2286	86	25	=	=	SYM
ajlm-2286	86	26	-0.197	-0.197	PROPN
ajlm-2286	86	27	,	,	PUNCT
ajlm-2286	86	28	p	p	NOUN
ajlm-2286	86	29	=	=	NOUN
ajlm-2286	86	30	0.007	0.007	NUM
ajlm-2286	86	31	)	)	PUNCT
ajlm-2286	86	32	,	,	PUNCT
ajlm-2286	86	33	and	and	CCONJ
ajlm-2286	86	34	nhdlc	nhdlc	NOUN
ajlm-2286	86	35	(	(	PUNCT
ajlm-2286	86	36	r	r	NOUN
ajlm-2286	86	37	=	=	SYM
ajlm-2286	86	38	-0.190	-0.190	ADJ
ajlm-2286	86	39	,	,	PUNCT
ajlm-2286	86	40	p	p	NOUN
ajlm-2286	86	41	=	=	NOUN
ajlm-2286	86	42	0.009	0.009	NUM
ajlm-2286	86	43	)	)	PUNCT
ajlm-2286	86	44	among	among	ADP
ajlm-2286	86	45	all	all	DET
ajlm-2286	86	46	ascvd	ascvd	NOUN
ajlm-2286	86	47	patients	patient	NOUN
ajlm-2286	86	48	.	.	PUNCT
ajlm-2286	87	1	on	on	ADP
ajlm-2286	87	2	the	the	DET
ajlm-2286	87	3	other	other	ADJ
ajlm-2286	87	4	hand	hand	NOUN
ajlm-2286	87	5	,	,	PUNCT
ajlm-2286	87	6	lcat	lcat	ADV
ajlm-2286	87	7	correlated	correlate	VERB
ajlm-2286	87	8	positively	positively	ADV
ajlm-2286	87	9	with	with	ADP
ajlm-2286	87	10	pon-1	pon-1	X
ajlm-2286	87	11	(	(	PUNCT
ajlm-2286	87	12	r	r	NOUN
ajlm-2286	87	13	=	=	NOUN
ajlm-2286	87	14	0.151	0.151	NUM
ajlm-2286	87	15	,	,	PUNCT
ajlm-2286	87	16	p	p	X
ajlm-2286	87	17	=	=	NOUN
ajlm-2286	87	18	0.031	0.031	NUM
ajlm-2286	87	19	)	)	PUNCT
ajlm-2286	87	20	among	among	ADP
ajlm-2286	87	21	ascvd	ascvd	NOUN
ajlm-2286	87	22	patients	patient	NOUN
ajlm-2286	87	23	.	.	PUNCT
ajlm-2286	88	1	table	table	NOUN
ajlm-2286	88	2	4	4	NUM
ajlm-2286	88	3	:	:	PUNCT
ajlm-2286	88	4	 	 	SPACE
ajlm-2286	88	5	pearson	pearson	PROPN
ajlm-2286	88	6	bivariate	bivariate	ADJ
ajlm-2286	88	7	correlation	correlation	NOUN
ajlm-2286	88	8	between	between	ADP
ajlm-2286	88	9	lecithin	lecithin	NOUN
ajlm-2286	88	10	-	-	PUNCT
ajlm-2286	88	11	cholesterol	cholesterol	NOUN
ajlm-2286	88	12	acyltransferase	acyltransferase	NOUN
ajlm-2286	88	13	,	,	PUNCT
ajlm-2286	88	14	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	88	15	and	and	CCONJ
ajlm-2286	88	16	conventional	conventional	ADJ
ajlm-2286	88	17	lipid	lipid	NOUN
ajlm-2286	88	18	profile	profile	NOUN
ajlm-2286	88	19	of	of	ADP
ajlm-2286	88	20	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	88	21	cardiovascular	cardiovascular	ADJ
ajlm-2286	88	22	diseases	disease	NOUN
ajlm-2286	88	23	patients	patient	NOUN
ajlm-2286	88	24	at	at	ADP
ajlm-2286	88	25	lagos	lagos	PROPN
ajlm-2286	88	26	state	state	NOUN
ajlm-2286	88	27	university	university	PROPN
ajlm-2286	88	28	teaching	teaching	NOUN
ajlm-2286	88	29	hospital	hospital	NOUN
ajlm-2286	88	30	,	,	PUNCT
ajlm-2286	88	31	lagos	lago	NOUN
ajlm-2286	88	32	,	,	PUNCT
ajlm-2286	88	33	nigeria	nigeria	PROPN
ajlm-2286	88	34	,	,	PUNCT
ajlm-2286	88	35	between	between	ADP
ajlm-2286	88	36	march	march	PROPN
ajlm-2286	88	37	2022	2022	NUM
ajlm-2286	88	38	and	and	CCONJ
ajlm-2286	88	39	march	march	PROPN
ajlm-2286	88	40	2023	2023	NUM
ajlm-2286	88	41	.	.	PUNCT
ajlm-2286	89	1	variations	variation	NOUN
ajlm-2286	89	2	in	in	ADP
ajlm-2286	89	3	lecithin	lecithin	NOUN
ajlm-2286	89	4	-	-	PUNCT
ajlm-2286	89	5	cholesterol	cholesterol	NOUN
ajlm-2286	89	6	acyltransferase	acyltransferase	NOUN
ajlm-2286	89	7	and	and	CCONJ
ajlm-2286	89	8	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	89	9	concentrations	concentration	NOUN
ajlm-2286	89	10	in	in	ADP
ajlm-2286	89	11	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	89	12	cardiovascular	cardiovascular	ADJ
ajlm-2286	89	13	disease	disease	NOUN
ajlm-2286	89	14	subclasses	subclass	NOUN
ajlm-2286	89	15	graded	grade	VERB
ajlm-2286	89	16	variations	variation	NOUN
ajlm-2286	89	17	were	be	AUX
ajlm-2286	89	18	observed	observe	VERB
ajlm-2286	89	19	in	in	ADP
ajlm-2286	89	20	the	the	DET
ajlm-2286	89	21	mean	mean	ADJ
ajlm-2286	89	22	plasma	plasma	NOUN
ajlm-2286	89	23	lcat	lcat	ADJ
ajlm-2286	89	24	concentrations	concentration	NOUN
ajlm-2286	89	25	in	in	ADP
ajlm-2286	89	26	the	the	DET
ajlm-2286	89	27	various	various	ADJ
ajlm-2286	89	28	subclasses	subclass	NOUN
ajlm-2286	89	29	of	of	ADP
ajlm-2286	89	30	ascvd	ascvd	NOUN
ajlm-2286	89	31	studied	study	VERB
ajlm-2286	89	32	(	(	PUNCT
ajlm-2286	89	33	figure	figure	NOUN
ajlm-2286	89	34	1	1	NUM
ajlm-2286	89	35	)	)	PUNCT
ajlm-2286	89	36	.	.	PUNCT
ajlm-2286	90	1	myocardial	myocardial	ADJ
ajlm-2286	90	2	infarction	infarction	NOUN
ajlm-2286	90	3	patients	patient	NOUN
ajlm-2286	90	4	had	have	VERB
ajlm-2286	90	5	the	the	DET
ajlm-2286	90	6	lowest	low	ADJ
ajlm-2286	90	7	mean	mean	ADJ
ajlm-2286	90	8	plasma	plasma	NOUN
ajlm-2286	90	9	lcat	lcat	ADJ
ajlm-2286	90	10	level	level	NOUN
ajlm-2286	90	11	.	.	PUNCT
ajlm-2286	91	1	similarly	similarly	ADV
ajlm-2286	91	2	,	,	PUNCT
ajlm-2286	91	3	graded	grade	VERB
ajlm-2286	91	4	reductions	reduction	NOUN
ajlm-2286	91	5	were	be	AUX
ajlm-2286	91	6	also	also	ADV
ajlm-2286	91	7	observed	observe	VERB
ajlm-2286	91	8	in	in	ADP
ajlm-2286	91	9	the	the	DET
ajlm-2286	91	10	mean	mean	ADJ
ajlm-2286	91	11	plasma	plasma	NOUN
ajlm-2286	91	12	pon-1	pon-1	PUNCT
ajlm-2286	91	13	concentration	concentration	NOUN
ajlm-2286	91	14	in	in	ADP
ajlm-2286	91	15	ascvd	ascvd	NOUN
ajlm-2286	91	16	subclasses	subclass	NOUN
ajlm-2286	91	17	(	(	PUNCT
ajlm-2286	91	18	figure	figure	NOUN
ajlm-2286	91	19	2	2	NUM
ajlm-2286	91	20	)	)	PUNCT
ajlm-2286	91	21	.	.	PUNCT
ajlm-2286	92	1	the	the	DET
ajlm-2286	92	2	lowest	low	ADJ
ajlm-2286	92	3	mean	mean	ADJ
ajlm-2286	92	4	plasma	plasma	NOUN
ajlm-2286	92	5	pon-1	pon-1	PUNCT
ajlm-2286	92	6	concentration	concentration	NOUN
ajlm-2286	92	7	was	be	AUX
ajlm-2286	92	8	noted	note	VERB
ajlm-2286	92	9	in	in	ADP
ajlm-2286	92	10	ihd	ihd	ADJ
ajlm-2286	92	11	patients	patient	NOUN
ajlm-2286	92	12	,	,	PUNCT
ajlm-2286	92	13	followed	follow	VERB
ajlm-2286	92	14	by	by	ADP
ajlm-2286	92	15	patients	patient	NOUN
ajlm-2286	92	16	suffering	suffer	VERB
ajlm-2286	92	17	from	from	ADP
ajlm-2286	92	18	myocardial	myocardial	ADJ
ajlm-2286	92	19	infarction	infarction	NOUN
ajlm-2286	92	20	.	.	PUNCT
ajlm-2286	93	1	figure	figure	NOUN
ajlm-2286	93	2	2	2	NUM
ajlm-2286	93	3	:	:	PUNCT
ajlm-2286	93	4	graded	grade	VERB
ajlm-2286	93	5	variations	variation	NOUN
ajlm-2286	93	6	in	in	ADP
ajlm-2286	93	7	the	the	DET
ajlm-2286	93	8	mean	mean	ADJ
ajlm-2286	93	9	plasma	plasma	NOUN
ajlm-2286	93	10	paraoxonase-1	paraoxonase-1	NOUN
ajlm-2286	93	11	concentrations	concentration	NOUN
ajlm-2286	93	12	in	in	ADP
ajlm-2286	93	13	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	93	14	cardiovascular	cardiovascular	ADJ
ajlm-2286	93	15	disease	disease	NOUN
ajlm-2286	93	16	subclasses	subclass	NOUN
ajlm-2286	93	17	and	and	CCONJ
ajlm-2286	93	18	controls	control	NOUN
ajlm-2286	93	19	at	at	ADP
ajlm-2286	93	20	lagos	lagos	PROPN
ajlm-2286	93	21	state	state	NOUN
ajlm-2286	93	22	university	university	PROPN
ajlm-2286	93	23	teaching	teaching	NOUN
ajlm-2286	93	24	hospital	hospital	NOUN
ajlm-2286	93	25	,	,	PUNCT
ajlm-2286	93	26	lagos	lago	NOUN
ajlm-2286	93	27	,	,	PUNCT
ajlm-2286	93	28	nigeria	nigeria	PROPN
ajlm-2286	93	29	,	,	PUNCT
ajlm-2286	93	30	between	between	ADP
ajlm-2286	93	31	march	march	PROPN
ajlm-2286	93	32	2022	2022	NUM
ajlm-2286	93	33	and	and	CCONJ
ajlm-2286	93	34	march	march	PROPN
ajlm-2286	93	35	2023	2023	NUM
ajlm-2286	93	36	.	.	PUNCT
ajlm-2286	94	1	gender	gender	NOUN
ajlm-2286	94	2	and	and	CCONJ
ajlm-2286	94	3	lecithin	lecithin	NOUN
ajlm-2286	94	4	-	-	PUNCT
ajlm-2286	94	5	cholesterol	cholesterol	NOUN
ajlm-2286	94	6	acyltransferase	acyltransferase	NOUN
ajlm-2286	94	7	concentrations	concentration	NOUN
ajlm-2286	94	8	plasma	plasma	VERB
ajlm-2286	94	9	lcat	lcat	ADJ
ajlm-2286	94	10	concentrations	concentration	NOUN
ajlm-2286	94	11	were	be	AUX
ajlm-2286	94	12	significantly	significantly	ADV
ajlm-2286	94	13	elevated	elevate	VERB
ajlm-2286	94	14	in	in	ADP
ajlm-2286	94	15	female	female	ADJ
ajlm-2286	94	16	participants	participant	NOUN
ajlm-2286	94	17	compared	compare	VERB
ajlm-2286	94	18	to	to	ADP
ajlm-2286	94	19	their	their	PRON
ajlm-2286	94	20	male	male	ADJ
ajlm-2286	94	21	counterparts	counterpart	NOUN
ajlm-2286	94	22	(	(	PUNCT
ajlm-2286	94	23	online	online	ADJ
ajlm-2286	94	24	supplementary	supplementary	ADJ
ajlm-2286	94	25	table	table	NOUN
ajlm-2286	94	26	1	1	NUM
ajlm-2286	94	27	)	)	PUNCT
ajlm-2286	94	28	.	.	PUNCT
ajlm-2286	95	1	a	a	DET
ajlm-2286	95	2	marked	mark	VERB
ajlm-2286	95	3	gender	gender	NOUN
ajlm-2286	95	4	discrepancy	discrepancy	NOUN
ajlm-2286	95	5	in	in	ADP
ajlm-2286	95	6	lcat	lcat	ADJ
ajlm-2286	95	7	concentrations	concentration	NOUN
ajlm-2286	95	8	was	be	AUX
ajlm-2286	95	9	also	also	ADV
ajlm-2286	95	10	observed	observe	VERB
ajlm-2286	95	11	among	among	ADP
ajlm-2286	95	12	ascvd	ascvd	NOUN
ajlm-2286	95	13	patients	patient	NOUN
ajlm-2286	95	14	and	and	CCONJ
ajlm-2286	95	15	controls	control	NOUN
ajlm-2286	95	16	(	(	PUNCT
ajlm-2286	95	17	figure	figure	NOUN
ajlm-2286	95	18	3	3	NUM
ajlm-2286	95	19	)	)	PUNCT
ajlm-2286	95	20	.	.	PUNCT
ajlm-2286	96	1	figure	figure	VERB
ajlm-2286	96	2	3	3	NUM
ajlm-2286	96	3	:	:	PUNCT
ajlm-2286	96	4	stratification	stratification	NOUN
ajlm-2286	96	5	of	of	ADP
ajlm-2286	96	6	lecithin	lecithin	NOUN
ajlm-2286	96	7	-	-	PUNCT
ajlm-2286	96	8	cholesterol	cholesterol	NOUN
ajlm-2286	96	9	acyltransferase	acyltransferase	NOUN
ajlm-2286	96	10	concentrations	concentration	NOUN
ajlm-2286	96	11	based	base	VERB
ajlm-2286	96	12	on	on	ADP
ajlm-2286	96	13	gender	gender	NOUN
ajlm-2286	96	14	in	in	ADP
ajlm-2286	96	15	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	96	16	cardiovascular	cardiovascular	ADJ
ajlm-2286	96	17	disease	disease	NOUN
ajlm-2286	96	18	patients	patient	NOUN
ajlm-2286	96	19	and	and	CCONJ
ajlm-2286	96	20	controls	control	NOUN
ajlm-2286	96	21	at	at	ADP
ajlm-2286	96	22	lagos	lagos	PROPN
ajlm-2286	96	23	state	state	NOUN
ajlm-2286	96	24	university	university	PROPN
ajlm-2286	96	25	teaching	teaching	NOUN
ajlm-2286	96	26	hospital	hospital	NOUN
ajlm-2286	96	27	,	,	PUNCT
ajlm-2286	96	28	lagos	lago	NOUN
ajlm-2286	96	29	,	,	PUNCT
ajlm-2286	96	30	nigeria	nigeria	PROPN
ajlm-2286	96	31	,	,	PUNCT
ajlm-2286	96	32	between	between	ADP
ajlm-2286	96	33	march	march	PROPN
ajlm-2286	96	34	2022	2022	NUM
ajlm-2286	96	35	and	and	CCONJ
ajlm-2286	96	36	march	march	PROPN
ajlm-2286	96	37	2023	2023	NUM
ajlm-2286	96	38	.	.	PUNCT
ajlm-2286	97	1	discussion	discussion	NOUN
ajlm-2286	97	2	the	the	DET
ajlm-2286	97	3	present	present	ADJ
ajlm-2286	97	4	study	study	NOUN
ajlm-2286	97	5	showed	show	VERB
ajlm-2286	97	6	that	that	SCONJ
ajlm-2286	97	7	the	the	DET
ajlm-2286	97	8	mean	mean	ADJ
ajlm-2286	97	9	weight	weight	NOUN
ajlm-2286	97	10	,	,	PUNCT
ajlm-2286	97	11	waist	waist	NOUN
ajlm-2286	97	12	circumference	circumference	NOUN
ajlm-2286	97	13	,	,	PUNCT
ajlm-2286	97	14	hip	hip	NOUN
ajlm-2286	97	15	circumference	circumference	NOUN
ajlm-2286	97	16	,	,	PUNCT
ajlm-2286	97	17	waist	waist	NOUN
ajlm-2286	97	18	-	-	PUNCT
ajlm-2286	97	19	to	to	ADP
ajlm-2286	97	20	-	-	PUNCT
ajlm-2286	97	21	hip	hip	NOUN
ajlm-2286	97	22	ratio	ratio	NOUN
ajlm-2286	97	23	,	,	PUNCT
ajlm-2286	97	24	bmi	bmi	NOUN
ajlm-2286	97	25	,	,	PUNCT
ajlm-2286	97	26	and	and	CCONJ
ajlm-2286	97	27	systolic	systolic	ADJ
ajlm-2286	97	28	blood	blood	NOUN
ajlm-2286	97	29	pressure	pressure	NOUN
ajlm-2286	97	30	and	and	CCONJ
ajlm-2286	97	31	diastolic	diastolic	ADJ
ajlm-2286	97	32	blood	blood	NOUN
ajlm-2286	97	33	pressure	pressure	NOUN
ajlm-2286	97	34	were	be	AUX
ajlm-2286	97	35	significantly	significantly	ADV
ajlm-2286	97	36	higher	high	ADJ
ajlm-2286	97	37	in	in	ADP
ajlm-2286	97	38	ascvd	ascvd	NOUN
ajlm-2286	97	39	patients	patient	NOUN
ajlm-2286	97	40	compared	compare	VERB
ajlm-2286	97	41	to	to	ADP
ajlm-2286	97	42	the	the	DET
ajlm-2286	97	43	mean	mean	ADJ
ajlm-2286	97	44	control	control	NOUN
ajlm-2286	97	45	values	value	NOUN
ajlm-2286	97	46	.	.	PUNCT
ajlm-2286	98	1	these	these	DET
ajlm-2286	98	2	findings	finding	NOUN
ajlm-2286	98	3	were	be	AUX
ajlm-2286	98	4	consistent	consistent	ADJ
ajlm-2286	98	5	with	with	ADP
ajlm-2286	98	6	previous	previous	ADJ
ajlm-2286	98	7	studies	study	NOUN
ajlm-2286	98	8	conducted	conduct	VERB
ajlm-2286	98	9	in	in	ADP
ajlm-2286	98	10	europe	europe	PROPN
ajlm-2286	98	11	that	that	PRON
ajlm-2286	98	12	reported	report	VERB
ajlm-2286	98	13	significant	significant	ADJ
ajlm-2286	98	14	increases	increase	NOUN
ajlm-2286	98	15	in	in	ADP
ajlm-2286	98	16	the	the	DET
ajlm-2286	98	17	bmi	bmi	NOUN
ajlm-2286	98	18	,	,	PUNCT
ajlm-2286	98	19	waist	waist	NOUN
ajlm-2286	98	20	circumference	circumference	NOUN
ajlm-2286	98	21	,	,	PUNCT
ajlm-2286	98	22	waist	waist	NOUN
ajlm-2286	98	23	-	-	PUNCT
ajlm-2286	98	24	to	to	ADP
ajlm-2286	98	25	-	-	PUNCT
ajlm-2286	98	26	hip	hip	NOUN
ajlm-2286	98	27	ratio	ratio	NOUN
ajlm-2286	98	28	,	,	PUNCT
ajlm-2286	98	29	and	and	CCONJ
ajlm-2286	98	30	blood	blood	NOUN
ajlm-2286	98	31	pressure	pressure	NOUN
ajlm-2286	98	32	in	in	ADP
ajlm-2286	98	33	ascvd	ascvd	PROPN
ajlm-2286	98	34	patients.27	patients.27	PROPN
ajlm-2286	98	35	although	although	SCONJ
ajlm-2286	98	36	obesity	obesity	NOUN
ajlm-2286	98	37	(	(	PUNCT
ajlm-2286	98	38	bmi	bmi	X
ajlm-2286	98	39	>	>	X
ajlm-2286	98	40	30	30	NUM
ajlm-2286	98	41	kg	kg	NOUN
ajlm-2286	98	42	/	/	SYM
ajlm-2286	98	43	m2	m2	PROPN
ajlm-2286	98	44	)	)	PUNCT
ajlm-2286	98	45	was	be	AUX
ajlm-2286	98	46	not	not	PART
ajlm-2286	98	47	a	a	DET
ajlm-2286	98	48	distinctive	distinctive	ADJ
ajlm-2286	98	49	attribute	attribute	NOUN
ajlm-2286	98	50	in	in	ADP
ajlm-2286	98	51	any	any	PRON
ajlm-2286	98	52	of	of	ADP
ajlm-2286	98	53	the	the	DET
ajlm-2286	98	54	ascvd	ascvd	NOUN
ajlm-2286	98	55	subclasses	subclass	NOUN
ajlm-2286	98	56	,	,	PUNCT
ajlm-2286	98	57	earlier	early	ADJ
ajlm-2286	98	58	studies	study	NOUN
ajlm-2286	98	59	have	have	AUX
ajlm-2286	98	60	shown	show	VERB
ajlm-2286	98	61	that	that	SCONJ
ajlm-2286	98	62	the	the	DET
ajlm-2286	98	63	listed	list	VERB
ajlm-2286	98	64	anthropometric	anthropometric	ADJ
ajlm-2286	98	65	variables	variable	NOUN
ajlm-2286	98	66	are	be	AUX
ajlm-2286	98	67	obesity	obesity	NOUN
ajlm-2286	98	68	-	-	PUNCT
ajlm-2286	98	69	related	relate	VERB
ajlm-2286	98	70	parameters	parameter	NOUN
ajlm-2286	98	71	and	and	CCONJ
ajlm-2286	98	72	well	well	ADV
ajlm-2286	98	73	-	-	PUNCT
ajlm-2286	98	74	established	establish	VERB
ajlm-2286	98	75	risk	risk	NOUN
ajlm-2286	98	76	factors	factor	NOUN
ajlm-2286	98	77	for	for	ADP
ajlm-2286	98	78	ascvd.28	ascvd.28	NOUN
ajlm-2286	98	79	the	the	DET
ajlm-2286	98	80	present	present	ADJ
ajlm-2286	98	81	study	study	NOUN
ajlm-2286	98	82	also	also	ADV
ajlm-2286	98	83	reported	report	VERB
ajlm-2286	98	84	severe	severe	ADJ
ajlm-2286	98	85	alterations	alteration	NOUN
ajlm-2286	98	86	in	in	ADP
ajlm-2286	98	87	atherogenic	atherogenic	ADJ
ajlm-2286	98	88	lipids	lipid	NOUN
ajlm-2286	98	89	and	and	CCONJ
ajlm-2286	98	90	lipoproteins	lipoprotein	NOUN
ajlm-2286	98	91	in	in	ADP
ajlm-2286	98	92	ascvd	ascvd	NOUN
ajlm-2286	98	93	patients	patient	NOUN
ajlm-2286	98	94	.	.	PUNCT
ajlm-2286	99	1	there	there	PRON
ajlm-2286	99	2	were	be	VERB
ajlm-2286	99	3	significant	significant	ADJ
ajlm-2286	99	4	increases	increase	NOUN
ajlm-2286	99	5	in	in	ADP
ajlm-2286	99	6	plasma	plasma	NOUN
ajlm-2286	99	7	tc	tc	NOUN
ajlm-2286	99	8	,	,	PUNCT
ajlm-2286	99	9	triglycerides	triglyceride	NOUN
ajlm-2286	99	10	,	,	PUNCT
ajlm-2286	99	11	ldlc	ldlc	NOUN
ajlm-2286	99	12	,	,	PUNCT
ajlm-2286	99	13	and	and	CCONJ
ajlm-2286	99	14	nhdlc	nhdlc	NOUN
ajlm-2286	99	15	,	,	PUNCT
ajlm-2286	99	16	while	while	SCONJ
ajlm-2286	99	17	hdlc	hdlc	PROPN
ajlm-2286	99	18	(	(	PUNCT
ajlm-2286	99	19	anti	anti	ADJ
ajlm-2286	99	20	-	-	ADJ
ajlm-2286	99	21	atherogenic	atherogenic	ADJ
ajlm-2286	99	22	lipoprotein	lipoprotein	NOUN
ajlm-2286	99	23	)	)	PUNCT
ajlm-2286	99	24	was	be	AUX
ajlm-2286	99	25	remarkably	remarkably	ADV
ajlm-2286	99	26	reduced	reduce	VERB
ajlm-2286	99	27	compared	compare	VERB
ajlm-2286	99	28	to	to	ADP
ajlm-2286	99	29	the	the	DET
ajlm-2286	99	30	control	control	NOUN
ajlm-2286	99	31	values	value	NOUN
ajlm-2286	99	32	.	.	PUNCT
ajlm-2286	100	1	in	in	ADP
ajlm-2286	100	2	addition	addition	NOUN
ajlm-2286	100	3	,	,	PUNCT
ajlm-2286	100	4	it	it	PRON
ajlm-2286	100	5	is	be	AUX
ajlm-2286	100	6	worth	worth	ADJ
ajlm-2286	100	7	noting	note	VERB
ajlm-2286	100	8	that	that	SCONJ
ajlm-2286	100	9	the	the	DET
ajlm-2286	100	10	lipid	lipid	ADJ
ajlm-2286	100	11	profiles	profile	NOUN
ajlm-2286	100	12	of	of	ADP
ajlm-2286	100	13	the	the	DET
ajlm-2286	100	14	different	different	ADJ
ajlm-2286	100	15	subclasses	subclass	NOUN
ajlm-2286	100	16	of	of	ADP
ajlm-2286	100	17	ascvd	ascvd	NOUN
ajlm-2286	100	18	showed	show	VERB
ajlm-2286	100	19	significant	significant	ADJ
ajlm-2286	100	20	variations	variation	NOUN
ajlm-2286	100	21	among	among	ADP
ajlm-2286	100	22	the	the	DET
ajlm-2286	100	23	different	different	ADJ
ajlm-2286	100	24	groups	group	NOUN
ajlm-2286	100	25	assayed	assayed	ADJ
ajlm-2286	100	26	.	.	PUNCT
ajlm-2286	101	1	notably	notably	ADV
ajlm-2286	101	2	,	,	PUNCT
ajlm-2286	101	3	the	the	DET
ajlm-2286	101	4	highest	high	ADJ
ajlm-2286	101	5	increase	increase	NOUN
ajlm-2286	101	6	in	in	ADP
ajlm-2286	101	7	atherogenic	atherogenic	ADJ
ajlm-2286	101	8	lipids	lipid	NOUN
ajlm-2286	101	9	and	and	CCONJ
ajlm-2286	101	10	lipoproteins	lipoprotein	NOUN
ajlm-2286	101	11	(	(	PUNCT
ajlm-2286	101	12	tc	tc	NOUN
ajlm-2286	101	13	,	,	PUNCT
ajlm-2286	101	14	triglycerides	triglyceride	NOUN
ajlm-2286	101	15	,	,	PUNCT
ajlm-2286	101	16	ldlc	ldlc	NOUN
ajlm-2286	101	17	,	,	PUNCT
ajlm-2286	101	18	and	and	CCONJ
ajlm-2286	101	19	nhdlc	nhdlc	ADJ
ajlm-2286	101	20	)	)	PUNCT
ajlm-2286	101	21	concentrations	concentration	NOUN
ajlm-2286	101	22	was	be	AUX
ajlm-2286	101	23	observed	observe	VERB
ajlm-2286	101	24	in	in	ADP
ajlm-2286	101	25	myocardial	myocardial	ADJ
ajlm-2286	101	26	infarction	infarction	NOUN
ajlm-2286	101	27	and	and	CCONJ
ajlm-2286	101	28	ihd	ihd	ADJ
ajlm-2286	101	29	patients	patient	NOUN
ajlm-2286	101	30	.	.	PUNCT
ajlm-2286	102	1	conversely	conversely	ADV
ajlm-2286	102	2	,	,	PUNCT
ajlm-2286	102	3	these	these	DET
ajlm-2286	102	4	classes	class	NOUN
ajlm-2286	102	5	of	of	ADP
ajlm-2286	102	6	ascvd	ascvd	NOUN
ajlm-2286	102	7	also	also	ADV
ajlm-2286	102	8	demonstrated	demonstrate	VERB
ajlm-2286	102	9	the	the	DET
ajlm-2286	102	10	lowest	low	ADJ
ajlm-2286	102	11	reduction	reduction	NOUN
ajlm-2286	102	12	in	in	ADP
ajlm-2286	102	13	the	the	DET
ajlm-2286	102	14	levels	level	NOUN
ajlm-2286	102	15	of	of	ADP
ajlm-2286	102	16	the	the	DET
ajlm-2286	102	17	anti	anti	ADJ
ajlm-2286	102	18	-	-	ADJ
ajlm-2286	102	19	atherogenic	atherogenic	ADJ
ajlm-2286	102	20	hdlc	hdlc	NOUN
ajlm-2286	102	21	compared	compare	VERB
ajlm-2286	102	22	to	to	ADP
ajlm-2286	102	23	other	other	ADJ
ajlm-2286	102	24	groups	group	NOUN
ajlm-2286	102	25	.	.	PUNCT
ajlm-2286	103	1	these	these	DET
ajlm-2286	103	2	findings	finding	NOUN
ajlm-2286	103	3	were	be	AUX
ajlm-2286	103	4	similar	similar	ADJ
ajlm-2286	103	5	to	to	ADP
ajlm-2286	103	6	an	an	DET
ajlm-2286	103	7	earlier	early	ADJ
ajlm-2286	103	8	report	report	NOUN
ajlm-2286	103	9	by	by	ADP
ajlm-2286	103	10	ebesunun	ebesunun	PROPN
ajlm-2286	103	11	et	et	NOUN
ajlm-2286	103	12	al.20	al.20	PROPN
ajlm-2286	103	13	in	in	ADP
ajlm-2286	103	14	southwest	southwest	PROPN
ajlm-2286	103	15	nigeria	nigeria	PROPN
ajlm-2286	103	16	in	in	ADP
ajlm-2286	103	17	2013	2013	NUM
ajlm-2286	103	18	,	,	PUNCT
ajlm-2286	103	19	and	and	CCONJ
ajlm-2286	103	20	hedayatnia	hedayatnia	NOUN
ajlm-2286	103	21	et	et	NOUN
ajlm-2286	103	22	al.29	al.29	PROPN
ajlm-2286	103	23	in	in	ADP
ajlm-2286	103	24	northeastern	northeastern	ADJ
ajlm-2286	103	25	iran	iran	PROPN
ajlm-2286	103	26	in	in	ADP
ajlm-2286	103	27	2020	2020	NUM
ajlm-2286	103	28	.	.	PUNCT
ajlm-2286	104	1	both	both	DET
ajlm-2286	104	2	studies	study	NOUN
ajlm-2286	104	3	reported	report	VERB
ajlm-2286	104	4	severe	severe	ADJ
ajlm-2286	104	5	alteration	alteration	NOUN
ajlm-2286	104	6	in	in	ADP
ajlm-2286	104	7	the	the	DET
ajlm-2286	104	8	atherogenic	atherogenic	ADJ
ajlm-2286	104	9	lipids	lipid	NOUN
ajlm-2286	104	10	and	and	CCONJ
ajlm-2286	104	11	lipoproteins	lipoprotein	NOUN
ajlm-2286	104	12	in	in	ADP
ajlm-2286	104	13	patients	patient	NOUN
ajlm-2286	104	14	suffering	suffer	VERB
ajlm-2286	104	15	from	from	ADP
ajlm-2286	104	16	myocardial	myocardial	ADJ
ajlm-2286	104	17	infarction	infarction	NOUN
ajlm-2286	104	18	and	and	CCONJ
ajlm-2286	104	19	ihd	ihd	ADJ
ajlm-2286	104	20	compared	compare	VERB
ajlm-2286	104	21	to	to	ADP
ajlm-2286	104	22	other	other	ADJ
ajlm-2286	104	23	classes	class	NOUN
ajlm-2286	104	24	of	of	ADP
ajlm-2286	104	25	ascvd	ascvd	NOUN
ajlm-2286	104	26	.	.	PUNCT
ajlm-2286	105	1	the	the	DET
ajlm-2286	105	2	findings	finding	NOUN
ajlm-2286	105	3	in	in	ADP
ajlm-2286	105	4	the	the	DET
ajlm-2286	105	5	present	present	ADJ
ajlm-2286	105	6	study	study	NOUN
ajlm-2286	105	7	further	far	ADV
ajlm-2286	105	8	confirmed	confirm	VERB
ajlm-2286	105	9	the	the	DET
ajlm-2286	105	10	severity	severity	NOUN
ajlm-2286	105	11	of	of	ADP
ajlm-2286	105	12	dyslipidaemia	dyslipidaemia	NOUN
ajlm-2286	105	13	in	in	ADP
ajlm-2286	105	14	these	these	DET
ajlm-2286	105	15	classes	class	NOUN
ajlm-2286	105	16	of	of	ADP
ajlm-2286	105	17	patients	patient	NOUN
ajlm-2286	105	18	.	.	PUNCT
ajlm-2286	106	1	in	in	ADP
ajlm-2286	106	2	addition	addition	NOUN
ajlm-2286	106	3	,	,	PUNCT
ajlm-2286	106	4	this	this	DET
ajlm-2286	106	5	study	study	NOUN
ajlm-2286	106	6	showed	show	VERB
ajlm-2286	106	7	a	a	DET
ajlm-2286	106	8	remarkably	remarkably	ADV
ajlm-2286	106	9	significant	significant	ADJ
ajlm-2286	106	10	reduction	reduction	NOUN
ajlm-2286	106	11	in	in	ADP
ajlm-2286	106	12	the	the	DET
ajlm-2286	106	13	mean	mean	ADJ
ajlm-2286	106	14	plasma	plasma	NOUN
ajlm-2286	106	15	pon-1	pon-1	NOUN
ajlm-2286	106	16	concentration	concentration	NOUN
ajlm-2286	106	17	in	in	ADP
ajlm-2286	106	18	all	all	DET
ajlm-2286	106	19	the	the	DET
ajlm-2286	106	20	established	establish	VERB
ajlm-2286	106	21	cases	case	NOUN
ajlm-2286	106	22	of	of	ADP
ajlm-2286	106	23	ascvd	ascvd	NOUN
ajlm-2286	106	24	patients	patient	NOUN
ajlm-2286	106	25	compared	compare	VERB
ajlm-2286	106	26	to	to	ADP
ajlm-2286	106	27	the	the	DET
ajlm-2286	106	28	mean	mean	ADJ
ajlm-2286	106	29	control	control	NOUN
ajlm-2286	106	30	values	value	NOUN
ajlm-2286	106	31	.	.	PUNCT
ajlm-2286	107	1	this	this	DET
ajlm-2286	107	2	result	result	NOUN
ajlm-2286	107	3	is	be	AUX
ajlm-2286	107	4	consistent	consistent	ADJ
ajlm-2286	107	5	with	with	ADP
ajlm-2286	107	6	previous	previous	ADJ
ajlm-2286	107	7	studies	study	NOUN
ajlm-2286	107	8	in	in	ADP
ajlm-2286	107	9	other	other	ADJ
ajlm-2286	107	10	populations	population	NOUN
ajlm-2286	107	11	worldwide	worldwide	ADV
ajlm-2286	107	12	that	that	SCONJ
ajlm-2286	107	13	associated	associate	VERB
ajlm-2286	107	14	low	low	ADJ
ajlm-2286	107	15	pon-1	pon-1	PUNCT
ajlm-2286	107	16	concentration	concentration	NOUN
ajlm-2286	107	17	and	and	CCONJ
ajlm-2286	107	18	activity	activity	NOUN
ajlm-2286	107	19	with	with	ADP
ajlm-2286	107	20	an	an	DET
ajlm-2286	107	21	increased	increase	VERB
ajlm-2286	107	22	risk	risk	NOUN
ajlm-2286	107	23	of	of	ADP
ajlm-2286	107	24	major	major	ADJ
ajlm-2286	107	25	cardiovascular	cardiovascular	NOUN
ajlm-2286	107	26	events.6,8	events.6,8	ADP
ajlm-2286	107	27	the	the	DET
ajlm-2286	107	28	reduction	reduction	NOUN
ajlm-2286	107	29	in	in	ADP
ajlm-2286	107	30	plasma	plasma	NOUN
ajlm-2286	107	31	pon-1	pon-1	PUNCT
ajlm-2286	107	32	concentrations	concentration	NOUN
ajlm-2286	107	33	observed	observe	VERB
ajlm-2286	107	34	in	in	ADP
ajlm-2286	107	35	the	the	DET
ajlm-2286	107	36	present	present	ADJ
ajlm-2286	107	37	study	study	NOUN
ajlm-2286	107	38	probably	probably	ADV
ajlm-2286	107	39	suggests	suggest	VERB
ajlm-2286	107	40	impaired	impaired	ADJ
ajlm-2286	107	41	antioxidant	antioxidant	NOUN
ajlm-2286	107	42	and	and	CCONJ
ajlm-2286	107	43	anti	anti	ADJ
ajlm-2286	107	44	-	-	ADJ
ajlm-2286	107	45	inflammatory	inflammatory	ADJ
ajlm-2286	107	46	functions	function	NOUN
ajlm-2286	107	47	,	,	PUNCT
ajlm-2286	107	48	which	which	PRON
ajlm-2286	107	49	may	may	AUX
ajlm-2286	107	50	contribute	contribute	VERB
ajlm-2286	107	51	to	to	ADP
ajlm-2286	107	52	the	the	DET
ajlm-2286	107	53	progression	progression	NOUN
ajlm-2286	107	54	of	of	ADP
ajlm-2286	107	55	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	107	56	.	.	PUNCT
ajlm-2286	108	1	oxidised	oxidise	VERB
ajlm-2286	108	2	ldlc	ldlc	NOUN
ajlm-2286	108	3	can	can	AUX
ajlm-2286	108	4	accumulate	accumulate	VERB
ajlm-2286	108	5	in	in	ADP
ajlm-2286	108	6	arterial	arterial	NOUN
ajlm-2286	108	7	walls,30	walls,30	NOUN
ajlm-2286	108	8	leading	lead	VERB
ajlm-2286	108	9	to	to	ADP
ajlm-2286	108	10	the	the	DET
ajlm-2286	108	11	formation	formation	NOUN
ajlm-2286	108	12	of	of	ADP
ajlm-2286	108	13	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	108	14	plaques	plaque	NOUN
ajlm-2286	108	15	,	,	PUNCT
ajlm-2286	108	16	and	and	CCONJ
ajlm-2286	108	17	reduced	reduce	VERB
ajlm-2286	108	18	pon-1	pon-1	PUNCT
ajlm-2286	108	19	activity	activity	NOUN
ajlm-2286	108	20	could	could	AUX
ajlm-2286	108	21	further	far	ADV
ajlm-2286	108	22	exacerbate	exacerbate	VERB
ajlm-2286	108	23	this	this	DET
ajlm-2286	108	24	process	process	NOUN
ajlm-2286	108	25	.	.	PUNCT
ajlm-2286	109	1	it	it	PRON
ajlm-2286	109	2	is	be	AUX
ajlm-2286	109	3	also	also	ADV
ajlm-2286	109	4	important	important	ADJ
ajlm-2286	109	5	to	to	PART
ajlm-2286	109	6	note	note	VERB
ajlm-2286	109	7	that	that	SCONJ
ajlm-2286	109	8	the	the	DET
ajlm-2286	109	9	lowest	low	ADJ
ajlm-2286	109	10	reduction	reduction	NOUN
ajlm-2286	109	11	in	in	ADP
ajlm-2286	109	12	plasma	plasma	NOUN
ajlm-2286	109	13	pon-1	pon-1	PUNCT
ajlm-2286	109	14	concentrations	concentration	NOUN
ajlm-2286	109	15	occurred	occur	VERB
ajlm-2286	109	16	in	in	ADP
ajlm-2286	109	17	patients	patient	NOUN
ajlm-2286	109	18	suffering	suffer	VERB
ajlm-2286	109	19	from	from	ADP
ajlm-2286	109	20	ihd	ihd	ADJ
ajlm-2286	109	21	as	as	ADV
ajlm-2286	109	22	well	well	ADV
ajlm-2286	109	23	as	as	ADP
ajlm-2286	109	24	myocardial	myocardial	ADJ
ajlm-2286	109	25	infarction	infarction	NOUN
ajlm-2286	109	26	.	.	PUNCT
ajlm-2286	110	1	the	the	DET
ajlm-2286	110	2	mean	mean	ADJ
ajlm-2286	110	3	plasma	plasma	NOUN
ajlm-2286	110	4	pon-1	pon-1	PART
ajlm-2286	110	5	concentration	concentration	NOUN
ajlm-2286	110	6	in	in	ADP
ajlm-2286	110	7	both	both	DET
ajlm-2286	110	8	cases	case	NOUN
ajlm-2286	110	9	was	be	AUX
ajlm-2286	110	10	approximately	approximately	ADV
ajlm-2286	110	11	50	50	NUM
ajlm-2286	110	12	%	%	NOUN
ajlm-2286	110	13	less	less	ADJ
ajlm-2286	110	14	than	than	ADP
ajlm-2286	110	15	the	the	DET
ajlm-2286	110	16	mean	mean	ADJ
ajlm-2286	110	17	control	control	NOUN
ajlm-2286	110	18	values	value	NOUN
ajlm-2286	110	19	.	.	PUNCT
ajlm-2286	111	1	thus	thus	ADV
ajlm-2286	111	2	,	,	PUNCT
ajlm-2286	111	3	it	it	PRON
ajlm-2286	111	4	suggests	suggest	VERB
ajlm-2286	111	5	the	the	DET
ajlm-2286	111	6	crucial	crucial	ADJ
ajlm-2286	111	7	role	role	NOUN
ajlm-2286	111	8	pon-1	pon-1	PUNCT
ajlm-2286	111	9	plays	play	VERB
ajlm-2286	111	10	in	in	ADP
ajlm-2286	111	11	the	the	DET
ajlm-2286	111	12	presentation	presentation	NOUN
ajlm-2286	111	13	of	of	ADP
ajlm-2286	111	14	ihd	ihd	ADJ
ajlm-2286	111	15	and	and	CCONJ
ajlm-2286	111	16	myocardial	myocardial	ADJ
ajlm-2286	111	17	infarction	infarction	NOUN
ajlm-2286	111	18	.	.	PUNCT
ajlm-2286	112	1	furthermore	furthermore	ADV
ajlm-2286	112	2	,	,	PUNCT
ajlm-2286	112	3	worthy	worthy	ADJ
ajlm-2286	112	4	of	of	ADP
ajlm-2286	112	5	note	note	NOUN
ajlm-2286	112	6	is	be	AUX
ajlm-2286	112	7	the	the	DET
ajlm-2286	112	8	significant	significant	ADJ
ajlm-2286	112	9	reduction	reduction	NOUN
ajlm-2286	112	10	in	in	ADP
ajlm-2286	112	11	the	the	DET
ajlm-2286	112	12	mean	mean	ADJ
ajlm-2286	112	13	plasma	plasma	NOUN
ajlm-2286	112	14	lcat	lcat	ADJ
ajlm-2286	112	15	concentrations	concentration	NOUN
ajlm-2286	112	16	observed	observe	VERB
ajlm-2286	112	17	in	in	ADP
ajlm-2286	112	18	the	the	DET
ajlm-2286	112	19	ascvd	ascvd	NOUN
ajlm-2286	112	20	patients	patient	NOUN
ajlm-2286	112	21	compared	compare	VERB
ajlm-2286	112	22	to	to	ADP
ajlm-2286	112	23	the	the	DET
ajlm-2286	112	24	control	control	NOUN
ajlm-2286	112	25	values	value	NOUN
ajlm-2286	112	26	.	.	PUNCT
ajlm-2286	113	1	this	this	DET
ajlm-2286	113	2	finding	finding	NOUN
ajlm-2286	113	3	was	be	AUX
ajlm-2286	113	4	at	at	ADP
ajlm-2286	113	5	variance	variance	NOUN
ajlm-2286	113	6	with	with	ADP
ajlm-2286	113	7	some	some	DET
ajlm-2286	113	8	earlier	early	ADJ
ajlm-2286	113	9	studies	study	NOUN
ajlm-2286	113	10	that	that	PRON
ajlm-2286	113	11	showed	show	VERB
ajlm-2286	113	12	no	no	DET
ajlm-2286	113	13	association	association	NOUN
ajlm-2286	113	14	between	between	ADP
ajlm-2286	113	15	lcat	lcat	ADJ
ajlm-2286	113	16	and	and	CCONJ
ajlm-2286	113	17	cardiovascular	cardiovascular	ADJ
ajlm-2286	113	18	disease,14,31	disease,14,31	NOUN
ajlm-2286	113	19	but	but	CCONJ
ajlm-2286	113	20	on	on	ADP
ajlm-2286	113	21	the	the	DET
ajlm-2286	113	22	other	other	ADJ
ajlm-2286	113	23	hand	hand	NOUN
ajlm-2286	113	24	,	,	PUNCT
ajlm-2286	113	25	it	it	PRON
ajlm-2286	113	26	was	be	AUX
ajlm-2286	113	27	in	in	ADP
ajlm-2286	113	28	agreement	agreement	NOUN
ajlm-2286	113	29	with	with	ADP
ajlm-2286	113	30	others,32,33	others,32,33	PROPN
ajlm-2286	113	31	which	which	PRON
ajlm-2286	113	32	reported	report	VERB
ajlm-2286	113	33	reduced	reduce	VERB
ajlm-2286	113	34	lcat	lcat	ADJ
ajlm-2286	113	35	activity	activity	NOUN
ajlm-2286	113	36	and	and	CCONJ
ajlm-2286	113	37	concentration	concentration	NOUN
ajlm-2286	113	38	in	in	ADP
ajlm-2286	113	39	patients	patient	NOUN
ajlm-2286	113	40	with	with	ADP
ajlm-2286	113	41	cardiovascular	cardiovascular	ADJ
ajlm-2286	113	42	disease	disease	NOUN
ajlm-2286	113	43	and	and	CCONJ
ajlm-2286	113	44	individuals	individual	NOUN
ajlm-2286	113	45	at	at	ADP
ajlm-2286	113	46	high	high	ADJ
ajlm-2286	113	47	cardiovascular	cardiovascular	ADJ
ajlm-2286	113	48	risk	risk	NOUN
ajlm-2286	113	49	.	.	PUNCT
ajlm-2286	114	1	the	the	DET
ajlm-2286	114	2	reduction	reduction	NOUN
ajlm-2286	114	3	in	in	ADP
ajlm-2286	114	4	the	the	DET
ajlm-2286	114	5	mean	mean	ADJ
ajlm-2286	114	6	plasma	plasma	NOUN
ajlm-2286	114	7	lcat	lcat	ADJ
ajlm-2286	114	8	concentrations	concentration	NOUN
ajlm-2286	114	9	observed	observe	VERB
ajlm-2286	114	10	in	in	ADP
ajlm-2286	114	11	ascvd	ascvd	NOUN
ajlm-2286	114	12	patients	patient	NOUN
ajlm-2286	114	13	may	may	AUX
ajlm-2286	114	14	reflect	reflect	VERB
ajlm-2286	114	15	impaired	impaired	ADJ
ajlm-2286	114	16	cholesterol	cholesterol	NOUN
ajlm-2286	114	17	esterification	esterification	NOUN
ajlm-2286	114	18	and	and	CCONJ
ajlm-2286	114	19	hdl	hdl	PROPN
ajlm-2286	114	20	metabolism	metabolism	NOUN
ajlm-2286	114	21	.	.	PUNCT
ajlm-2286	115	1	this	this	PRON
ajlm-2286	115	2	can	can	AUX
ajlm-2286	115	3	lead	lead	VERB
ajlm-2286	115	4	to	to	ADP
ajlm-2286	115	5	reduced	reduce	VERB
ajlm-2286	115	6	hdl	hdl	PROPN
ajlm-2286	115	7	functionality	functionality	NOUN
ajlm-2286	115	8	and	and	CCONJ
ajlm-2286	115	9	impaired	impaired	ADJ
ajlm-2286	115	10	reverse	reverse	ADJ
ajlm-2286	115	11	cholesterol	cholesterol	NOUN
ajlm-2286	115	12	transport	transport	NOUN
ajlm-2286	115	13	,	,	PUNCT
ajlm-2286	115	14	a	a	DET
ajlm-2286	115	15	process	process	NOUN
ajlm-2286	115	16	in	in	ADP
ajlm-2286	115	17	which	which	PRON
ajlm-2286	115	18	excess	excess	ADJ
ajlm-2286	115	19	cholesterol	cholesterol	NOUN
ajlm-2286	115	20	is	be	AUX
ajlm-2286	115	21	transported	transport	VERB
ajlm-2286	115	22	from	from	ADP
ajlm-2286	115	23	peripheral	peripheral	ADJ
ajlm-2286	115	24	tissues	tissue	NOUN
ajlm-2286	115	25	back	back	ADV
ajlm-2286	115	26	to	to	ADP
ajlm-2286	115	27	the	the	DET
ajlm-2286	115	28	liver	liver	NOUN
ajlm-2286	115	29	for	for	ADP
ajlm-2286	115	30	excretion.13	excretion.13	PROPN
ajlm-2286	115	31	dysfunctional	dysfunctional	ADJ
ajlm-2286	115	32	hdl	hdl	PROPN
ajlm-2286	115	33	and	and	CCONJ
ajlm-2286	115	34	impaired	impaired	ADJ
ajlm-2286	115	35	reverse	reverse	ADJ
ajlm-2286	115	36	cholesterol	cholesterol	NOUN
ajlm-2286	115	37	transport	transport	NOUN
ajlm-2286	115	38	are	be	AUX
ajlm-2286	115	39	associated	associate	VERB
ajlm-2286	115	40	with	with	ADP
ajlm-2286	115	41	an	an	DET
ajlm-2286	115	42	increased	increase	VERB
ajlm-2286	115	43	risk	risk	NOUN
ajlm-2286	115	44	of	of	ADP
ajlm-2286	115	45	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	115	46	and	and	CCONJ
ajlm-2286	115	47	ascvd.13	ascvd.13	NOUN
ajlm-2286	115	48	it	it	PRON
ajlm-2286	115	49	is	be	AUX
ajlm-2286	115	50	noteworthy	noteworthy	ADJ
ajlm-2286	115	51	that	that	SCONJ
ajlm-2286	115	52	the	the	DET
ajlm-2286	115	53	mean	mean	ADJ
ajlm-2286	115	54	plasma	plasma	NOUN
ajlm-2286	115	55	lcat	lcat	ADJ
ajlm-2286	115	56	concentrations	concentration	NOUN
ajlm-2286	115	57	of	of	ADP
ajlm-2286	115	58	the	the	DET
ajlm-2286	115	59	different	different	ADJ
ajlm-2286	115	60	subclasses	subclass	NOUN
ajlm-2286	115	61	of	of	ADP
ajlm-2286	115	62	ascvd	ascvd	NOUN
ajlm-2286	115	63	showed	show	VERB
ajlm-2286	115	64	significant	significant	ADJ
ajlm-2286	115	65	variations	variation	NOUN
ajlm-2286	115	66	among	among	ADP
ajlm-2286	115	67	different	different	ADJ
ajlm-2286	115	68	groups	group	NOUN
ajlm-2286	115	69	,	,	PUNCT
ajlm-2286	115	70	with	with	ADP
ajlm-2286	115	71	the	the	DET
ajlm-2286	115	72	lowest	low	ADJ
ajlm-2286	115	73	value	value	NOUN
ajlm-2286	115	74	observed	observe	VERB
ajlm-2286	115	75	in	in	ADP
ajlm-2286	115	76	myocardial	myocardial	ADJ
ajlm-2286	115	77	infarction	infarction	NOUN
ajlm-2286	115	78	patients	patient	NOUN
ajlm-2286	115	79	.	.	PUNCT
ajlm-2286	116	1	this	this	DET
ajlm-2286	116	2	observation	observation	NOUN
ajlm-2286	116	3	also	also	ADV
ajlm-2286	116	4	agreed	agree	VERB
ajlm-2286	116	5	with	with	ADP
ajlm-2286	116	6	earlier	early	ADJ
ajlm-2286	116	7	studies32,33	studies32,33	NOUN
ajlm-2286	116	8	which	which	PRON
ajlm-2286	116	9	reported	report	VERB
ajlm-2286	116	10	a	a	DET
ajlm-2286	116	11	marked	mark	VERB
ajlm-2286	116	12	reduction	reduction	NOUN
ajlm-2286	116	13	in	in	ADP
ajlm-2286	116	14	plasma	plasma	NOUN
ajlm-2286	116	15	lcat	lcat	ADJ
ajlm-2286	116	16	activity	activity	NOUN
ajlm-2286	116	17	in	in	ADP
ajlm-2286	116	18	patients	patient	NOUN
ajlm-2286	116	19	suffering	suffer	VERB
ajlm-2286	116	20	from	from	ADP
ajlm-2286	116	21	myocardial	myocardial	ADJ
ajlm-2286	116	22	infarction	infarction	NOUN
ajlm-2286	116	23	.	.	PUNCT
ajlm-2286	117	1	the	the	DET
ajlm-2286	117	2	marked	mark	VERB
ajlm-2286	117	3	decrease	decrease	NOUN
ajlm-2286	117	4	in	in	ADP
ajlm-2286	117	5	lcat	lcat	ADJ
ajlm-2286	117	6	concentrations	concentration	NOUN
ajlm-2286	117	7	observed	observe	VERB
ajlm-2286	117	8	in	in	ADP
ajlm-2286	117	9	myocardial	myocardial	ADJ
ajlm-2286	117	10	infarction	infarction	NOUN
ajlm-2286	117	11	patients	patient	NOUN
ajlm-2286	117	12	may	may	AUX
ajlm-2286	117	13	have	have	VERB
ajlm-2286	117	14	a	a	DET
ajlm-2286	117	15	causal	causal	ADJ
ajlm-2286	117	16	relationship	relationship	NOUN
ajlm-2286	117	17	with	with	ADP
ajlm-2286	117	18	its	its	PRON
ajlm-2286	117	19	aetiology	aetiology	NOUN
ajlm-2286	117	20	in	in	ADP
ajlm-2286	117	21	these	these	DET
ajlm-2286	117	22	patients	patient	NOUN
ajlm-2286	117	23	.	.	PUNCT
ajlm-2286	118	1	another	another	DET
ajlm-2286	118	2	important	important	ADJ
ajlm-2286	118	3	and	and	CCONJ
ajlm-2286	118	4	striking	striking	ADJ
ajlm-2286	118	5	finding	finding	NOUN
ajlm-2286	118	6	in	in	ADP
ajlm-2286	118	7	this	this	DET
ajlm-2286	118	8	present	present	ADJ
ajlm-2286	118	9	study	study	NOUN
ajlm-2286	118	10	is	be	AUX
ajlm-2286	118	11	the	the	DET
ajlm-2286	118	12	marked	mark	VERB
ajlm-2286	118	13	gender	gender	NOUN
ajlm-2286	118	14	discrepancy	discrepancy	NOUN
ajlm-2286	118	15	in	in	ADP
ajlm-2286	118	16	the	the	DET
ajlm-2286	118	17	mean	mean	ADJ
ajlm-2286	118	18	plasma	plasma	NOUN
ajlm-2286	118	19	lcat	lcat	ADJ
ajlm-2286	118	20	concentration	concentration	NOUN
ajlm-2286	118	21	of	of	ADP
ajlm-2286	118	22	the	the	DET
ajlm-2286	118	23	participants	participant	NOUN
ajlm-2286	118	24	studied	study	VERB
ajlm-2286	118	25	.	.	PUNCT
ajlm-2286	119	1	plasma	plasma	NOUN
ajlm-2286	119	2	lcat	lcat	ADJ
ajlm-2286	119	3	concentrations	concentration	NOUN
ajlm-2286	119	4	were	be	AUX
ajlm-2286	119	5	remarkably	remarkably	ADV
ajlm-2286	119	6	elevated	elevate	VERB
ajlm-2286	119	7	in	in	ADP
ajlm-2286	119	8	the	the	DET
ajlm-2286	119	9	female	female	ADJ
ajlm-2286	119	10	participants	participant	NOUN
ajlm-2286	119	11	compared	compare	VERB
ajlm-2286	119	12	to	to	ADP
ajlm-2286	119	13	their	their	PRON
ajlm-2286	119	14	male	male	ADJ
ajlm-2286	119	15	counterparts	counterpart	NOUN
ajlm-2286	119	16	,	,	PUNCT
ajlm-2286	119	17	both	both	PRON
ajlm-2286	119	18	in	in	ADP
ajlm-2286	119	19	the	the	DET
ajlm-2286	119	20	ascvd	ascvd	NOUN
ajlm-2286	119	21	patients	patient	NOUN
ajlm-2286	119	22	and	and	CCONJ
ajlm-2286	119	23	the	the	DET
ajlm-2286	119	24	controls	control	NOUN
ajlm-2286	119	25	.	.	PUNCT
ajlm-2286	120	1	this	this	DET
ajlm-2286	120	2	finding	finding	NOUN
ajlm-2286	120	3	is	be	AUX
ajlm-2286	120	4	consistent	consistent	ADJ
ajlm-2286	120	5	with	with	ADP
ajlm-2286	120	6	that	that	PRON
ajlm-2286	120	7	of	of	ADP
ajlm-2286	120	8	earlier	early	ADJ
ajlm-2286	120	9	studies14,30	studies14,30	NOUN
ajlm-2286	120	10	in	in	ADP
ajlm-2286	120	11	other	other	ADJ
ajlm-2286	120	12	communities	community	NOUN
ajlm-2286	120	13	around	around	ADP
ajlm-2286	120	14	the	the	DET
ajlm-2286	120	15	world	world	NOUN
ajlm-2286	120	16	that	that	PRON
ajlm-2286	120	17	reported	report	VERB
ajlm-2286	120	18	higher	high	ADJ
ajlm-2286	120	19	values	value	NOUN
ajlm-2286	120	20	of	of	ADP
ajlm-2286	120	21	plasma	plasma	NOUN
ajlm-2286	120	22	lcat	lcat	ADJ
ajlm-2286	120	23	concentrations	concentration	NOUN
ajlm-2286	120	24	in	in	ADP
ajlm-2286	120	25	females	female	NOUN
ajlm-2286	120	26	compared	compare	VERB
ajlm-2286	120	27	to	to	ADP
ajlm-2286	120	28	their	their	PRON
ajlm-2286	120	29	male	male	ADJ
ajlm-2286	120	30	counterparts	counterpart	NOUN
ajlm-2286	120	31	.	.	PUNCT
ajlm-2286	121	1	in	in	ADP
ajlm-2286	121	2	addition	addition	NOUN
ajlm-2286	121	3	,	,	PUNCT
ajlm-2286	121	4	a	a	DET
ajlm-2286	121	5	significant	significant	ADJ
ajlm-2286	121	6	negative	negative	ADJ
ajlm-2286	121	7	correlation	correlation	NOUN
ajlm-2286	121	8	was	be	AUX
ajlm-2286	121	9	observed	observe	VERB
ajlm-2286	121	10	between	between	ADP
ajlm-2286	121	11	plasma	plasma	NOUN
ajlm-2286	121	12	pon-1	pon-1	NOUN
ajlm-2286	121	13	,	,	PUNCT
ajlm-2286	121	14	lcat	lcat	ADJ
ajlm-2286	121	15	,	,	PUNCT
ajlm-2286	121	16	and	and	CCONJ
ajlm-2286	121	17	the	the	DET
ajlm-2286	121	18	mean	mean	ADJ
ajlm-2286	121	19	body	body	NOUN
ajlm-2286	121	20	weight	weight	NOUN
ajlm-2286	121	21	(	(	PUNCT
ajlm-2286	121	22	an	an	DET
ajlm-2286	121	23	established	establish	VERB
ajlm-2286	121	24	risk	risk	NOUN
ajlm-2286	121	25	factor	factor	NOUN
ajlm-2286	121	26	for	for	ADP
ajlm-2286	121	27	ascvd	ascvd	NOUN
ajlm-2286	121	28	)	)	PUNCT
ajlm-2286	121	29	.	.	PUNCT
ajlm-2286	122	1	a	a	DET
ajlm-2286	122	2	strong	strong	ADJ
ajlm-2286	122	3	inverse	inverse	NOUN
ajlm-2286	122	4	correlation	correlation	NOUN
ajlm-2286	122	5	observed	observe	VERB
ajlm-2286	122	6	between	between	ADP
ajlm-2286	122	7	lcat	lcat	NOUN
ajlm-2286	122	8	and	and	CCONJ
ajlm-2286	122	9	the	the	DET
ajlm-2286	122	10	atherogenic	atherogenic	ADJ
ajlm-2286	122	11	lipid	lipid	NOUN
ajlm-2286	122	12	and	and	CCONJ
ajlm-2286	122	13	lipoproteins	lipoprotein	NOUN
ajlm-2286	122	14	(	(	PUNCT
ajlm-2286	122	15	tc	tc	NOUN
ajlm-2286	122	16	,	,	PUNCT
ajlm-2286	122	17	ldlc	ldlc	NOUN
ajlm-2286	122	18	,	,	PUNCT
ajlm-2286	122	19	and	and	CCONJ
ajlm-2286	122	20	nhdlc	nhdlc	NOUN
ajlm-2286	122	21	)	)	PUNCT
ajlm-2286	122	22	probably	probably	ADV
ajlm-2286	122	23	emphasised	emphasise	VERB
ajlm-2286	122	24	the	the	DET
ajlm-2286	122	25	important	important	ADJ
ajlm-2286	122	26	role	role	NOUN
ajlm-2286	122	27	played	play	VERB
ajlm-2286	122	28	by	by	ADP
ajlm-2286	122	29	lcat	lcat	NOUN
ajlm-2286	122	30	in	in	ADP
ajlm-2286	122	31	part	part	NOUN
ajlm-2286	122	32	in	in	ADP
ajlm-2286	122	33	countering	counter	VERB
ajlm-2286	122	34	the	the	DET
ajlm-2286	122	35	effect	effect	NOUN
ajlm-2286	122	36	of	of	ADP
ajlm-2286	122	37	atherogenic	atherogenic	ADJ
ajlm-2286	122	38	lipids	lipid	NOUN
ajlm-2286	122	39	and	and	CCONJ
ajlm-2286	122	40	lipoproteins	lipoprotein	NOUN
ajlm-2286	122	41	in	in	ADP
ajlm-2286	122	42	ascvd	ascvd	NOUN
ajlm-2286	122	43	patients	patient	NOUN
ajlm-2286	122	44	.	.	PUNCT
ajlm-2286	123	1	furthermore	furthermore	ADV
ajlm-2286	123	2	,	,	PUNCT
ajlm-2286	123	3	the	the	DET
ajlm-2286	123	4	present	present	ADJ
ajlm-2286	123	5	study	study	NOUN
ajlm-2286	123	6	demonstrated	demonstrate	VERB
ajlm-2286	123	7	a	a	DET
ajlm-2286	123	8	significant	significant	ADJ
ajlm-2286	123	9	positive	positive	ADJ
ajlm-2286	123	10	correlation	correlation	NOUN
ajlm-2286	123	11	between	between	ADP
ajlm-2286	123	12	plasma	plasma	NOUN
ajlm-2286	123	13	lcat	lcat	NOUN
ajlm-2286	123	14	and	and	CCONJ
ajlm-2286	123	15	pon-1	pon-1	NOUN
ajlm-2286	123	16	,	,	PUNCT
ajlm-2286	123	17	suggesting	suggest	VERB
ajlm-2286	123	18	that	that	SCONJ
ajlm-2286	123	19	the	the	DET
ajlm-2286	123	20	two	two	NUM
ajlm-2286	123	21	lipoprotein	lipoprotein	ADJ
ajlm-2286	123	22	-	-	PUNCT
ajlm-2286	123	23	associated	associate	VERB
ajlm-2286	123	24	enzymes	enzyme	NOUN
ajlm-2286	123	25	may	may	AUX
ajlm-2286	123	26	play	play	VERB
ajlm-2286	123	27	synergistic	synergistic	ADJ
ajlm-2286	123	28	roles	role	NOUN
ajlm-2286	123	29	on	on	ADP
ajlm-2286	123	30	hdl	hdl	PROPN
ajlm-2286	123	31	particles	particle	NOUN
ajlm-2286	123	32	to	to	PART
ajlm-2286	123	33	counter	counter	VERB
ajlm-2286	123	34	the	the	DET
ajlm-2286	123	35	effects	effect	NOUN
ajlm-2286	123	36	of	of	ADP
ajlm-2286	123	37	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	123	38	and	and	CCONJ
ajlm-2286	123	39	ascvd	ascvd	NOUN
ajlm-2286	123	40	progression	progression	NOUN
ajlm-2286	123	41	.	.	PUNCT
ajlm-2286	124	1	limitations	limitation	NOUN
ajlm-2286	124	2	one	one	NUM
ajlm-2286	124	3	notable	notable	ADJ
ajlm-2286	124	4	limitation	limitation	NOUN
ajlm-2286	124	5	of	of	ADP
ajlm-2286	124	6	this	this	DET
ajlm-2286	124	7	study	study	NOUN
ajlm-2286	124	8	is	be	AUX
ajlm-2286	124	9	the	the	DET
ajlm-2286	124	10	absence	absence	NOUN
ajlm-2286	124	11	of	of	ADP
ajlm-2286	124	12	recent	recent	ADJ
ajlm-2286	124	13	prevalence	prevalence	NOUN
ajlm-2286	124	14	data	datum	NOUN
ajlm-2286	124	15	on	on	ADP
ajlm-2286	124	16	ascvd	ascvd	NOUN
ajlm-2286	124	17	in	in	ADP
ajlm-2286	124	18	nigeria	nigeria	PROPN
ajlm-2286	124	19	that	that	PRON
ajlm-2286	124	20	could	could	AUX
ajlm-2286	124	21	inform	inform	VERB
ajlm-2286	124	22	sample	sample	NOUN
ajlm-2286	124	23	size	size	NOUN
ajlm-2286	124	24	calculations	calculation	NOUN
ajlm-2286	124	25	.	.	PUNCT
ajlm-2286	125	1	this	this	DET
ajlm-2286	125	2	limitation	limitation	NOUN
ajlm-2286	125	3	was	be	AUX
ajlm-2286	125	4	addressed	address	VERB
ajlm-2286	125	5	using	use	VERB
ajlm-2286	125	6	the	the	DET
ajlm-2286	125	7	available	available	ADJ
ajlm-2286	125	8	data	datum	NOUN
ajlm-2286	125	9	,	,	PUNCT
ajlm-2286	125	10	and	and	CCONJ
ajlm-2286	125	11	the	the	DET
ajlm-2286	125	12	sample	sample	NOUN
ajlm-2286	125	13	size	size	NOUN
ajlm-2286	125	14	was	be	AUX
ajlm-2286	125	15	adjusted	adjust	VERB
ajlm-2286	125	16	upward	upward	ADV
ajlm-2286	125	17	.	.	PUNCT
ajlm-2286	126	1	we	we	PRON
ajlm-2286	126	2	suggest	suggest	VERB
ajlm-2286	126	3	that	that	SCONJ
ajlm-2286	126	4	future	future	ADJ
ajlm-2286	126	5	studies	study	NOUN
ajlm-2286	126	6	may	may	AUX
ajlm-2286	126	7	benefit	benefit	VERB
ajlm-2286	126	8	from	from	ADP
ajlm-2286	126	9	updated	update	VERB
ajlm-2286	126	10	prevalence	prevalence	NOUN
ajlm-2286	126	11	data	datum	NOUN
ajlm-2286	126	12	on	on	ADP
ajlm-2286	126	13	ascvd	ascvd	PROPN
ajlm-2286	126	14	.	.	PUNCT
ajlm-2286	127	1	conclusion	conclusion	NOUN
ajlm-2286	127	2	the	the	DET
ajlm-2286	127	3	present	present	ADJ
ajlm-2286	127	4	study	study	NOUN
ajlm-2286	127	5	demonstrated	demonstrate	VERB
ajlm-2286	127	6	significant	significant	ADJ
ajlm-2286	127	7	decreases	decrease	NOUN
ajlm-2286	127	8	in	in	ADP
ajlm-2286	127	9	plasma	plasma	NOUN
ajlm-2286	127	10	pon-1	pon-1	PUNCT
ajlm-2286	127	11	and	and	CCONJ
ajlm-2286	127	12	lcat	lcat	ADJ
ajlm-2286	127	13	levels	level	NOUN
ajlm-2286	127	14	with	with	ADP
ajlm-2286	127	15	severe	severe	ADJ
ajlm-2286	127	16	alterations	alteration	NOUN
ajlm-2286	127	17	in	in	ADP
ajlm-2286	127	18	atherogenic	atherogenic	ADJ
ajlm-2286	127	19	lipids	lipid	NOUN
ajlm-2286	127	20	and	and	CCONJ
ajlm-2286	127	21	lipoproteins	lipoprotein	NOUN
ajlm-2286	127	22	in	in	ADP
ajlm-2286	127	23	ascvd	ascvd	NOUN
ajlm-2286	127	24	patients	patient	NOUN
ajlm-2286	127	25	,	,	PUNCT
ajlm-2286	127	26	especially	especially	ADV
ajlm-2286	127	27	the	the	DET
ajlm-2286	127	28	subtypes	subtype	NOUN
ajlm-2286	127	29	of	of	ADP
ajlm-2286	127	30	myocardial	myocardial	ADJ
ajlm-2286	127	31	infarction	infarction	NOUN
ajlm-2286	127	32	and	and	CCONJ
ajlm-2286	127	33	ihd	ihd	ADJ
ajlm-2286	127	34	.	.	PUNCT
ajlm-2286	128	1	these	these	DET
ajlm-2286	128	2	observations	observation	NOUN
ajlm-2286	128	3	provide	provide	VERB
ajlm-2286	128	4	valuable	valuable	ADJ
ajlm-2286	128	5	supportive	supportive	ADJ
ajlm-2286	128	6	evidence	evidence	NOUN
ajlm-2286	128	7	for	for	ADP
ajlm-2286	128	8	the	the	DET
ajlm-2286	128	9	interplay	interplay	NOUN
ajlm-2286	128	10	of	of	ADP
ajlm-2286	128	11	pon-1	pon-1	NOUN
ajlm-2286	128	12	,	,	PUNCT
ajlm-2286	128	13	lcat	lcat	ADJ
ajlm-2286	128	14	,	,	PUNCT
ajlm-2286	128	15	and	and	CCONJ
ajlm-2286	128	16	lipid	lipid	ADJ
ajlm-2286	128	17	metabolism	metabolism	NOUN
ajlm-2286	128	18	in	in	ADP
ajlm-2286	128	19	the	the	DET
ajlm-2286	128	20	pathogenesis	pathogenesis	NOUN
ajlm-2286	128	21	of	of	ADP
ajlm-2286	128	22	this	this	DET
ajlm-2286	128	23	disease	disease	NOUN
ajlm-2286	128	24	.	.	PUNCT
ajlm-2286	129	1	these	these	DET
ajlm-2286	129	2	findings	finding	NOUN
ajlm-2286	129	3	could	could	AUX
ajlm-2286	129	4	potentially	potentially	ADV
ajlm-2286	129	5	lead	lead	VERB
ajlm-2286	129	6	patients	patient	NOUN
ajlm-2286	129	7	,	,	PUNCT
ajlm-2286	129	8	in	in	ADP
ajlm-2286	129	9	part	part	NOUN
ajlm-2286	129	10	,	,	PUNCT
ajlm-2286	129	11	to	to	PART
ajlm-2286	129	12	develop	develop	VERB
ajlm-2286	129	13	therapeutic	therapeutic	ADJ
ajlm-2286	129	14	strategies	strategy	NOUN
ajlm-2286	129	15	for	for	ADP
ajlm-2286	129	16	ascvd	ascvd	NOUN
ajlm-2286	129	17	prevention	prevention	NOUN
ajlm-2286	129	18	and	and	CCONJ
ajlm-2286	129	19	treatment	treatment	NOUN
ajlm-2286	129	20	in	in	ADP
ajlm-2286	129	21	future	future	ADJ
ajlm-2286	129	22	research	research	NOUN
ajlm-2286	129	23	.	.	PUNCT
ajlm-2286	130	1	acknowledgements	acknowledgement	NOUN
ajlm-2286	130	2	the	the	DET
ajlm-2286	130	3	authors	author	NOUN
ajlm-2286	130	4	would	would	AUX
ajlm-2286	130	5	like	like	VERB
ajlm-2286	130	6	to	to	PART
ajlm-2286	130	7	acknowledge	acknowledge	VERB
ajlm-2286	130	8	dr	dr	PROPN
ajlm-2286	130	9	olanrewaju	olanrewaju	PROPN
ajlm-2286	130	10	abdulazeez	abdulazeez	PROPN
ajlm-2286	130	11	and	and	CCONJ
ajlm-2286	130	12	his	his	PRON
ajlm-2286	130	13	team	team	NOUN
ajlm-2286	130	14	at	at	ADP
ajlm-2286	130	15	the	the	DET
ajlm-2286	130	16	lagos	lagos	PROPN
ajlm-2286	130	17	state	state	PROPN
ajlm-2286	130	18	university	university	PROPN
ajlm-2286	130	19	teaching	teaching	NOUN
ajlm-2286	130	20	hospital	hospital	NOUN
ajlm-2286	130	21	,	,	PUNCT
ajlm-2286	130	22	nigeria	nigeria	PROPN
ajlm-2286	130	23	,	,	PUNCT
ajlm-2286	130	24	for	for	ADP
ajlm-2286	130	25	their	their	PRON
ajlm-2286	130	26	assistance	assistance	NOUN
ajlm-2286	130	27	in	in	ADP
ajlm-2286	130	28	recruiting	recruit	VERB
ajlm-2286	130	29	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	130	30	cardiovascular	cardiovascular	ADJ
ajlm-2286	130	31	disease	disease	NOUN
ajlm-2286	130	32	patients	patient	NOUN
ajlm-2286	130	33	for	for	ADP
ajlm-2286	130	34	this	this	DET
ajlm-2286	130	35	study	study	NOUN
ajlm-2286	130	36	.	.	PUNCT
ajlm-2286	131	1	we	we	PRON
ajlm-2286	131	2	are	be	AUX
ajlm-2286	131	3	also	also	ADV
ajlm-2286	131	4	extremely	extremely	ADV
ajlm-2286	131	5	grateful	grateful	ADJ
ajlm-2286	131	6	to	to	ADP
ajlm-2286	131	7	mrs	mrs	PROPN
ajlm-2286	131	8	okereke	okereke	PROPN
ajlm-2286	131	9	doreen	doreen	PROPN
ajlm-2286	131	10	,	,	PUNCT
ajlm-2286	131	11	deputy	deputy	NOUN
ajlm-2286	131	12	director	director	NOUN
ajlm-2286	131	13	of	of	ADP
ajlm-2286	131	14	the	the	DET
ajlm-2286	131	15	medical	medical	ADJ
ajlm-2286	131	16	laboratory	laboratory	NOUN
ajlm-2286	131	17	unit	unit	NOUN
ajlm-2286	131	18	at	at	ADP
ajlm-2286	131	19	the	the	DET
ajlm-2286	131	20	national	national	ADJ
ajlm-2286	131	21	orthopaedic	orthopaedic	ADJ
ajlm-2286	131	22	hospital	hospital	NOUN
ajlm-2286	131	23	,	,	PUNCT
ajlm-2286	131	24	igbobi	igbobi	PROPN
ajlm-2286	131	25	,	,	PUNCT
ajlm-2286	131	26	nigeria	nigeria	PROPN
ajlm-2286	131	27	,	,	PUNCT
ajlm-2286	131	28	for	for	ADP
ajlm-2286	131	29	her	her	PRON
ajlm-2286	131	30	assistance	assistance	NOUN
ajlm-2286	131	31	in	in	ADP
ajlm-2286	131	32	granting	grant	VERB
ajlm-2286	131	33	us	we	PRON
ajlm-2286	131	34	permission	permission	NOUN
ajlm-2286	131	35	to	to	PART
ajlm-2286	131	36	make	make	VERB
ajlm-2286	131	37	use	use	NOUN
ajlm-2286	131	38	of	of	ADP
ajlm-2286	131	39	their	their	PRON
ajlm-2286	131	40	facility	facility	NOUN
ajlm-2286	131	41	for	for	ADP
ajlm-2286	131	42	some	some	PRON
ajlm-2286	131	43	of	of	ADP
ajlm-2286	131	44	our	our	PRON
ajlm-2286	131	45	analysis	analysis	NOUN
ajlm-2286	131	46	.	.	PUNCT
ajlm-2286	132	1	this	this	DET
ajlm-2286	132	2	article	article	NOUN
ajlm-2286	132	3	is	be	AUX
ajlm-2286	132	4	partially	partially	ADV
ajlm-2286	132	5	based	base	VERB
ajlm-2286	132	6	on	on	ADP
ajlm-2286	132	7	the	the	DET
ajlm-2286	132	8	author	author	NOUN
ajlm-2286	132	9	’s	’s	PART
ajlm-2286	132	10	thesis	thesis	NOUN
ajlm-2286	132	11	entitled	entitle	VERB
ajlm-2286	132	12	‘	'	PUNCT
ajlm-2286	132	13	assessment	assessment	NOUN
ajlm-2286	132	14	of	of	ADP
ajlm-2286	132	15	lipid	lipid	NOUN
ajlm-2286	132	16	profile	profile	NOUN
ajlm-2286	132	17	,	,	PUNCT
ajlm-2286	132	18	phospholipids	phospholipid	NOUN
ajlm-2286	132	19	,	,	PUNCT
ajlm-2286	132	20	apolipoproteins	apolipoprotein	NOUN
ajlm-2286	132	21	,	,	PUNCT
ajlm-2286	132	22	lecithin	lecithin	NOUN
ajlm-2286	132	23	-	-	PUNCT
ajlm-2286	132	24	cholesterol	cholesterol	NOUN
ajlm-2286	132	25	-	-	PUNCT
ajlm-2286	132	26	acyltransferase	acyltransferase	NOUN
ajlm-2286	132	27	and	and	CCONJ
ajlm-2286	132	28	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	132	29	among	among	ADP
ajlm-2286	132	30	lagos	lagos	NOUN
ajlm-2286	132	31	residents	resident	NOUN
ajlm-2286	132	32	with	with	ADP
ajlm-2286	132	33	cardiovascular	cardiovascular	ADJ
ajlm-2286	132	34	diseases	disease	NOUN
ajlm-2286	132	35	’	'	PUNCT
ajlm-2286	132	36	towards	towards	ADP
ajlm-2286	132	37	the	the	DET
ajlm-2286	132	38	degree	degree	NOUN
ajlm-2286	132	39	of	of	ADP
ajlm-2286	132	40	phd	phd	NOUN
ajlm-2286	132	41	in	in	ADP
ajlm-2286	132	42	the	the	DET
ajlm-2286	132	43	department	department	PROPN
ajlm-2286	132	44	of	of	ADP
ajlm-2286	132	45	chemical	chemical	PROPN
ajlm-2286	132	46	pathology	pathology	PROPN
ajlm-2286	132	47	&	&	CCONJ
ajlm-2286	132	48	immunology	immunology	NOUN
ajlm-2286	132	49	,	,	PUNCT
ajlm-2286	132	50	olabisi	olabisi	ADJ
ajlm-2286	132	51	onabanjo	onabanjo	PROPN
ajlm-2286	132	52	university	university	PROPN
ajlm-2286	132	53	,	,	PUNCT
ajlm-2286	132	54	nigeria	nigeria	PROPN
ajlm-2286	132	55	,	,	PUNCT
ajlm-2286	132	56	march	march	PROPN
ajlm-2286	132	57	,	,	PUNCT
ajlm-2286	132	58	2024	2024	NUM
ajlm-2286	132	59	,	,	PUNCT
ajlm-2286	132	60	with	with	ADP
ajlm-2286	132	61	supervisors	supervisor	NOUN
ajlm-2286	132	62	,	,	PUNCT
ajlm-2286	132	63	dr	dr	PROPN
ajlm-2286	132	64	m.o	m.o	PROPN
ajlm-2286	132	65	.	.	PROPN
ajlm-2286	133	1	ebesunun	ebesunun	PROPN
ajlm-2286	133	2	and	and	CCONJ
ajlm-2286	133	3	dr	dr	PROPN
ajlm-2286	133	4	a.a	a.a	PROPN
ajlm-2286	133	5	.	.	PROPN
ajlm-2286	133	6	amballi	amballi	PROPN
ajlm-2286	133	7	.	.	PUNCT
ajlm-2286	134	1	it	it	PRON
ajlm-2286	134	2	is	be	AUX
ajlm-2286	134	3	available	available	ADJ
ajlm-2286	134	4	at	at	ADP
ajlm-2286	134	5	olabisi	olabisi	ADJ
ajlm-2286	134	6	onabanjo	onabanjo	PROPN
ajlm-2286	134	7	university	university	PROPN
ajlm-2286	134	8	central	central	ADJ
ajlm-2286	134	9	library	library	NOUN
ajlm-2286	134	10	,	,	PUNCT
ajlm-2286	134	11	ogun	ogun	PROPN
ajlm-2286	134	12	state	state	PROPN
ajlm-2286	134	13	,	,	PUNCT
ajlm-2286	134	14	nigeria	nigeria	PROPN
ajlm-2286	134	15	.	.	PUNCT
ajlm-2286	135	1	competing	compete	VERB
ajlm-2286	135	2	interests	interest	NOUN
ajlm-2286	135	3	the	the	DET
ajlm-2286	135	4	authors	author	NOUN
ajlm-2286	135	5	declare	declare	VERB
ajlm-2286	135	6	that	that	SCONJ
ajlm-2286	135	7	they	they	PRON
ajlm-2286	135	8	have	have	VERB
ajlm-2286	135	9	no	no	DET
ajlm-2286	135	10	financial	financial	ADJ
ajlm-2286	135	11	or	or	CCONJ
ajlm-2286	135	12	personal	personal	ADJ
ajlm-2286	135	13	relationships	relationship	NOUN
ajlm-2286	135	14	that	that	PRON
ajlm-2286	135	15	may	may	AUX
ajlm-2286	135	16	have	have	AUX
ajlm-2286	135	17	inappropriately	inappropriately	ADV
ajlm-2286	135	18	influenced	influence	VERB
ajlm-2286	135	19	them	they	PRON
ajlm-2286	135	20	in	in	ADP
ajlm-2286	135	21	writing	write	VERB
ajlm-2286	135	22	this	this	DET
ajlm-2286	135	23	article	article	NOUN
ajlm-2286	135	24	.	.	PUNCT
ajlm-2286	136	1	authors	author	NOUN
ajlm-2286	136	2	’	’	PART
ajlm-2286	136	3	contributions	contribution	NOUN
ajlm-2286	136	4	p.c.n	p.c.n	PROPN
ajlm-2286	136	5	.	.	PROPN
ajlm-2286	136	6	developed	develop	VERB
ajlm-2286	136	7	the	the	DET
ajlm-2286	136	8	concept	concept	NOUN
ajlm-2286	136	9	and	and	CCONJ
ajlm-2286	136	10	performed	perform	VERB
ajlm-2286	136	11	the	the	DET
ajlm-2286	136	12	laboratory	laboratory	NOUN
ajlm-2286	136	13	procedures	procedure	NOUN
ajlm-2286	136	14	,	,	PUNCT
ajlm-2286	136	15	statistical	statistical	ADJ
ajlm-2286	136	16	analysis	analysis	NOUN
ajlm-2286	136	17	and	and	CCONJ
ajlm-2286	136	18	interpretation	interpretation	NOUN
ajlm-2286	136	19	of	of	ADP
ajlm-2286	136	20	the	the	DET
ajlm-2286	136	21	data	datum	NOUN
ajlm-2286	136	22	.	.	PUNCT
ajlm-2286	137	1	p.c.n	p.c.n	PROPN
ajlm-2286	137	2	.	.	PROPN
ajlm-2286	137	3	also	also	ADV
ajlm-2286	137	4	drafted	draft	VERB
ajlm-2286	137	5	and	and	CCONJ
ajlm-2286	137	6	edited	edit	VERB
ajlm-2286	137	7	the	the	DET
ajlm-2286	137	8	manuscript	manuscript	NOUN
ajlm-2286	137	9	.	.	PUNCT
ajlm-2286	138	1	m.o.e	m.o.e	NOUN
ajlm-2286	138	2	.	.	PUNCT
ajlm-2286	138	3	was	be	AUX
ajlm-2286	138	4	involved	involve	VERB
ajlm-2286	138	5	in	in	ADP
ajlm-2286	138	6	the	the	DET
ajlm-2286	138	7	conception	conception	NOUN
ajlm-2286	138	8	,	,	PUNCT
ajlm-2286	138	9	supervised	supervise	VERB
ajlm-2286	138	10	the	the	DET
ajlm-2286	138	11	project	project	NOUN
ajlm-2286	138	12	,	,	PUNCT
ajlm-2286	138	13	provided	provide	VERB
ajlm-2286	138	14	intellectual	intellectual	ADJ
ajlm-2286	138	15	input	input	NOUN
ajlm-2286	138	16	,	,	PUNCT
ajlm-2286	138	17	and	and	CCONJ
ajlm-2286	138	18	engaged	engage	VERB
ajlm-2286	138	19	in	in	ADP
ajlm-2286	138	20	reviewing	review	VERB
ajlm-2286	138	21	and	and	CCONJ
ajlm-2286	138	22	editing	edit	VERB
ajlm-2286	138	23	the	the	DET
ajlm-2286	138	24	manuscript	manuscript	NOUN
ajlm-2286	138	25	.	.	PUNCT
ajlm-2286	139	1	o.m.o	o.m.o	NOUN
ajlm-2286	139	2	.	.	PUNCT
ajlm-2286	139	3	contributed	contribute	VERB
ajlm-2286	139	4	to	to	ADP
ajlm-2286	139	5	the	the	DET
ajlm-2286	139	6	selection	selection	NOUN
ajlm-2286	139	7	of	of	ADP
ajlm-2286	139	8	patients	patient	NOUN
ajlm-2286	139	9	,	,	PUNCT
ajlm-2286	139	10	the	the	DET
ajlm-2286	139	11	acquisition	acquisition	NOUN
ajlm-2286	139	12	and	and	CCONJ
ajlm-2286	139	13	interpretation	interpretation	NOUN
ajlm-2286	139	14	of	of	ADP
ajlm-2286	139	15	data	data	PROPN
ajlm-2286	139	16	,	,	PUNCT
ajlm-2286	139	17	the	the	DET
ajlm-2286	139	18	reviewing	reviewing	NOUN
ajlm-2286	139	19	and	and	CCONJ
ajlm-2286	139	20	editing	editing	NOUN
ajlm-2286	139	21	of	of	ADP
ajlm-2286	139	22	the	the	DET
ajlm-2286	139	23	manuscript	manuscript	NOUN
ajlm-2286	139	24	,	,	PUNCT
ajlm-2286	139	25	and	and	CCONJ
ajlm-2286	139	26	the	the	DET
ajlm-2286	139	27	approval	approval	NOUN
ajlm-2286	139	28	of	of	ADP
ajlm-2286	139	29	the	the	DET
ajlm-2286	139	30	final	final	ADJ
ajlm-2286	139	31	version	version	NOUN
ajlm-2286	139	32	to	to	PART
ajlm-2286	139	33	be	be	AUX
ajlm-2286	139	34	published	publish	VERB
ajlm-2286	139	35	.	.	PUNCT
ajlm-2286	140	1	sources	source	NOUN
ajlm-2286	140	2	of	of	ADP
ajlm-2286	140	3	support	support	NOUN
ajlm-2286	140	4	the	the	DET
ajlm-2286	140	5	authors	author	NOUN
ajlm-2286	140	6	received	receive	VERB
ajlm-2286	140	7	no	no	DET
ajlm-2286	140	8	financial	financial	ADJ
ajlm-2286	140	9	support	support	NOUN
ajlm-2286	140	10	for	for	ADP
ajlm-2286	140	11	the	the	DET
ajlm-2286	140	12	research	research	NOUN
ajlm-2286	140	13	,	,	PUNCT
ajlm-2286	140	14	authorship	authorship	NOUN
ajlm-2286	140	15	,	,	PUNCT
ajlm-2286	140	16	and/or	and/or	CCONJ
ajlm-2286	140	17	publication	publication	NOUN
ajlm-2286	140	18	of	of	ADP
ajlm-2286	140	19	this	this	DET
ajlm-2286	140	20	article	article	NOUN
ajlm-2286	140	21	.	.	PUNCT
ajlm-2286	141	1	data	datum	NOUN
ajlm-2286	141	2	availability	availability	NOUN
ajlm-2286	141	3	the	the	DET
ajlm-2286	141	4	authors	author	NOUN
ajlm-2286	141	5	confirm	confirm	VERB
ajlm-2286	141	6	that	that	SCONJ
ajlm-2286	141	7	the	the	DET
ajlm-2286	141	8	data	datum	NOUN
ajlm-2286	141	9	supporting	support	VERB
ajlm-2286	141	10	the	the	DET
ajlm-2286	141	11	findings	finding	NOUN
ajlm-2286	141	12	of	of	ADP
ajlm-2286	141	13	this	this	DET
ajlm-2286	141	14	study	study	NOUN
ajlm-2286	141	15	is	be	AUX
ajlm-2286	141	16	available	available	ADJ
ajlm-2286	141	17	within	within	ADP
ajlm-2286	141	18	the	the	DET
ajlm-2286	141	19	article	article	NOUN
ajlm-2286	141	20	.	.	PUNCT
ajlm-2286	142	1	disclaimer	disclaimer	VERB
ajlm-2286	142	2	the	the	DET
ajlm-2286	142	3	views	view	NOUN
ajlm-2286	142	4	and	and	CCONJ
ajlm-2286	142	5	opinions	opinion	NOUN
ajlm-2286	142	6	expressed	express	VERB
ajlm-2286	142	7	in	in	ADP
ajlm-2286	142	8	this	this	DET
ajlm-2286	142	9	article	article	NOUN
ajlm-2286	142	10	are	be	AUX
ajlm-2286	142	11	those	those	PRON
ajlm-2286	142	12	of	of	ADP
ajlm-2286	142	13	the	the	DET
ajlm-2286	142	14	authors	author	NOUN
ajlm-2286	142	15	and	and	CCONJ
ajlm-2286	142	16	are	be	AUX
ajlm-2286	142	17	the	the	DET
ajlm-2286	142	18	product	product	NOUN
ajlm-2286	142	19	of	of	ADP
ajlm-2286	142	20	professional	professional	ADJ
ajlm-2286	142	21	research	research	NOUN
ajlm-2286	142	22	.	.	PUNCT
ajlm-2286	143	1	it	it	PRON
ajlm-2286	143	2	does	do	AUX
ajlm-2286	143	3	not	not	PART
ajlm-2286	143	4	necessarily	necessarily	ADV
ajlm-2286	143	5	reflect	reflect	VERB
ajlm-2286	143	6	the	the	DET
ajlm-2286	143	7	official	official	ADJ
ajlm-2286	143	8	policy	policy	NOUN
ajlm-2286	143	9	or	or	CCONJ
ajlm-2286	143	10	position	position	NOUN
ajlm-2286	143	11	of	of	ADP
ajlm-2286	143	12	any	any	DET
ajlm-2286	143	13	affiliated	affiliated	ADJ
ajlm-2286	143	14	institution	institution	NOUN
ajlm-2286	143	15	,	,	PUNCT
ajlm-2286	143	16	funder	funder	NOUN
ajlm-2286	143	17	,	,	PUNCT
ajlm-2286	143	18	agency	agency	NOUN
ajlm-2286	143	19	,	,	PUNCT
ajlm-2286	143	20	or	or	CCONJ
ajlm-2286	143	21	that	that	PRON
ajlm-2286	143	22	of	of	ADP
ajlm-2286	143	23	the	the	DET
ajlm-2286	143	24	publisher	publisher	NOUN
ajlm-2286	143	25	.	.	PUNCT
ajlm-2286	144	1	the	the	DET
ajlm-2286	144	2	authors	author	NOUN
ajlm-2286	144	3	are	be	AUX
ajlm-2286	144	4	responsible	responsible	ADJ
ajlm-2286	144	5	for	for	ADP
ajlm-2286	144	6	this	this	DET
ajlm-2286	144	7	article	article	NOUN
ajlm-2286	144	8	’s	’s	PART
ajlm-2286	144	9	results	result	NOUN
ajlm-2286	144	10	,	,	PUNCT
ajlm-2286	144	11	findings	finding	NOUN
ajlm-2286	144	12	,	,	PUNCT
ajlm-2286	144	13	and	and	CCONJ
ajlm-2286	144	14	content	content	NOUN
ajlm-2286	144	15	.	.	PUNCT
ajlm-2286	145	1	references	reference	NOUN
ajlm-2286	145	2	makover	makover	PROPN
ajlm-2286	145	3	me	i	PRON
ajlm-2286	145	4	,	,	PUNCT
ajlm-2286	145	5	shapiro	shapiro	PROPN
ajlm-2286	145	6	md	md	PROPN
ajlm-2286	145	7	,	,	PUNCT
ajlm-2286	145	8	toth	toth	PROPN
ajlm-2286	145	9	pp	pp	PROPN
ajlm-2286	145	10	.	.	PUNCT
ajlm-2286	146	1	there	there	PRON
ajlm-2286	146	2	is	be	VERB
ajlm-2286	146	3	urgent	urgent	ADJ
ajlm-2286	146	4	need	need	NOUN
ajlm-2286	146	5	to	to	PART
ajlm-2286	146	6	treat	treat	VERB
ajlm-2286	146	7	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	146	8	cardiovascular	cardiovascular	ADJ
ajlm-2286	146	9	disease	disease	NOUN
ajlm-2286	146	10	risk	risk	NOUN
ajlm-2286	146	11	earlier	early	ADV
ajlm-2286	146	12	,	,	PUNCT
ajlm-2286	146	13	more	more	ADV
ajlm-2286	146	14	intensively	intensively	ADV
ajlm-2286	146	15	,	,	PUNCT
ajlm-2286	146	16	and	and	CCONJ
ajlm-2286	146	17	with	with	ADP
ajlm-2286	146	18	greater	great	ADJ
ajlm-2286	146	19	precision	precision	NOUN
ajlm-2286	146	20	:	:	PUNCT
ajlm-2286	146	21	a	a	DET
ajlm-2286	146	22	review	review	NOUN
ajlm-2286	146	23	of	of	ADP
ajlm-2286	146	24	current	current	ADJ
ajlm-2286	146	25	practice	practice	NOUN
ajlm-2286	146	26	and	and	CCONJ
ajlm-2286	146	27	recommendations	recommendation	NOUN
ajlm-2286	146	28	for	for	ADP
ajlm-2286	146	29	improved	improved	ADJ
ajlm-2286	146	30	effectiveness	effectiveness	NOUN
ajlm-2286	146	31	.	.	PUNCT
ajlm-2286	147	1	am	be	AUX
ajlm-2286	147	2	j	j	PROPN
ajlm-2286	147	3	prevent	prevent	PROPN
ajlm-2286	147	4	cardiol	cardiol	NOUN
ajlm-2286	147	5	.	.	PUNCT
ajlm-2286	148	1	2022;12:100371	2022;12:100371	X
ajlm-2286	148	2	.	.	PUNCT
ajlm-2286	149	1	https://doi.org/10.1016/j.ajpc.2022.100371	https://doi.org/10.1016/j.ajpc.2022.100371	PROPN
ajlm-2286	149	2	mahmood	mahmood	PROPN
ajlm-2286	149	3	t	t	PROPN
ajlm-2286	149	4	,	,	PUNCT
ajlm-2286	149	5	shapiro	shapiro	PROPN
ajlm-2286	149	6	md	md	PROPN
ajlm-2286	149	7	.	.	PUNCT
ajlm-2286	150	1	the	the	DET
ajlm-2286	150	2	questions	question	NOUN
ajlm-2286	150	3	on	on	ADP
ajlm-2286	150	4	everyone	everyone	PRON
ajlm-2286	150	5	’s	’s	PART
ajlm-2286	150	6	mind	mind	NOUN
ajlm-2286	150	7	:	:	PUNCT
ajlm-2286	150	8	what	what	PRON
ajlm-2286	150	9	is	be	AUX
ajlm-2286	150	10	and	and	CCONJ
ajlm-2286	150	11	why	why	SCONJ
ajlm-2286	150	12	do	do	AUX
ajlm-2286	150	13	we	we	PRON
ajlm-2286	150	14	need	need	VERB
ajlm-2286	150	15	preventive	preventive	ADJ
ajlm-2286	150	16	cardiology	cardiology	NOUN
ajlm-2286	150	17	?	?	PUNCT
ajlm-2286	151	1	methodist	methodist	PROPN
ajlm-2286	151	2	debakey	debakey	PROPN
ajlm-2286	151	3	cardiovasc	cardiovasc	PROPN
ajlm-2286	151	4	j.	j.	PROPN
ajlm-2286	151	5	2021	2021	NUM
ajlm-2286	151	6	sep	sep	PROPN
ajlm-2286	151	7	24;17(4):8–14	24;17(4):8–14	PROPN
ajlm-2286	151	8	.	.	PUNCT
ajlm-2286	152	1	https://doi.org/10.14797/mdcvj.698	https://doi.org/10.14797/mdcvj.698	PROPN
ajlm-2286	152	2	ossoli	ossoli	PROPN
ajlm-2286	152	3	a	a	PRON
ajlm-2286	152	4	,	,	PUNCT
ajlm-2286	152	5	simonelli	simonelli	PROPN
ajlm-2286	152	6	s	s	PROPN
ajlm-2286	152	7	,	,	PUNCT
ajlm-2286	152	8	vitali	vitali	PROPN
ajlm-2286	152	9	c	c	PROPN
ajlm-2286	152	10	,	,	PUNCT
ajlm-2286	152	11	franceschini	franceschini	PROPN
ajlm-2286	152	12	g	g	PROPN
ajlm-2286	152	13	,	,	PUNCT
ajlm-2286	152	14	calabresi	calabresi	PROPN
ajlm-2286	152	15	l.	l.	PROPN
ajlm-2286	152	16	role	role	NOUN
ajlm-2286	152	17	of	of	ADP
ajlm-2286	152	18	lcat	lcat	NOUN
ajlm-2286	152	19	in	in	ADP
ajlm-2286	152	20	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	152	21	.	.	PUNCT
ajlm-2286	153	1	j	j	PROPN
ajlm-2286	153	2	atheroscler	atheroscler	PROPN
ajlm-2286	153	3	thromb	thromb	PROPN
ajlm-2286	153	4	.	.	PUNCT
ajlm-2286	154	1	2016;23(2):119–127	2016;23(2):119–127	X
ajlm-2286	154	2	.	.	PUNCT
ajlm-2286	155	1	https://doi.org/10.5551/jat.32854	https://doi.org/10.5551/jat.32854	PROPN
ajlm-2286	155	2	chistiakov	chistiakov	PROPN
ajlm-2286	155	3	da	da	PROPN
ajlm-2286	155	4	,	,	PUNCT
ajlm-2286	155	5	melnichenko	melnichenko	NOUN
ajlm-2286	155	6	aa	aa	NOUN
ajlm-2286	155	7	,	,	PUNCT
ajlm-2286	155	8	orekhov	orekhov	ADJ
ajlm-2286	155	9	an	an	PRON
ajlm-2286	155	10	,	,	PUNCT
ajlm-2286	155	11	bobryshev	bobryshev	PROPN
ajlm-2286	155	12	yv	yv	PROPN
ajlm-2286	155	13	.	.	PUNCT
ajlm-2286	155	14	paraoxonase	paraoxonase	PROPN
ajlm-2286	155	15	and	and	CCONJ
ajlm-2286	155	16	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	155	17	-	-	PUNCT
ajlm-2286	155	18	related	relate	VERB
ajlm-2286	155	19	cardiovascular	cardiovascular	ADJ
ajlm-2286	155	20	diseases	disease	NOUN
ajlm-2286	155	21	.	.	PUNCT
ajlm-2286	156	1	biochimie	biochimie	PROPN
ajlm-2286	156	2	.	.	PUNCT
ajlm-2286	157	1	2017	2017	NUM
ajlm-2286	157	2	jan;132:19–27	jan;132:19–27	NOUN
ajlm-2286	157	3	.	.	PUNCT
ajlm-2286	158	1	https://doi.org/10.1016/j.biochi.2016.10.010	https://doi.org/10.1016/j.biochi.2016.10.010	NOUN
ajlm-2286	158	2	yokoyama	yokoyama	PROPN
ajlm-2286	158	3	k	k	PROPN
ajlm-2286	158	4	,	,	PUNCT
ajlm-2286	158	5	tani	tani	PROPN
ajlm-2286	158	6	s	s	PROPN
ajlm-2286	158	7	,	,	PUNCT
ajlm-2286	158	8	matsuo	matsuo	PROPN
ajlm-2286	158	9	r	r	PROPN
ajlm-2286	158	10	,	,	PUNCT
ajlm-2286	158	11	matsumoto	matsumoto	PROPN
ajlm-2286	158	12	n.	n.	PROPN
ajlm-2286	158	13	association	association	PROPN
ajlm-2286	158	14	of	of	ADP
ajlm-2286	158	15	lecithin	lecithin	NOUN
ajlm-2286	158	16	-	-	PUNCT
ajlm-2286	158	17	cholesterol	cholesterol	NOUN
ajlm-2286	158	18	acyltransferase	acyltransferase	NOUN
ajlm-2286	158	19	activity	activity	NOUN
ajlm-2286	158	20	and	and	CCONJ
ajlm-2286	158	21	low	low	ADJ
ajlm-2286	158	22	-	-	PUNCT
ajlm-2286	158	23	density	density	NOUN
ajlm-2286	158	24	lipoprotein	lipoprotein	ADJ
ajlm-2286	158	25	heterogeneity	heterogeneity	NOUN
ajlm-2286	158	26	with	with	ADP
ajlm-2286	158	27	atherosclerotic	atherosclerotic	ADJ
ajlm-2286	158	28	cardiovascular	cardiovascular	ADJ
ajlm-2286	158	29	disease	disease	NOUN
ajlm-2286	158	30	risk	risk	NOUN
ajlm-2286	158	31	:	:	PUNCT
ajlm-2286	158	32	a	a	DET
ajlm-2286	158	33	longitudinal	longitudinal	ADJ
ajlm-2286	158	34	pilot	pilot	NOUN
ajlm-2286	158	35	study	study	NOUN
ajlm-2286	158	36	.	.	PUNCT
ajlm-2286	159	1	bmc	bmc	PROPN
ajlm-2286	159	2	cardiovasc	cardiovasc	PROPN
ajlm-2286	159	3	disord	disord	PROPN
ajlm-2286	159	4	.	.	PUNCT
ajlm-2286	160	1	2018	2018	NUM
ajlm-2286	160	2	dec	dec	PROPN
ajlm-2286	160	3	5;18(1):224	5;18(1):224	NUM
ajlm-2286	160	4	.	.	PUNCT
ajlm-2286	161	1	https://doi.org/10.1186/s12872-018-0967-1	https://doi.org/10.1186/s12872-018-0967-1	NUM
ajlm-2286	161	2	shunmoogam	shunmoogam	PROPN
ajlm-2286	161	3	n	n	CCONJ
ajlm-2286	161	4	,	,	PUNCT
ajlm-2286	161	5	naidoo	naidoo	PROPN
ajlm-2286	161	6	p	p	PROPN
ajlm-2286	161	7	,	,	PUNCT
ajlm-2286	161	8	chilton	chilton	PROPN
ajlm-2286	161	9	r.	r.	PROPN
ajlm-2286	161	10	paraoxonase	paraoxonase	PROPN
ajlm-2286	161	11	(	(	PUNCT
ajlm-2286	161	12	pon)-1	pon)-1	NOUN
ajlm-2286	161	13	:	:	PUNCT
ajlm-2286	161	14	a	a	DET
ajlm-2286	161	15	brief	brief	ADJ
ajlm-2286	161	16	overview	overview	NOUN
ajlm-2286	161	17	on	on	ADP
ajlm-2286	161	18	genetics	genetic	NOUN
ajlm-2286	161	19	,	,	PUNCT
ajlm-2286	161	20	structure	structure	NOUN
ajlm-2286	161	21	,	,	PUNCT
ajlm-2286	161	22	polymorphisms	polymorphism	NOUN
ajlm-2286	161	23	and	and	CCONJ
ajlm-2286	161	24	clinical	clinical	ADJ
ajlm-2286	161	25	relevance	relevance	NOUN
ajlm-2286	161	26	.	.	PUNCT
ajlm-2286	162	1	vasc	vasc	PROPN
ajlm-2286	162	2	health	health	NOUN
ajlm-2286	162	3	risk	risk	NOUN
ajlm-2286	162	4	manag	manag	NOUN
ajlm-2286	162	5	.	.	PUNCT
ajlm-2286	162	6	2018	2018	NUM
ajlm-2286	162	7	jun	jun	PROPN
ajlm-2286	162	8	18;14:137–143	18;14:137–143	NUM
ajlm-2286	162	9	.	.	PUNCT
ajlm-2286	163	1	https://doi.org/10.2147/vhrm.s165173	https://doi.org/10.2147/vhrm.s165173	PROPN
ajlm-2286	163	2	mackness	mackness	PROPN
ajlm-2286	163	3	m	m	PROPN
ajlm-2286	163	4	,	,	PUNCT
ajlm-2286	163	5	mackness	mackness	PROPN
ajlm-2286	163	6	b.	b.	PROPN
ajlm-2286	163	7	human	human	PROPN
ajlm-2286	163	8	paraoxonase-1	paraoxonase-1	PROPN
ajlm-2286	163	9	(	(	PUNCT
ajlm-2286	163	10	pon1	pon1	NOUN
ajlm-2286	163	11	):	):	PUNCT
ajlm-2286	163	12	gene	gene	NOUN
ajlm-2286	163	13	structure	structure	NOUN
ajlm-2286	163	14	and	and	CCONJ
ajlm-2286	163	15	expression	expression	NOUN
ajlm-2286	163	16	,	,	PUNCT
ajlm-2286	163	17	promiscuous	promiscuous	ADJ
ajlm-2286	163	18	activities	activity	NOUN
ajlm-2286	163	19	and	and	CCONJ
ajlm-2286	163	20	multiple	multiple	ADJ
ajlm-2286	163	21	physiological	physiological	ADJ
ajlm-2286	163	22	roles	role	NOUN
ajlm-2286	163	23	.	.	PUNCT
ajlm-2286	164	1	gene	gene	NOUN
ajlm-2286	164	2	.	.	PUNCT
ajlm-2286	165	1	2015	2015	NUM
ajlm-2286	165	2	aug	aug	PROPN
ajlm-2286	165	3	1;567(1):12–21	1;567(1):12–21	NUM
ajlm-2286	165	4	.	.	PUNCT
ajlm-2286	166	1	https://doi.org/10.1016/j.gene.2015.04.088	https://doi.org/10.1016/j.gene.2015.04.088	PRON
ajlm-2286	166	2	kunutsor	kunutsor	NOUN
ajlm-2286	166	3	sk	sk	PROPN
ajlm-2286	166	4	,	,	PUNCT
ajlm-2286	166	5	bakker	bakker	PROPN
ajlm-2286	166	6	sj	sj	PROPN
ajlm-2286	166	7	,	,	PUNCT
ajlm-2286	166	8	james	james	PROPN
ajlm-2286	166	9	rw	rw	PROPN
ajlm-2286	166	10	,	,	PUNCT
ajlm-2286	166	11	dullaart	dullaart	NOUN
ajlm-2286	166	12	rp	rp	PROPN
ajlm-2286	166	13	.	.	PUNCT
ajlm-2286	167	1	serum	serum	PROPN
ajlm-2286	167	2	paraoxonase-1	paraoxonase-1	NUM
ajlm-2286	167	3	activity	activity	NOUN
ajlm-2286	167	4	and	and	CCONJ
ajlm-2286	167	5	risk	risk	NOUN
ajlm-2286	167	6	of	of	ADP
ajlm-2286	167	7	incident	incident	NOUN
ajlm-2286	167	8	cardiovascular	cardiovascular	ADJ
ajlm-2286	167	9	disease	disease	NOUN
ajlm-2286	167	10	:	:	PUNCT
ajlm-2286	167	11	the	the	DET
ajlm-2286	167	12	prevend	prevend	NOUN
ajlm-2286	167	13	study	study	NOUN
ajlm-2286	167	14	and	and	CCONJ
ajlm-2286	167	15	meta	meta	NOUN
ajlm-2286	167	16	-	-	PUNCT
ajlm-2286	167	17	analysis	analysis	NOUN
ajlm-2286	167	18	of	of	ADP
ajlm-2286	167	19	prospective	prospective	ADJ
ajlm-2286	167	20	population	population	NOUN
ajlm-2286	167	21	studies	study	NOUN
ajlm-2286	167	22	.	.	PUNCT
ajlm-2286	168	1	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	168	2	.	.	PUNCT
ajlm-2286	169	1	2016	2016	NUM
ajlm-2286	169	2	feb;245:143–154	feb;245:143–154	PROPN
ajlm-2286	169	3	.	.	PUNCT
ajlm-2286	170	1	https://doi.org/10.1016/j.atherosclerosis.2015.12.021	https://doi.org/10.1016/j.atherosclerosis.2015.12.021	NOUN
ajlm-2286	170	2	mackness	mackness	PROPN
ajlm-2286	170	3	b	b	PROPN
ajlm-2286	170	4	,	,	PUNCT
ajlm-2286	170	5	durrington	durrington	ADJ
ajlm-2286	170	6	pn	pn	PROPN
ajlm-2286	170	7	,	,	PUNCT
ajlm-2286	170	8	mackness	mackness	PROPN
ajlm-2286	170	9	mi	mi	PROPN
ajlm-2286	170	10	.	.	PROPN
ajlm-2286	170	11	human	human	PROPN
ajlm-2286	170	12	serum	serum	PROPN
ajlm-2286	170	13	paraoxonase	paraoxonase	PROPN
ajlm-2286	170	14	.	.	PUNCT
ajlm-2286	171	1	gen	gen	PROPN
ajlm-2286	171	2	pharmacol	pharmacol	PROPN
ajlm-2286	171	3	.	.	PUNCT
ajlm-2286	172	1	1998	1998	NUM
ajlm-2286	172	2	sep;31(3):329–336	sep;31(3):329–336	NOUN
ajlm-2286	172	3	.	.	PUNCT
ajlm-2286	173	1	https://doi.org/10.1016/s0306-3623(98)00028-7	https://doi.org/10.1016/s0306-3623(98)00028-7	PROPN
ajlm-2286	173	2	roest	ro	ADJ
ajlm-2286	173	3	m	m	PROPN
ajlm-2286	173	4	,	,	PUNCT
ajlm-2286	173	5	van	van	PROPN
ajlm-2286	173	6	himbergen	himbergen	PROPN
ajlm-2286	173	7	tm	tm	PROPN
ajlm-2286	173	8	,	,	PUNCT
ajlm-2286	173	9	barendrecht	barendrecht	PROPN
ajlm-2286	173	10	ab	ab	PROPN
ajlm-2286	173	11	,	,	PUNCT
ajlm-2286	173	12	peeters	peeter	NOUN
ajlm-2286	173	13	ph	ph	VERB
ajlm-2286	173	14	,	,	PUNCT
ajlm-2286	173	15	van	van	PROPN
ajlm-2286	173	16	der	der	NOUN
ajlm-2286	173	17	schouw	schouw	PROPN
ajlm-2286	173	18	yt	yt	PROPN
ajlm-2286	173	19	,	,	PUNCT
ajlm-2286	173	20	voorbij	voorbij	VERB
ajlm-2286	173	21	ha	ha	INTJ
ajlm-2286	173	22	.	.	PUNCT
ajlm-2286	173	23	genetic	genetic	ADJ
ajlm-2286	173	24	and	and	CCONJ
ajlm-2286	173	25	environmental	environmental	ADJ
ajlm-2286	173	26	determinants	determinant	NOUN
ajlm-2286	173	27	of	of	ADP
ajlm-2286	173	28	the	the	DET
ajlm-2286	173	29	pon-1	pon-1	PUNCT
ajlm-2286	173	30	phenotype	phenotype	NOUN
ajlm-2286	173	31	.	.	PUNCT
ajlm-2286	174	1	eur	eur	PROPN
ajlm-2286	174	2	j	j	PROPN
ajlm-2286	174	3	clin	clin	PROPN
ajlm-2286	174	4	invest	invest	PROPN
ajlm-2286	174	5	.	.	PUNCT
ajlm-2286	175	1	2007	2007	NUM
ajlm-2286	175	2	mar;37(3):187–196	mar;37(3):187–196	X
ajlm-2286	175	3	.	.	PUNCT
ajlm-2286	176	1	https://doi.org/10.1111/j.1365-2362.2007.01769.x	https://doi.org/10.1111/j.1365-2362.2007.01769.x	PROPN
ajlm-2286	176	2	longo	longo	PROPN
ajlm-2286	176	3	a	a	PRON
ajlm-2286	176	4	,	,	PUNCT
ajlm-2286	176	5	veiga	veiga	ADJ
ajlm-2286	176	6	gb	gb	PROPN
ajlm-2286	176	7	,	,	PUNCT
ajlm-2286	176	8	cousen	cousen	PROPN
ajlm-2286	176	9	mis	mis	PROPN
ajlm-2286	176	10	,	,	PUNCT
ajlm-2286	176	11	et	et	PROPN
ajlm-2286	176	12	al	al	PROPN
ajlm-2286	176	13	.	.	PUNCT
ajlm-2286	177	1	factors	factor	NOUN
ajlm-2286	177	2	associated	associate	VERB
ajlm-2286	177	3	with	with	ADP
ajlm-2286	177	4	serum	serum	NOUN
ajlm-2286	177	5	paraoxonase	paraoxonase	NOUN
ajlm-2286	177	6	1	1	NUM
ajlm-2286	177	7	activity	activity	NOUN
ajlm-2286	177	8	in	in	ADP
ajlm-2286	177	9	patients	patient	NOUN
ajlm-2286	177	10	with	with	ADP
ajlm-2286	177	11	cardiovascular	cardiovascular	ADJ
ajlm-2286	177	12	disease	disease	NOUN
ajlm-2286	177	13	.	.	PUNCT
ajlm-2286	178	1	arch	arch	ADJ
ajlm-2286	178	2	endocrinol	endocrinol	NOUN
ajlm-2286	178	3	metab	metab	NOUN
ajlm-2286	178	4	.	.	PUNCT
ajlm-2286	179	1	2021	2021	NUM
ajlm-2286	179	2	nov	nov	NOUN
ajlm-2286	179	3	24;65(6):676–683	24;65(6):676–683	NUM
ajlm-2286	179	4	.	.	PUNCT
ajlm-2286	180	1	https://doi.org/10.20945/2359-3997000000354	https://doi.org/10.20945/2359-3997000000354	PROPN
ajlm-2286	180	2	haj	haj	PROPN
ajlm-2286	180	3	mouhamed	mouhamed	PROPN
ajlm-2286	180	4	d	d	PROPN
ajlm-2286	180	5	,	,	PUNCT
ajlm-2286	180	6	ezzaher	ezzaher	ADV
ajlm-2286	180	7	a	a	X
ajlm-2286	180	8	,	,	PUNCT
ajlm-2286	180	9	mechri	mechri	PROPN
ajlm-2286	180	10	a	a	PRON
ajlm-2286	180	11	,	,	PUNCT
ajlm-2286	180	12	et	et	PROPN
ajlm-2286	180	13	al	al	PROPN
ajlm-2286	180	14	.	.	PROPN
ajlm-2286	180	15	effect	effect	NOUN
ajlm-2286	180	16	of	of	ADP
ajlm-2286	180	17	cigarette	cigarette	NOUN
ajlm-2286	180	18	smoking	smoking	NOUN
ajlm-2286	180	19	on	on	ADP
ajlm-2286	180	20	paraoxonase	paraoxonase	NOUN
ajlm-2286	180	21	1	1	NUM
ajlm-2286	180	22	activity	activity	NOUN
ajlm-2286	180	23	according	accord	VERB
ajlm-2286	180	24	to	to	ADP
ajlm-2286	180	25	pon1	pon1	PROPN
ajlm-2286	180	26	l55	l55	ADJ
ajlm-2286	180	27	m	m	PROPN
ajlm-2286	180	28	and	and	CCONJ
ajlm-2286	180	29	pon1	pon1	PROPN
ajlm-2286	180	30	q192r	q192r	PROPN
ajlm-2286	180	31	gene	gene	NOUN
ajlm-2286	180	32	polymorphisms	polymorphism	NOUN
ajlm-2286	180	33	.	.	PUNCT
ajlm-2286	181	1	environ	environ	PROPN
ajlm-2286	181	2	health	health	PROPN
ajlm-2286	181	3	prev	prev	PROPN
ajlm-2286	181	4	med	med	PROPN
ajlm-2286	181	5	.	.	PUNCT
ajlm-2286	182	1	2012	2012	NUM
ajlm-2286	182	2	jul;17(4):316–321	jul;17(4):316–321	PROPN
ajlm-2286	182	3	.	.	PROPN
ajlm-2286	182	4	https://doi.org/10.1007/s12199-011-0256-4	https://doi.org/10.1007/s12199-011-0256-4	NUM
ajlm-2286	182	5	ossoli	ossoli	PROPN
ajlm-2286	182	6	a	a	PRON
ajlm-2286	182	7	,	,	PUNCT
ajlm-2286	182	8	pavanello	pavanello	PROPN
ajlm-2286	182	9	c	c	NOUN
ajlm-2286	182	10	,	,	PUNCT
ajlm-2286	182	11	calabresi	calabresi	PROPN
ajlm-2286	182	12	l.	l.	PROPN
ajlm-2286	182	13	high	high	ADJ
ajlm-2286	182	14	-	-	PUNCT
ajlm-2286	182	15	density	density	NOUN
ajlm-2286	182	16	lipoprotein	lipoprotein	ADJ
ajlm-2286	182	17	,	,	PUNCT
ajlm-2286	182	18	lecithin	lecithin	NOUN
ajlm-2286	182	19	:	:	PUNCT
ajlm-2286	182	20	cholesterol	cholesterol	NOUN
ajlm-2286	182	21	acyltransferase	acyltransferase	NOUN
ajlm-2286	182	22	,	,	PUNCT
ajlm-2286	182	23	and	and	CCONJ
ajlm-2286	182	24	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	182	25	.	.	PUNCT
ajlm-2286	183	1	endocrinol	endocrinol	NOUN
ajlm-2286	183	2	metab	metab	NOUN
ajlm-2286	183	3	(	(	PUNCT
ajlm-2286	183	4	seoul	seoul	PROPN
ajlm-2286	183	5	)	)	PUNCT
ajlm-2286	183	6	.	.	PUNCT
ajlm-2286	184	1	2016	2016	NUM
ajlm-2286	184	2	jun;31(2):223–229	jun;31(2):223–229	PROPN
ajlm-2286	184	3	.	.	PUNCT
ajlm-2286	185	1	https://doi.org/10.3803/enm.2016.31.2.223	https://doi.org/10.3803/enm.2016.31.2.223	PROPN
ajlm-2286	185	2	calabresi	calabresi	PROPN
ajlm-2286	185	3	l	l	PROPN
ajlm-2286	185	4	,	,	PUNCT
ajlm-2286	185	5	baldassarre	baldassarre	PROPN
ajlm-2286	186	1	d	d	PROPN
ajlm-2286	186	2	,	,	PUNCT
ajlm-2286	186	3	simonelli	simonelli	PROPN
ajlm-2286	186	4	s	s	PROPN
ajlm-2286	186	5	,	,	PUNCT
ajlm-2286	186	6	et	et	PROPN
ajlm-2286	186	7	al	al	PROPN
ajlm-2286	186	8	.	.	PUNCT
ajlm-2286	187	1	plasma	plasma	NOUN
ajlm-2286	187	2	lecithin	lecithin	NOUN
ajlm-2286	187	3	:	:	PUNCT
ajlm-2286	187	4	cholesterol	cholesterol	NOUN
ajlm-2286	187	5	acyltransferase	acyltransferase	PROPN
ajlm-2286	187	6	and	and	CCONJ
ajlm-2286	187	7	carotid	carotid	VERB
ajlm-2286	187	8	intima	intima	ADJ
ajlm-2286	187	9	-	-	PUNCT
ajlm-2286	187	10	media	media	NOUN
ajlm-2286	187	11	thickness	thickness	NOUN
ajlm-2286	187	12	in	in	ADP
ajlm-2286	187	13	european	european	ADJ
ajlm-2286	187	14	individuals	individual	NOUN
ajlm-2286	187	15	at	at	ADP
ajlm-2286	187	16	high	high	ADJ
ajlm-2286	187	17	cardiovascular	cardiovascular	ADJ
ajlm-2286	187	18	risk	risk	NOUN
ajlm-2286	187	19	.	.	PUNCT
ajlm-2286	188	1	j	j	PROPN
ajlm-2286	188	2	lipid	lipid	PROPN
ajlm-2286	188	3	res	re	NOUN
ajlm-2286	188	4	.	.	PUNCT
ajlm-2286	188	5	2011	2011	NUM
ajlm-2286	188	6	aug;52(8):1569–1574	aug;52(8):1569–1574	NOUN
ajlm-2286	188	7	.	.	PUNCT
ajlm-2286	189	1	https://doi.org/10.1194/jlr.p014977	https://doi.org/10.1194/jlr.p014977	PRON
ajlm-2286	189	2	kunnen	kunnen	PROPN
ajlm-2286	189	3	s	s	PROPN
ajlm-2286	189	4	,	,	PUNCT
ajlm-2286	189	5	van	van	PROPN
ajlm-2286	189	6	eck	eck	PROPN
ajlm-2286	189	7	m.	m.	NOUN
ajlm-2286	189	8	lecithin	lecithin	NOUN
ajlm-2286	189	9	:	:	PUNCT
ajlm-2286	189	10	cholesterol	cholesterol	PROPN
ajlm-2286	189	11	acyltransferase	acyltransferase	PROPN
ajlm-2286	189	12	:	:	PUNCT
ajlm-2286	189	13	old	old	ADJ
ajlm-2286	189	14	friend	friend	NOUN
ajlm-2286	189	15	or	or	CCONJ
ajlm-2286	189	16	foe	foe	NOUN
ajlm-2286	189	17	in	in	ADP
ajlm-2286	189	18	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	189	19	?	?	PUNCT
ajlm-2286	190	1	j	j	PROPN
ajlm-2286	190	2	lipid	lipid	PROPN
ajlm-2286	190	3	res	re	NOUN
ajlm-2286	190	4	.	.	PUNCT
ajlm-2286	190	5	2012	2012	NUM
ajlm-2286	190	6	sep;53(9):1783–1799	sep;53(9):1783–1799	PROPN
ajlm-2286	190	7	.	.	PUNCT
ajlm-2286	191	1	https://doi.org/10.1194/jlr.r024513	https://doi.org/10.1194/jlr.r024513	PROPN
ajlm-2286	191	2	wang	wang	PROPN
ajlm-2286	191	3	f	f	PROPN
ajlm-2286	191	4	,	,	PUNCT
ajlm-2286	191	5	liu	liu	PROPN
ajlm-2286	191	6	y	y	PROPN
ajlm-2286	191	7	,	,	PUNCT
ajlm-2286	191	8	cong	cong	VERB
ajlm-2286	191	9	y	y	PROPN
ajlm-2286	191	10	,	,	PUNCT
ajlm-2286	192	1	et	et	PROPN
ajlm-2286	192	2	al	al	PROPN
ajlm-2286	192	3	.	.	PUNCT
ajlm-2286	192	4	shift	shift	NOUN
ajlm-2286	192	5	of	of	ADP
ajlm-2286	192	6	the	the	DET
ajlm-2286	192	7	interconnection	interconnection	NOUN
ajlm-2286	192	8	from	from	ADP
ajlm-2286	192	9	the	the	DET
ajlm-2286	192	10	reaction	reaction	NOUN
ajlm-2286	192	11	system	system	NOUN
ajlm-2286	192	12	of	of	ADP
ajlm-2286	192	13	paraoxonase	paraoxonase	NOUN
ajlm-2286	192	14	1	1	NUM
ajlm-2286	192	15	to	to	ADP
ajlm-2286	192	16	the	the	DET
ajlm-2286	192	17	peroxidation	peroxidation	NOUN
ajlm-2286	192	18	reaction	reaction	NOUN
ajlm-2286	192	19	system	system	NOUN
ajlm-2286	192	20	of	of	ADP
ajlm-2286	192	21	myeloperoxidase	myeloperoxidase	NOUN
ajlm-2286	192	22	with	with	ADP
ajlm-2286	192	23	hdl	hdl	PROPN
ajlm-2286	192	24	-	-	PUNCT
ajlm-2286	192	25	c	c	NOUN
ajlm-2286	192	26	levels	level	NOUN
ajlm-2286	192	27	:	:	PUNCT
ajlm-2286	192	28	a	a	DET
ajlm-2286	192	29	marker	marker	NOUN
ajlm-2286	192	30	of	of	ADP
ajlm-2286	192	31	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	192	32	in	in	ADP
ajlm-2286	192	33	patients	patient	NOUN
ajlm-2286	192	34	with	with	ADP
ajlm-2286	192	35	normal	normal	ADJ
ajlm-2286	192	36	cholesterol	cholesterol	NOUN
ajlm-2286	192	37	levels	level	NOUN
ajlm-2286	192	38	.	.	PUNCT
ajlm-2286	193	1	clin	clin	PROPN
ajlm-2286	193	2	chim	chim	PROPN
ajlm-2286	193	3	acta	acta	PROPN
ajlm-2286	193	4	.	.	PUNCT
ajlm-2286	194	1	2015	2015	NUM
ajlm-2286	194	2	jan	jan	PROPN
ajlm-2286	194	3	1;438:370–375	1;438:370–375	NUM
ajlm-2286	194	4	.	.	PUNCT
ajlm-2286	195	1	https://doi.org/10.1016/j.cca.2014.09.020	https://doi.org/10.1016/j.cca.2014.09.020	PROPN
ajlm-2286	195	2	shokri	shokri	PROPN
ajlm-2286	195	3	y	y	PROPN
ajlm-2286	195	4	,	,	PUNCT
ajlm-2286	195	5	variji	variji	VERB
ajlm-2286	195	6	a	a	PRON
ajlm-2286	195	7	,	,	PUNCT
ajlm-2286	195	8	nosrati	nosrati	NOUN
ajlm-2286	195	9	m	m	PROPN
ajlm-2286	195	10	,	,	PUNCT
ajlm-2286	195	11	et	et	PROPN
ajlm-2286	195	12	al	al	PROPN
ajlm-2286	195	13	.	.	PUNCT
ajlm-2286	196	1	importance	importance	NOUN
ajlm-2286	196	2	of	of	ADP
ajlm-2286	196	3	paraoxonase	paraoxonase	NOUN
ajlm-2286	196	4	1	1	NUM
ajlm-2286	196	5	(	(	PUNCT
ajlm-2286	196	6	pon1	pon1	PROPN
ajlm-2286	196	7	)	)	PUNCT
ajlm-2286	196	8	as	as	ADP
ajlm-2286	196	9	an	an	DET
ajlm-2286	196	10	antioxidant	antioxidant	ADJ
ajlm-2286	196	11	and	and	CCONJ
ajlm-2286	196	12	antiatherogenic	antiatherogenic	ADJ
ajlm-2286	196	13	enzyme	enzyme	NOUN
ajlm-2286	196	14	in	in	ADP
ajlm-2286	196	15	the	the	DET
ajlm-2286	196	16	cardiovascular	cardiovascular	ADJ
ajlm-2286	196	17	complications	complication	NOUN
ajlm-2286	196	18	of	of	ADP
ajlm-2286	196	19	type	type	NOUN
ajlm-2286	196	20	2	2	NUM
ajlm-2286	196	21	diabetes	diabetes	NOUN
ajlm-2286	196	22	:	:	PUNCT
ajlm-2286	196	23	genotypic	genotypic	NOUN
ajlm-2286	196	24	and	and	CCONJ
ajlm-2286	196	25	phenotypic	phenotypic	ADJ
ajlm-2286	196	26	evaluation	evaluation	NOUN
ajlm-2286	196	27	.	.	PUNCT
ajlm-2286	197	1	diabetes	diabetes	NOUN
ajlm-2286	197	2	res	re	VERB
ajlm-2286	197	3	clin	clin	PROPN
ajlm-2286	197	4	pract	pract	PROPN
ajlm-2286	197	5	.	.	PUNCT
ajlm-2286	198	1	2020	2020	NUM
ajlm-2286	198	2	mar;161:108067	mar;161:108067	NOUN
ajlm-2286	198	3	.	.	PUNCT
ajlm-2286	199	1	https://doi.org/10.1016/j.diabres.2020.108067	https://doi.org/10.1016/j.diabres.2020.108067	PROPN
ajlm-2286	199	2	cervellati	cervellati	PROPN
ajlm-2286	199	3	c	c	PROPN
ajlm-2286	199	4	,	,	PUNCT
ajlm-2286	199	5	valacchi	valacchi	NOUN
ajlm-2286	199	6	g	g	NOUN
ajlm-2286	199	7	,	,	PUNCT
ajlm-2286	199	8	tisato	tisato	NOUN
ajlm-2286	199	9	v	v	NOUN
ajlm-2286	199	10	,	,	PUNCT
ajlm-2286	199	11	zuliani	zuliani	PROPN
ajlm-2286	199	12	g	g	NOUN
ajlm-2286	199	13	,	,	PUNCT
ajlm-2286	199	14	marsillach	marsillach	NOUN
ajlm-2286	199	15	j.	j.	PROPN
ajlm-2286	199	16	evaluating	evaluate	VERB
ajlm-2286	199	17	the	the	DET
ajlm-2286	199	18	link	link	NOUN
ajlm-2286	199	19	between	between	ADP
ajlm-2286	199	20	paraoxonase-1	paraoxonase-1	PROPN
ajlm-2286	199	21	levels	level	NOUN
ajlm-2286	199	22	and	and	CCONJ
ajlm-2286	199	23	alzheimer	alzheimer	PROPN
ajlm-2286	199	24	’s	’s	PART
ajlm-2286	199	25	disease	disease	NOUN
ajlm-2286	199	26	development	development	NOUN
ajlm-2286	199	27	.	.	PUNCT
ajlm-2286	200	1	minerva	minerva	PROPN
ajlm-2286	200	2	med	med	PROPN
ajlm-2286	200	3	.	.	PROPN
ajlm-2286	201	1	2019	2019	NUM
ajlm-2286	201	2	jun;110(3):238–250	jun;110(3):238–250	PROPN
ajlm-2286	201	3	.	.	PUNCT
ajlm-2286	202	1	https://doi.org/10.23736/s0026-4806.18.05875-5	https://doi.org/10.23736/s0026-4806.18.05875-5	PROPN
ajlm-2286	202	2	pavanello	pavanello	PROPN
ajlm-2286	202	3	c	c	PROPN
ajlm-2286	202	4	,	,	PUNCT
ajlm-2286	202	5	ossoli	ossoli	PROPN
ajlm-2286	202	6	a	a	PRON
ajlm-2286	202	7	,	,	PUNCT
ajlm-2286	202	8	arca	arca	PROPN
ajlm-2286	202	9	m	m	PROPN
ajlm-2286	202	10	,	,	PUNCT
ajlm-2286	202	11	et	et	PROPN
ajlm-2286	202	12	al	al	PROPN
ajlm-2286	202	13	.	.	PUNCT
ajlm-2286	202	14	progression	progression	NOUN
ajlm-2286	202	15	of	of	ADP
ajlm-2286	202	16	chronic	chronic	ADJ
ajlm-2286	202	17	kidney	kidney	NOUN
ajlm-2286	202	18	disease	disease	NOUN
ajlm-2286	202	19	in	in	ADP
ajlm-2286	202	20	familial	familial	ADJ
ajlm-2286	202	21	lcat	lcat	ADJ
ajlm-2286	202	22	deficiency	deficiency	NOUN
ajlm-2286	202	23	:	:	PUNCT
ajlm-2286	202	24	a	a	DET
ajlm-2286	202	25	follow	follow	NOUN
ajlm-2286	202	26	-	-	PUNCT
ajlm-2286	202	27	up	up	NOUN
ajlm-2286	202	28	of	of	ADP
ajlm-2286	202	29	the	the	DET
ajlm-2286	202	30	italian	italian	ADJ
ajlm-2286	202	31	cohort	cohort	NOUN
ajlm-2286	202	32	.	.	PUNCT
ajlm-2286	203	1	j	j	PROPN
ajlm-2286	203	2	lipid	lipid	PROPN
ajlm-2286	203	3	res	re	NOUN
ajlm-2286	203	4	.	.	PUNCT
ajlm-2286	204	1	2020	2020	NUM
ajlm-2286	204	2	dec;61(12):1784–1788	dec;61(12):1784–1788	NOUN
ajlm-2286	204	3	.	.	PUNCT
ajlm-2286	205	1	https://doi.org/10.1194/jlr.p120000976	https://doi.org/10.1194/jlr.p120000976	NOUN
ajlm-2286	205	2	ebesunun	ebesunun	PROPN
ajlm-2286	205	3	mo	mo	PROPN
ajlm-2286	205	4	,	,	PUNCT
ajlm-2286	205	5	agbedana	agbedana	NOUN
ajlm-2286	205	6	eo	eo	PROPN
ajlm-2286	205	7	,	,	PUNCT
ajlm-2286	205	8	taylor	taylor	PROPN
ajlm-2286	205	9	go	go	VERB
ajlm-2286	205	10	,	,	PUNCT
ajlm-2286	205	11	oladapo	oladapo	ADV
ajlm-2286	205	12	oo	oo	INTJ
ajlm-2286	205	13	.	.	PUNCT
ajlm-2286	206	1	variations	variation	NOUN
ajlm-2286	206	2	in	in	ADP
ajlm-2286	206	3	plasma	plasma	NOUN
ajlm-2286	206	4	lipids	lipid	NOUN
ajlm-2286	206	5	and	and	CCONJ
ajlm-2286	206	6	lipoproteins	lipoprotein	NOUN
ajlm-2286	206	7	among	among	ADP
ajlm-2286	206	8	cardiovascular	cardiovascular	ADJ
ajlm-2286	206	9	disease	disease	NOUN
ajlm-2286	206	10	patients	patient	NOUN
ajlm-2286	206	11	in	in	ADP
ajlm-2286	206	12	southwestern	southwestern	ADJ
ajlm-2286	206	13	nigerians	nigerians	PROPN
ajlm-2286	206	14	.	.	PUNCT
ajlm-2286	207	1	biokemistri	biokemistri	ADJ
ajlm-2286	207	2	.	.	PUNCT
ajlm-2286	208	1	2013;25(2):45–51	2013;25(2):45–51	X
ajlm-2286	208	2	.	.	PUNCT
ajlm-2286	209	1	ebesunun	ebesunun	PROPN
ajlm-2286	209	2	mo	mo	PROPN
ajlm-2286	209	3	,	,	PUNCT
ajlm-2286	209	4	agbedana	agbedana	PROPN
ajlm-2286	209	5	eo	eo	PROPN
ajlm-2286	209	6	,	,	PUNCT
ajlm-2286	209	7	taylor	taylor	PROPN
ajlm-2286	209	8	go	go	VERB
ajlm-2286	209	9	,	,	PUNCT
ajlm-2286	209	10	oladapo	oladapo	ADV
ajlm-2286	209	11	oo	oo	INTJ
ajlm-2286	209	12	.	.	PUNCT
ajlm-2286	210	1	plasma	plasma	NOUN
ajlm-2286	210	2	lipoprotein	lipoprotein	ADJ
ajlm-2286	210	3	(	(	PUNCT
ajlm-2286	210	4	a	a	NOUN
ajlm-2286	210	5	)	)	PUNCT
ajlm-2286	210	6	,	,	PUNCT
ajlm-2286	210	7	homocysteine	homocysteine	NOUN
ajlm-2286	210	8	,	,	PUNCT
ajlm-2286	210	9	and	and	CCONJ
ajlm-2286	210	10	other	other	ADJ
ajlm-2286	210	11	cardiovascular	cardiovascular	ADJ
ajlm-2286	210	12	disease	disease	NOUN
ajlm-2286	210	13	(	(	PUNCT
ajlm-2286	210	14	cvd	cvd	NOUN
ajlm-2286	210	15	)	)	PUNCT
ajlm-2286	210	16	risk	risk	NOUN
ajlm-2286	210	17	factors	factor	NOUN
ajlm-2286	210	18	in	in	ADP
ajlm-2286	210	19	nigerians	nigerians	PROPN
ajlm-2286	210	20	with	with	ADP
ajlm-2286	210	21	cvd	cvd	PROPN
ajlm-2286	210	22	.	.	PUNCT
ajlm-2286	211	1	appl	appl	PROPN
ajlm-2286	211	2	physiol	physiol	PROPN
ajlm-2286	211	3	nutr	nutr	PROPN
ajlm-2286	211	4	metab	metab	PROPN
ajlm-2286	211	5	.	.	PUNCT
ajlm-2286	212	1	2008;33(2):282–289	2008;33(2):282–289	NUM
ajlm-2286	212	2	.	.	NOUN
ajlm-2286	212	3	https://doi.org/10.1139/h07-186	https://doi.org/10.1139/h07-186	PROPN
ajlm-2286	212	4	allain	allain	PROPN
ajlm-2286	212	5	cc	cc	PROPN
ajlm-2286	212	6	,	,	PUNCT
ajlm-2286	212	7	poon	poon	NOUN
ajlm-2286	212	8	ls	ls	PROPN
ajlm-2286	212	9	,	,	PUNCT
ajlm-2286	212	10	chan	chan	PROPN
ajlm-2286	212	11	cs	cs	PROPN
ajlm-2286	212	12	,	,	PUNCT
ajlm-2286	212	13	richmond	richmond	PROPN
ajlm-2286	212	14	w	w	PROPN
ajlm-2286	212	15	,	,	PUNCT
ajlm-2286	212	16	fu	fu	ADJ
ajlm-2286	212	17	pc	pc	NOUN
ajlm-2286	212	18	.	.	PUNCT
ajlm-2286	213	1	enzymatic	enzymatic	ADJ
ajlm-2286	213	2	determination	determination	NOUN
ajlm-2286	213	3	of	of	ADP
ajlm-2286	213	4	total	total	ADJ
ajlm-2286	213	5	serum	serum	NOUN
ajlm-2286	213	6	cholesterol	cholesterol	PROPN
ajlm-2286	213	7	.	.	PUNCT
ajlm-2286	214	1	clin	clin	PROPN
ajlm-2286	214	2	chem	chem	NOUN
ajlm-2286	214	3	.	.	PUNCT
ajlm-2286	215	1	1974;20(4):470–475	1974;20(4):470–475	NUM
ajlm-2286	215	2	.	.	PUNCT
ajlm-2286	216	1	https://doi.org/10.1093/clinchem/20.4.470	https://doi.org/10.1093/clinchem/20.4.470	NUM
ajlm-2286	216	2	bucolo	bucolo	PROPN
ajlm-2286	216	3	g	g	PROPN
ajlm-2286	216	4	,	,	PUNCT
ajlm-2286	216	5	david	david	PROPN
ajlm-2286	216	6	h.	h.	PROPN
ajlm-2286	216	7	quantitative	quantitative	ADJ
ajlm-2286	216	8	determination	determination	NOUN
ajlm-2286	216	9	of	of	ADP
ajlm-2286	216	10	serum	serum	NOUN
ajlm-2286	216	11	triglycerides	triglyceride	NOUN
ajlm-2286	216	12	by	by	ADP
ajlm-2286	216	13	the	the	DET
ajlm-2286	216	14	use	use	NOUN
ajlm-2286	216	15	of	of	ADP
ajlm-2286	216	16	enzymes	enzyme	NOUN
ajlm-2286	216	17	.	.	PUNCT
ajlm-2286	217	1	clin	clin	PROPN
ajlm-2286	217	2	chem	chem	PROPN
ajlm-2286	217	3	.	.	PUNCT
ajlm-2286	218	1	1973;19(5):476–482	1973;19(5):476–482	NUM
ajlm-2286	218	2	.	.	PUNCT
ajlm-2286	218	3	https://doi.org/10.1093/clinchem/19.5.476	https://doi.org/10.1093/clinchem/19.5.476	NUM
ajlm-2286	218	4	friedewald	friedewald	ADJ
ajlm-2286	218	5	wt	wt	NOUN
ajlm-2286	218	6	,	,	PUNCT
ajlm-2286	218	7	levy	levy	NOUN
ajlm-2286	218	8	ri	ri	PROPN
ajlm-2286	218	9	,	,	PUNCT
ajlm-2286	218	10	fredrickson	fredrickson	PROPN
ajlm-2286	218	11	ds	ds	PROPN
ajlm-2286	218	12	.	.	PROPN
ajlm-2286	218	13	estimation	estimation	NOUN
ajlm-2286	218	14	of	of	ADP
ajlm-2286	218	15	the	the	DET
ajlm-2286	218	16	concentration	concentration	NOUN
ajlm-2286	218	17	of	of	ADP
ajlm-2286	218	18	low	low	ADJ
ajlm-2286	218	19	-	-	PUNCT
ajlm-2286	218	20	density	density	NOUN
ajlm-2286	218	21	lipoprotein	lipoprotein	ADJ
ajlm-2286	218	22	cholesterol	cholesterol	NOUN
ajlm-2286	218	23	in	in	ADP
ajlm-2286	218	24	plasma	plasma	NOUN
ajlm-2286	218	25	,	,	PUNCT
ajlm-2286	218	26	without	without	ADP
ajlm-2286	218	27	the	the	DET
ajlm-2286	218	28	use	use	NOUN
ajlm-2286	218	29	of	of	ADP
ajlm-2286	218	30	the	the	DET
ajlm-2286	218	31	preparative	preparative	ADJ
ajlm-2286	218	32	ultracentrifuge	ultracentrifuge	NOUN
ajlm-2286	218	33	.	.	PUNCT
ajlm-2286	219	1	clin	clin	PROPN
ajlm-2286	219	2	chem	chem	PROPN
ajlm-2286	219	3	.	.	PUNCT
ajlm-2286	220	1	1972;18:499–502	1972;18:499–502	PROPN
ajlm-2286	220	2	.	.	PUNCT
ajlm-2286	221	1	https://doi.org/10.1093/clinchem/18.6.499	https://doi.org/10.1093/clinchem/18.6.499	PROPN
ajlm-2286	221	2	sun	sun	PROPN
ajlm-2286	221	3	cj	cj	PROPN
ajlm-2286	221	4	,	,	PUNCT
ajlm-2286	221	5	mccudden	mccudden	ADJ
ajlm-2286	221	6	c	c	NOUN
ajlm-2286	221	7	,	,	PUNCT
ajlm-2286	221	8	brisson	brisson	NOUN
ajlm-2286	221	9	d	d	PROPN
ajlm-2286	221	10	,	,	PUNCT
ajlm-2286	221	11	shaw	shaw	PROPN
ajlm-2286	221	12	j	j	PROPN
ajlm-2286	221	13	,	,	PUNCT
ajlm-2286	221	14	gaudet	gaudet	PROPN
ajlm-2286	221	15	d	d	PROPN
ajlm-2286	221	16	,	,	PUNCT
ajlm-2286	221	17	ooi	ooi	PROPN
ajlm-2286	221	18	tc	tc	PROPN
ajlm-2286	221	19	.	.	PROPN
ajlm-2286	221	20	calculated	calculate	VERB
ajlm-2286	221	21	non	non	ADJ
ajlm-2286	221	22	-	-	ADJ
ajlm-2286	221	23	hdl	hdl	ADJ
ajlm-2286	221	24	cholesterol	cholesterol	NOUN
ajlm-2286	221	25	includes	include	VERB
ajlm-2286	221	26	cholesterol	cholesterol	NOUN
ajlm-2286	221	27	in	in	ADP
ajlm-2286	221	28	larger	large	ADJ
ajlm-2286	221	29	triglyceride	triglyceride	ADJ
ajlm-2286	221	30	-	-	PUNCT
ajlm-2286	221	31	rich	rich	ADJ
ajlm-2286	221	32	lipoproteins	lipoprotein	NOUN
ajlm-2286	221	33	in	in	ADP
ajlm-2286	221	34	hypertriglyceridemia	hypertriglyceridemia	NOUN
ajlm-2286	221	35	.	.	PUNCT
ajlm-2286	222	1	j	j	PROPN
ajlm-2286	222	2	endocr	endocr	PROPN
ajlm-2286	222	3	soc	soc	PROPN
ajlm-2286	222	4	.	.	PUNCT
ajlm-2286	223	1	2019	2019	NUM
ajlm-2286	223	2	nov	nov	PROPN
ajlm-2286	223	3	3;4(1):bvz010	3;4(1):bvz010	PROPN
ajlm-2286	223	4	.	.	PUNCT
ajlm-2286	224	1	https://doi.org/10.1210/jendso/bvz010	https://doi.org/10.1210/jendso/bvz010	PROPN
ajlm-2286	224	2	engvall	engvall	PROPN
ajlm-2286	224	3	e	e	PROPN
ajlm-2286	224	4	,	,	PUNCT
ajlm-2286	224	5	perlmann	perlmann	NOUN
ajlm-2286	224	6	p.	p.	NOUN
ajlm-2286	224	7	enzyme	enzyme	NOUN
ajlm-2286	224	8	-	-	PUNCT
ajlm-2286	224	9	linked	link	VERB
ajlm-2286	224	10	immunosorbent	immunosorbent	NOUN
ajlm-2286	224	11	assay	assay	PROPN
ajlm-2286	224	12	(	(	PUNCT
ajlm-2286	224	13	elisa	elisa	NOUN
ajlm-2286	224	14	)	)	PUNCT
ajlm-2286	224	15	.	.	PUNCT
ajlm-2286	225	1	quantitative	quantitative	ADJ
ajlm-2286	225	2	assay	assay	PROPN
ajlm-2286	225	3	of	of	ADP
ajlm-2286	225	4	immunoglobulin	immunoglobulin	PROPN
ajlm-2286	225	5	g.	g.	PROPN
ajlm-2286	225	6	immunochemistry	immunochemistry	PROPN
ajlm-2286	225	7	.	.	PUNCT
ajlm-2286	226	1	1971	1971	NUM
ajlm-2286	226	2	sep;8(9):871–874	sep;8(9):871–874	PROPN
ajlm-2286	226	3	.	.	PUNCT
ajlm-2286	227	1	https://doi.org/10.1016/0019-2791(71)90454-x	https://doi.org/10.1016/0019-2791(71)90454-x	ADP
ajlm-2286	227	2	flint	flint	PROPN
ajlm-2286	227	3	a	a	PRON
ajlm-2286	227	4	,	,	PUNCT
ajlm-2286	227	5	conell	conell	PROPN
ajlm-2286	227	6	c	c	X
ajlm-2286	227	7	,	,	PUNCT
ajlm-2286	227	8	ren	ren	ADJ
ajlm-2286	227	9	x.	x.	NOUN
ajlm-2286	227	10	effect	effect	NOUN
ajlm-2286	227	11	of	of	ADP
ajlm-2286	227	12	systolic	systolic	ADJ
ajlm-2286	227	13	and	and	CCONJ
ajlm-2286	227	14	diastolic	diastolic	ADJ
ajlm-2286	227	15	blood	blood	NOUN
ajlm-2286	227	16	pressure	pressure	NOUN
ajlm-2286	227	17	on	on	ADP
ajlm-2286	227	18	cardiovascular	cardiovascular	ADJ
ajlm-2286	227	19	outcome	outcome	NOUN
ajlm-2286	227	20	.	.	PUNCT
ajlm-2286	228	1	n	n	PROPN
ajlm-2286	228	2	engl	engl	PROPN
ajlm-2286	228	3	j	j	PROPN
ajlm-2286	228	4	med	med	PROPN
ajlm-2286	228	5	.	.	PUNCT
ajlm-2286	229	1	2019;381:243	2019;381:243	NUM
ajlm-2286	229	2	.	.	PUNCT
ajlm-2286	230	1	https://doi.org/10.1056/nejmoa1803180	https://doi.org/10.1056/nejmoa1803180	PROPN
ajlm-2286	230	2	jayawardena	jayawardena	PROPN
ajlm-2286	230	3	r	r	PROPN
ajlm-2286	230	4	,	,	PUNCT
ajlm-2286	230	5	ranasinghe	ranasinghe	VERB
ajlm-2286	230	6	p	p	X
ajlm-2286	230	7	,	,	PUNCT
ajlm-2286	230	8	ranathunga	ranathunga	PROPN
ajlm-2286	230	9	t	t	PROPN
ajlm-2286	230	10	,	,	PUNCT
ajlm-2286	230	11	mathangasinghe	mathangasinghe	VERB
ajlm-2286	230	12	y	y	PROPN
ajlm-2286	230	13	,	,	PUNCT
ajlm-2286	230	14	wasalathanththri	wasalathanththri	PROPN
ajlm-2286	230	15	s	s	PROPN
ajlm-2286	230	16	,	,	PUNCT
ajlm-2286	230	17	hills	hills	PROPN
ajlm-2286	230	18	ap	ap	PROPN
ajlm-2286	230	19	.	.	PUNCT
ajlm-2286	231	1	novel	novel	ADJ
ajlm-2286	231	2	anthropometric	anthropometric	ADJ
ajlm-2286	231	3	parameters	parameter	NOUN
ajlm-2286	231	4	to	to	PART
ajlm-2286	231	5	define	define	VERB
ajlm-2286	231	6	obesity	obesity	NOUN
ajlm-2286	231	7	and	and	CCONJ
ajlm-2286	231	8	obesity	obesity	NOUN
ajlm-2286	231	9	-	-	PUNCT
ajlm-2286	231	10	related	relate	VERB
ajlm-2286	231	11	disease	disease	NOUN
ajlm-2286	231	12	in	in	ADP
ajlm-2286	231	13	adults	adult	NOUN
ajlm-2286	231	14	:	:	PUNCT
ajlm-2286	231	15	a	a	DET
ajlm-2286	231	16	systematic	systematic	ADJ
ajlm-2286	231	17	review	review	NOUN
ajlm-2286	231	18	.	.	PUNCT
ajlm-2286	232	1	nutr	nutr	PROPN
ajlm-2286	232	2	rev	rev	PROPN
ajlm-2286	232	3	.	.	PROPN
ajlm-2286	232	4	2020;78(6):498–513	2020;78(6):498–513	NUM
ajlm-2286	232	5	.	.	PUNCT
ajlm-2286	233	1	https://doi.org/10.1093/nutrit/nuz078	https://doi.org/10.1093/nutrit/nuz078	PROPN
ajlm-2286	233	2	hedayatnia	hedayatnia	PROPN
ajlm-2286	233	3	m	m	PROPN
ajlm-2286	233	4	,	,	PUNCT
ajlm-2286	233	5	asadi	asadi	PROPN
ajlm-2286	233	6	z	z	PROPN
ajlm-2286	233	7	,	,	PUNCT
ajlm-2286	233	8	zare	zare	NOUN
ajlm-2286	233	9	-	-	PUNCT
ajlm-2286	233	10	feyzabadi	feyzabadi	NOUN
ajlm-2286	233	11	r	r	NOUN
ajlm-2286	233	12	,	,	PUNCT
ajlm-2286	233	13	et	et	PROPN
ajlm-2286	233	14	al	al	PROPN
ajlm-2286	233	15	.	.	PROPN
ajlm-2286	233	16	dyslipidemia	dyslipidemia	NOUN
ajlm-2286	233	17	and	and	CCONJ
ajlm-2286	233	18	cardiovascular	cardiovascular	ADJ
ajlm-2286	233	19	disease	disease	NOUN
ajlm-2286	233	20	risk	risk	NOUN
ajlm-2286	233	21	among	among	ADP
ajlm-2286	233	22	the	the	DET
ajlm-2286	233	23	mashad	mashad	ADJ
ajlm-2286	233	24	study	study	NOUN
ajlm-2286	233	25	population	population	NOUN
ajlm-2286	233	26	.	.	PUNCT
ajlm-2286	234	1	lipids	lipids	ADP
ajlm-2286	234	2	health	health	NOUN
ajlm-2286	234	3	dis	dis	PROPN
ajlm-2286	234	4	.	.	PUNCT
ajlm-2286	235	1	2020;19(1):42	2020;19(1):42	X
ajlm-2286	235	2	.	.	PUNCT
ajlm-2286	236	1	https://doi.org/10.1186/s12944-020-01204-y	https://doi.org/10.1186/s12944-020-01204-y	PROPN
ajlm-2286	236	2	katarzyna	katarzyna	PROPN
ajlm-2286	236	3	k	k	PROPN
ajlm-2286	236	4	,	,	PUNCT
ajlm-2286	236	5	ewelina	ewelina	PROPN
ajlm-2286	236	6	s	s	PART
ajlm-2286	236	7	,	,	PUNCT
ajlm-2286	236	8	halina	halina	PROPN
ajlm-2286	236	9	m.	m.	VERB
ajlm-2286	236	10	the	the	DET
ajlm-2286	236	11	role	role	NOUN
ajlm-2286	236	12	of	of	ADP
ajlm-2286	236	13	paraoxonase	paraoxonase	NOUN
ajlm-2286	236	14	in	in	ADP
ajlm-2286	236	15	cardiovascular	cardiovascular	ADJ
ajlm-2286	236	16	diseases	disease	NOUN
ajlm-2286	236	17	.	.	PUNCT
ajlm-2286	237	1	ann	ann	PROPN
ajlm-2286	237	2	clin	clin	PROPN
ajlm-2286	237	3	lab	lab	PROPN
ajlm-2286	237	4	sci	sci	PROPN
ajlm-2286	237	5	.	.	PROPN
ajlm-2286	237	6	2015;45:226–233	2015;45:226–233	PROPN
ajlm-2286	237	7	.	.	PUNCT
ajlm-2286	238	1	holleboom	holleboom	VERB
ajlm-2286	238	2	a	a	DET
ajlm-2286	238	3	,	,	PUNCT
ajlm-2286	238	4	kuivenhoven	kuivenhoven	PROPN
ajlm-2286	238	5	j	j	PROPN
ajlm-2286	238	6	,	,	PUNCT
ajlm-2286	238	7	vergeer	vergeer	NOUN
ajlm-2286	238	8	m	m	PROPN
ajlm-2286	238	9	,	,	PUNCT
ajlm-2286	238	10	et	et	PROPN
ajlm-2286	238	11	al	al	PROPN
ajlm-2286	238	12	.	.	PUNCT
ajlm-2286	238	13	plasma	plasma	NOUN
ajlm-2286	238	14	levels	level	NOUN
ajlm-2286	238	15	of	of	ADP
ajlm-2286	238	16	lcat	lcat	NOUN
ajlm-2286	238	17	and	and	CCONJ
ajlm-2286	238	18	risk	risk	NOUN
ajlm-2286	238	19	of	of	ADP
ajlm-2286	238	20	future	future	ADJ
ajlm-2286	238	21	coronary	coronary	ADJ
ajlm-2286	238	22	artery	artery	NOUN
ajlm-2286	238	23	diseases	disease	NOUN
ajlm-2286	238	24	in	in	ADP
ajlm-2286	238	25	apparently	apparently	ADV
ajlm-2286	238	26	healthy	healthy	ADJ
ajlm-2286	238	27	men	man	NOUN
ajlm-2286	238	28	and	and	CCONJ
ajlm-2286	238	29	women	woman	NOUN
ajlm-2286	238	30	;	;	PUNCT
ajlm-2286	238	31	a	a	DET
ajlm-2286	238	32	prospective	prospective	ADJ
ajlm-2286	238	33	case	case	NOUN
ajlm-2286	238	34	-	-	PUNCT
ajlm-2286	238	35	control	control	NOUN
ajlm-2286	238	36	analysis	analysis	NOUN
ajlm-2286	238	37	nested	nest	VERB
ajlm-2286	238	38	in	in	ADP
ajlm-2286	238	39	the	the	DET
ajlm-2286	238	40	epic	epic	ADJ
ajlm-2286	238	41	-	-	PUNCT
ajlm-2286	238	42	norfolk	norfolk	PROPN
ajlm-2286	238	43	population	population	NOUN
ajlm-2286	238	44	study	study	NOUN
ajlm-2286	238	45	.	.	PUNCT
ajlm-2286	239	1	j	j	PROPN
ajlm-2286	239	2	lipid	lipid	PROPN
ajlm-2286	239	3	res	re	NOUN
ajlm-2286	239	4	.	.	PUNCT
ajlm-2286	240	1	2010;51:416–421	2010;51:416–421	NUM
ajlm-2286	240	2	.	.	PUNCT
ajlm-2286	241	1	https://doi.org/10.1194/p900038-jlr200	https://doi.org/10.1194/p900038-jlr200	NOUN
ajlm-2286	241	2	dullaart	dullaart	NOUN
ajlm-2286	241	3	rp	rp	NOUN
ajlm-2286	241	4	,	,	PUNCT
ajlm-2286	241	5	tietge	tietge	VERB
ajlm-2286	241	6	uj	uj	PROPN
ajlm-2286	241	7	,	,	PUNCT
ajlm-2286	241	8	kwakernaak	kwakernaak	PROPN
ajlm-2286	241	9	aj	aj	PROPN
ajlm-2286	241	10	,	,	PUNCT
ajlm-2286	241	11	dikkeschei	dikkeschei	PROPN
ajlm-2286	241	12	bd	bd	PROPN
ajlm-2286	241	13	,	,	PUNCT
ajlm-2286	241	14	perton	perton	PROPN
ajlm-2286	241	15	f	f	AUX
ajlm-2286	241	16	,	,	PUNCT
ajlm-2286	241	17	tio	tio	PROPN
ajlm-2286	241	18	ra	ra	PROPN
ajlm-2286	241	19	.	.	PUNCT
ajlm-2286	242	1	alterations	alteration	NOUN
ajlm-2286	242	2	in	in	ADP
ajlm-2286	242	3	plasma	plasma	NOUN
ajlm-2286	242	4	lecithin	lecithin	NOUN
ajlm-2286	242	5	:	:	PUNCT
ajlm-2286	242	6	cholesterol	cholesterol	NOUN
ajlm-2286	242	7	acyltransferase	acyltransferase	PROPN
ajlm-2286	242	8	and	and	CCONJ
ajlm-2286	242	9	myeloperoxidase	myeloperoxidase	VERB
ajlm-2286	242	10	in	in	ADP
ajlm-2286	242	11	acute	acute	ADJ
ajlm-2286	242	12	myocardial	myocardial	ADJ
ajlm-2286	242	13	infarction	infarction	NOUN
ajlm-2286	242	14	:	:	PUNCT
ajlm-2286	242	15	implications	implication	NOUN
ajlm-2286	242	16	for	for	ADP
ajlm-2286	242	17	the	the	DET
ajlm-2286	242	18	cardiac	cardiac	ADJ
ajlm-2286	242	19	outcome	outcome	NOUN
ajlm-2286	242	20	.	.	PUNCT
ajlm-2286	243	1	atherosclerosis	atherosclerosis	NOUN
ajlm-2286	243	2	.	.	PUNCT
ajlm-2286	244	1	2014;234(1):185–192	2014;234(1):185–192	X
ajlm-2286	244	2	.	.	PUNCT
ajlm-2286	244	3	https://doi.org/10.1016/j.atherosclerosis.2014.02.026	https://doi.org/10.1016/j.atherosclerosis.2014.02.026	AUX
ajlm-2286	244	4	sethia	sethia	VERB
ajlm-2286	244	5	a	a	PRON
ajlm-2286	244	6	,	,	PUNCT
ajlm-2286	244	7	sampson	sampson	PROPN
ajlm-2286	244	8	m	m	PROPN
ajlm-2286	244	9	,	,	PUNCT
ajlm-2286	244	10	warnick	warnick	PROPN
ajlm-2286	244	11	r	r	NOUN
ajlm-2286	244	12	,	,	PUNCT
ajlm-2286	244	13	et	et	PROPN
ajlm-2286	244	14	al	al	PROPN
ajlm-2286	244	15	.	.	PROPN
ajlm-2286	245	1	high	high	ADJ
ajlm-2286	245	2	pre	pre	ADJ
ajlm-2286	245	3	-	-	ADJ
ajlm-2286	245	4	beta1	beta1	ADJ
ajlm-2286	245	5	hdl	hdl	NOUN
ajlm-2286	245	6	concentrations	concentration	NOUN
ajlm-2286	245	7	and	and	CCONJ
ajlm-2286	245	8	low	low	ADJ
ajlm-2286	245	9	lcat	lcat	ADJ
ajlm-2286	245	10	transferase	transferase	NOUN
ajlm-2286	245	11	activities	activity	NOUN
ajlm-2286	245	12	are	be	AUX
ajlm-2286	245	13	strong	strong	ADJ
ajlm-2286	245	14	positive	positive	ADJ
ajlm-2286	245	15	risk	risk	NOUN
ajlm-2286	245	16	markers	marker	NOUN
ajlm-2286	245	17	for	for	ADP
ajlm-2286	245	18	ischemic	ischemic	ADJ
ajlm-2286	245	19	heart	heart	NOUN
ajlm-2286	245	20	disease	disease	NOUN
ajlm-2286	245	21	and	and	CCONJ
ajlm-2286	245	22	independent	independent	ADJ
ajlm-2286	245	23	of	of	ADP
ajlm-2286	245	24	hdl	hdl	PROPN
ajlm-2286	245	25	-	-	PUNCT
ajlm-2286	245	26	cholesterol	cholesterol	NOUN
ajlm-2286	245	27	.	.	PUNCT
ajlm-2286	246	1	clinchem	clinchem	PROPN
ajlm-2286	246	2	.	.	PUNCT
ajlm-2286	247	1	2010;56:1128–1137	2010;56:1128–1137	NUM
ajlm-2286	247	2	.	.	PUNCT
ajlm-2286	248	1	https://doi.org/10.1373/clinchem.2009.139931	https://doi.org/10.1373/clinchem.2009.139931	PROPN